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ZUSAMMENFASSUNG 
 
Das menschliche Genom unterliegt während der Zellteilung zwei wichtigen 
Prozessen um seine Integrität zu erhalten. Während der DNA Replikation wird das 
Genom zunächst vollständig dupliziert. Die duplizierte DNA wird dann verdichtet 
und während der Mitose gleichmäßig in beide Tochterzellen verteilt. Dies entspricht 
dem zweiten wesentlichen Prozess des Zellzyklus. Die korrekte Segregation der 
Schwesterchromatiden wird vorwiegend von Kinetochor-Komplexen reguliert, die 
sich während der Mitose an den Zentromeren ausbilden. Jedes menschliche 
Chromosom enthält ein Zentromer an einer definierten Position. Dabei ist die 
zugrunde liegende DNA Sequenz für die Festlegung der Zentromer-Identität nicht 
maßgeblich. Vielmehr ist eine zentromer spezifische H3 Histonvariante, das 
zentromere Protein A (engl. Centromere protein A, kurz CENP-A), das Merkmal für 
die epigenetische Definition von Zentromeren. Durch künstliches, zielgerichtetes 
Binden von CENP-A an definierte DNA Sequenzen (engl. „CENP-A targeting“) wird 
eine vererbbare Zentromer-Identität ausgebildet, die sich dann eigenständig erhält. 
Unser Labor entwickelte ein Plasmidsystem, um die „de novo“ Zentromer Entstehung 
durch „CENP-A targeting“ in humanen Zellen zu untersuchen (pCONCENP-A). Diese 
Plasmide replizieren in Abhängigkeit eines Virusproteins, während zur Segregation 
„CENP-A targeting“ zu der Ausbildung von Zentromeren führt, wodurch die 
Plasmide bei der Zellteilung über mehrere Monate stabil erhalten bleiben. 
Durch Immunfluoreszenz Analysen von Zellen, die mit pCONCENP-A transfiziert 
wurden, konnte ich zum ersten Mal zeigen, dass die Ausbildung einer Zentromere-
Identität durch „CENP-A targeting“ zur Rekrutierung von Komponenten des 
inneren und äußeren Kinetochors zu den Plasmiden führt. Dadurch wird ein aktiver 
Segregationsmechanismus induziert, den ich mit Lebend-Zell Mikroskopie  
untersuchte. Weiterhin konnte ich mit Plasmid-Erhaltungsanalysen nachweisen, dass 
die Etablierung der vererbbaren Zentromere innerhalb von vier Tagen stattfindet. 
Innerhalb dieses Zeitraumes werden endogene, „targeting“-unabhängige CENP-A 
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Histone an das Plasmid-Zentromer rekrutiert. Die endogenen CENP-A Proteine 
wurden in den Immunfluoreszenz Untersuchungen durch RFP:CENP-A 
Fusionsproteine repräsentiert. Zusätzlich entwickelte ich ein CRISPR/Cas9-
abhängiges System um Plasmide mit etabliertem Zentromer aus den Zellen zu 
reinigen. Mit dieser Methode konnte ich erste epigenetische Histonmodifikationen, 
die die Vererbbarkeit der Zentromere zusätzlich beeinflussen, nachweisen. 
Zusammenfassend untersucht diese Arbeit die „de novo“ Etablierung von 
vererbbaren Zentromeren auf Plasmiden in humanen Zellen, die bereits innerhalb 
von vier Tagen erreicht und durch epigenetische Faktoren bestimmt wird. 
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ABSTRACT 
 
The human genome undergoes two major processes during the cell cycle to ensure 
genome integrity in daughter cell generation. First, the genome is duplicated in a 
reaction called DNA replication. Duplicated DNA is then compacted and equally 
distributed to both daughter cells during mitosis. This reflects the second important 
process during cell division. Major regulator of correct sister-chromatid segregation 
is the kinetochore complex which is assembled at centromeres. Each human 
chromosome contains one centromere at a specified position. The underlying DNA 
sequence at centromeres is not responsible for defining centromere identity. In fact, a 
centromere specific histone H3 variant, the centromere protein A (CENP-A), is the 
hallmark for defining centromeres epigenetically. Artificial targeting of CENP-A 
leads to the formation of an inheritable and self-propagating centromere identity. 
Our laboratory developed a plasmid system to investigate de novo centromere 
formation in human cells by targeting CENP-A, called pCONCENP-A. The replication 
of these plasmids is dependent on a viral protein, whereas segregation is mediated 
by the formation of artificial centromeres induced by CENP-A targeting. This leads 
to a stable maintenance of plasmids in human cells over several months. 
By immune fluorescence analysis of cells transfected with pCONCENP-A, I showed for 
the first time that establishment of centromere identity by CENP-A targeting leads to 
the recruitment of inner and outer kinetochore components. Thus, an active 
segregation mechanism of the plasmids was induced, that I investigated by live cell 
imaging microscopy. Furthermore, I demonstrated by plasmid maintenance analysis 
that establishment of inheritable centromere identity already occurs within four 
days. Endogenous, targeting-independent CENP-A proteins, represented by 
RFP:CENP-A fusion proteins, were recruited to plasmids within this timeframe, 
verified by immune fluorescence experiments. In addition, I developed a 
CRISPR/Cas9-dependent targeting system for plasmid purification. With this 
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method I revealed first epigenetic histone modifications, influencing the inheritable 
centromere identity.  
In summary, this work deals with the de novo generation of inheritable centromeres 
on plasmids in human cells, already established after four days and determined by 
epigenetic factors. 
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 INTRODUCTION 1
 
In the 1940s Conrad Waddington introduced the term epigenetics and defined it as 
“the branch of biology which studies the causal interactions between genes and their 
products which bring the phenotype into being.” (Waddington, 1968). Nowadays, 
the definition changed more into “the study of changes in gene function that are 
mitotically and/or meiotically heritable and that do not entail a change in DNA 
sequence” (Wu and Morris, 2001). According to more current literature, epigenetics 
includes covalent modifications of DNA bases, posttranslational modifications of 
histones, histone variants and the RNAi pathway (Dupont et al., 2009). Epigenetic 
modifications fulfil several important functions besides the specification of cells to 
mitotically inheritable phenotype. They play certain roles in silencing of transposable 
elements or telomeres, reducing recombination between repetitive elements and 
ensuring attachment of microtubules to centromeres (Dupont et al., 2009). 
Centromeres are specific regions on chromosomes mediating kinetochore binding 
and proper segregation of sister-chromatides during mitosis. Epigenetic marks, like 
the centromere specific histone variant CENP-A and histone post translational 
modifications define the centromere position on chromosomes (McKinley and 
Cheeseman, 2016).  
In the following, I will give an overview about chromatin structure, important 
histone modifications, kinetochore assembly during mitosis and approaches to 
investigate de novo centromere formation.  
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1.1 Chromatin and histone modifications 
 
To fit into the microscopic space of the nucleus, eukaryotic negatively-charged DNA 
has to be compacted. Therefore, positively-charged proteins, the histones, strongly 
bind the DNA and pack it into small packing units, the nucleosomes. This chromatin 
structure is known as a repeating unit of complexes, consisting of four main types of 
histones and around 200 base pairs, distributed over all DNA since 1974 (Kornberg, 
1974). Kornberg characterized these packing units as histone octamers. (Kornberg 
and Thomas, 1974) 
20 years later, in 1997, Luger et al. solved the crystal structure of the nucleosome core 
particle (Figure 1). (Luger et al., 1997) 
 
 
 
 
 
 
 
 
 
 
The nucleosome core particle consists of two of each histones H2A, H2B, H3 and H4 
and 146 bp DNA. Histones form an octamer composed of a two H2A/H2B dimers 
and one (H3)2(H4)2 tetramer and the DNA is wrapped around (Figure 1). Together 
with the linker Histone H1 and additional linker DNA, the nucleosomes build a 
Figure 1: Nucleosome core particle 
Ribbon traces for the 146-bp DNA phosphodiester backbones 
(brown and turquoise) and eight histone protein main chains 
(blue: H3; green: H4; yellow: H2A; red: H2B.)  
From Luger et al., Nature (1997)  (Luger et al., 1997) 
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bead-on-a-string structure that can be observed by electron microscopy (Olins and 
Olins, 1974). Amino-terminal histone tails stick out of the nucleosome core particle. 
These are prone to be modified and influence the chromatin structure. Different 
histone-modifying enzymes set modifications mainly at serine, lysine and arginine 
residues of the N-terminal tails. The best characterized modifications are acetylations 
and methylations of lysines on H3 and H4 (Dupont et al., 2009). For example, 
transcriptional activation is often characterized by acetylation of lysine residues on 
H3 and H4, like H3K9ac, H3K14ac, H4K5ac or H4K12ac. Hyperacetylation of 
histones leads the formation of euchromatin and DNA is easier accessible due to 
loosening of DNA packaging (Struhl, 1998). Histone methylation is either activating 
(H3K4, H3K36, H3K79) or repressive (H3K9, H3K27, H4K20), depending on the 
amino acid residue and the extend of methylation (mono-, di-, or trimethylation) 
(Sims et al., 2003). 
Not only histone modifications determine the chromatin structure. Also histone 
variants, having some sequence and structural differences from canonical histones, 
alter the chromatin organization. Histone variants are mainly known for H2A and 
H3 (Yuan and Zhu, 2012). For example H2A.Z, which is a highly conserved histone 
H2A variant, differs from canonical H2A in its “docking” domain (Yuan and Zhu, 
2012). H3 has, in mammals, three different ubiquitously expressed variants, H3.1, 
H3.2 and H3.3. H3.1 is only expressed and deposited during S-phase, whereas H3.3 
incorporation is replication-independent. Consequently, the H3.3 histone variant is 
suggested to mediate epigenetic inheritance (Yuan and Zhu, 2012). 
The most prominent H3 variant in mammals is the centromere specific H3 variant, 
centromere protein A (CENP-A). This H3 variant is conserved in nearly all 
eukaryotes, and the sequence of CENP-A differs significantly from the other histone 
H3 variants (Henikoff et al., 2004). CENP-A nucleosomes define the structure of 
centromeric chromatin and are important for regulating mitotic progression. 
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1.2 Mitosis 
 
The eukaryotic cell cycle is separated into four phases that are essential to ensure 
correct genome maintenance. First, cells duplicate their genetic information during S-
phase, a process called DNA replication. Within a gap time, G2, the cells prepare for 
cell division in mitosis. During mitosis replicated and compacted DNA is segregated 
and equally distributed to the two daughter cells. After exit from mitosis, a second 
gap time, G1, follows before the next replication cycle, or cells rest in G0 without 
further proliferation. 
Mitosis is separated into five phases: prophase, prometaphase, metaphase, anaphase, 
and telophase as depicted in Figure 2. Main steps are the breakdown of nuclear 
envelope and kinetochore assembly in prophase, alignment of sister-chromatids at 
the metaphase plate and the movement of the chromatids to opposite spindle poles 
during anaphase (Cheeseman and Desai, 2008). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Mitotic chromosome segregation 
Overview of chromosome–spindle interactions during mitosis.: Assembly of 
kinetochores on the centromere regions of chromosomes; nuclear envelope 
breakdown; interaction of kinetochores with spindle microtubules; alignment of 
chromosomes on the metaphase plate; movement of sister-chromatids move to 
opposite spindle poles; de-condensation and re-establishment of nuclear envelope 
Adopted from Cheeseman & Desai, Nature Reviews, Molecular Cell Biology (2008) 
(Cheeseman and Desai, 2008) 
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The movement to the poles only occurs if sister-chromatids are accurately aligned 
and each is connected correctly to spindle microtubules. Therefore, the propagation 
from metaphase to anaphase is tightly regulated by the spindle assembly checkpoint 
(SAC) (Foley and Kapoor, 2013). SAC is regulated by a huge protein complex that is 
assembled at the centromeres of chromosomes, called the kinetochore complex. The 
kinetochore provides an adaptor function between centromeric chromatin on the one 
hand and microtubules on the other hand. This complex fulfils three main functions. 
First, it is responsible to maintain cohesion between sister-chromatins at the SAC. 
Second, it binds microtubules for the correct alignment during metaphase. Third, it 
monitors microtubule attachment status and signals errors to arrest mitotic 
progression. 
The structure and composition of kinetochores is detailed in the following. 
 
1.3 The kinetochore 
 
In an electron micrograph of a vertebrate kinetochore (Figure 3 B), McEwen et al. 
revealed a kinetochore structure composed of three layers. The inner, electron dense 
region, is directly associated to the centromere, the outer, also electron dense region, 
is attached to microtubules. A lighter less electron dense layer separates both regions 
(McEwen et al., 2007). If kinetochores are not attached to microtubules, for example if 
drugs are present preventing microtubule polymerization, another fibrous structure, 
the fibrous corona, is established (Figure 3 A left). 
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Since the early 2000s kinetochores are examined intensely by mass-spectrometry 
proteomics and functional genomics. This led to the identification of multiple 
kinetochore sub-complexes. After purification and reconstitution as well as structural 
characterization, the structure, composition and stoichiometry of kinetochores 
becomes clearer (Musacchio and Desai, 2017). 
Detailed information about inner and outer kinetochore composition are given in the 
following chapters. 
 
 Inner kinetochore 1.3.1
 
The inner kinetochore directly interacts with the centromeric chromatin and provides 
a binding platform for the outer kinetochore during mitosis. Inner kinetochore 
proteins are localized at the centromere throughout the cell cycle and are therefore 
named the constitutive centromere associated network (CCAN). The CCAN is 
subdivided into four subunits and CENP-C. The subunits are CENP-LN, CENP-
HIKM, CENP-OPQUR and CENP-TWSX (see Figure 4, green boxes). 
Figure 3 Ultrastructure of vertebrate kinetochore 
A) Schematic representation of paired sister-chromatins. On the left side the kinetochore 
is not attached to microtubules and the fibrous corona is established. On the right side 
the inner and outer kinetochore are represented and the outer kinetochore is attached to 
microtubules.  
B) Electron micrograph of a human kinetochore from McEwen et al. (McEwen et al., 
2007) 
Image was adopted from Cheeseman & Desai, Nature Reviews, Molecular Cell Biology 
(2008) (Cheeseman and Desai, 2008) 
A B 
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Only two CENP proteins, CENP-C and CENP-N, of CCAN interact directly and with 
a higher specificity to CENP-A than to H3 nucleosome (Carroll et al., 2010). CENP-N 
binds to the CENP-A targeting domain (CATD) (Carroll et al., 2009), whereas   
CENP-C interacts with the acidic patch of H2A and H2B and the C-terminal tail of 
CENP-A (Musacchio and Desai, 2017). Binding of CENP-C to the CENP-A tail is 
dependent on hydrophobic interactions rather than a specific amino acid sequence of 
CENP-A (Kato et al., 2013). Since CENP-N and CENP-C also bind to canonical H3 
nucleosomes, the selectivity is discussed to be enhanced by other CCAN components 
or posttranslational histone modifications (Bailey et al., 2013; Carroll et al., 2010; Hori 
et al., 2014). 
Another important factor within the CCAN interacting directly with centromeric 
chromatin is the CENP-B protein. It is the only centromere protein in mammals that 
recognizes a specific DNA sequence, the CENP-B box. This CENP-B box is a 
conserved 17 bp sequence and many copies are included in the α-satellite repeats 
(Masumoto et al., 1989). CENP-B is not an evolutionary conserved protein, therefore 
the role of CENP-B in stabilizing centromeres has been questioned. However,  
CENP-B has some important functions in humans. First, it is important for de novo 
centromere formation in human artificial chromosomes (HAC) (Okada et al., 2007). 
Second, it contributes to CENP-A nucleosome phasing, CENP-A stabilization and the 
unwrapping of DNA from CENP-A nucleosomes (Hasson et al., 2013). And third, 
CENP-B directly binds CENP-C, providing an alternative pathway of CENP-C 
recruitment (Hoffmann et al., 2016). 
The Sub-complexes CENP-LN, CENP-HIKM, CENP-OPQUR and CENP-TWSX 
contribute to inner kinetochore structure and binding to outer kinetochore proteins 
during mitosis (Musacchio and Desai, 2017). 
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 Outer kinetochore 1.3.2
 
The outer kinetochore mediates the interaction between centromeres and 
microtubules by the assembly of a protein complex consisting of 3 sub-complexes, 
Knl1, Mis12 and Ndc80 (KMN complex) (Figure 4, yellow boxes). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The outer kinetochore transduces the force generated by microtubule 
depolymerisation for chromosome movement and its three sub-complexes fulfil 
therefore distinct functions (Musacchio and Desai, 2017). 
Figure 4: Model for human kinetochore assembly 
Shown is the stoichiometry of kinetochore subunits at the CENP-A nucleosome. 
CENP-A nucleosome interacts with two CCAN complexes. CNEP-C and CENP-T 
bind to Mis12 and Ndc80 complexes and Knl1 is recruited by Mis12.  
Adopted from Musacchio & Desai, Biology (2017) (Musacchio and Desai, 2017) 
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The Mis12 complex forms the connection between KMN and inner kinetochore by 
directly interacting with CENP-C and CENP-T. Mis12 then provides direct binding 
sites for Knl1 and Ndc80 complexes. The interactions of Mis12 with the CCAN are 
phosphorylation dependent and therefore regulated in a cell cycle dependent 
manner by Aurora B kinase (Musacchio and Desai, 2017). 
Knl1 is the largest outer kinetochore subunit, has a disordered structure with an 
array of protein docking sites and is involved in SAC signaling (Musacchio and 
Desai, 2017). 
The best studied sub-complex of KMN is the Ndc80 complex. It is a dumbbell-shaped 
protein complex and responsible for the microtubule-binding of KMN by the HEC1 
subunit (Wei et al., 2007).  
Stoichiometry of kinetochore complex is dictated by linking mechanisms of inner and 
outer kinetochore proteins as represented in Figure 4. At human centromeres around 
20 microtubules are associated with ~100 CENP-A nucleosomes that are dispersed 
with H3 nucleosomes (Bodor et al., 2014). The centromeric chromatin provides a 
binding platform for the kinetochore during mitosis. Centromere loss, malfunction 
and gain of extra centromeres will lead to genome instability or aneuploidy. Hence, it 
is important to study centromere function in detail and to understand de novo 
centromere formation and inheritance of centromere identity over generations. 
 
1.4 The Centromere 
 
Described in the previous chapter, interactions of CCAN with centromeric chromatin 
are evolutionary highly conserved and, besides CENP-B, not dependent on the 
underlying DNA sequence. This indicates that centromere identity is epigenetically 
determined in eukaryotes. In the following I delineate differences in centromere 
structures in different organisms and specify what these centromeres have in 
common. 
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 Centromeres in different organisms 1.4.1
 
Since centromeres are of important function and all eukaryotes require centromeres, 
it is remarkable that there is a large variety of strategies in centromere formation. The 
smallest and also simplest centromere is found in budding yeast Saccharomyces 
cerevisiae. Centromeric DNA is separated into three domains, CDEI, CDEII and 
CDEIII, forming a ~120 nt long sequence. Centromere identity is established on 
CDEII, an AT-rich sequence where one centromeric nucleosome is assembled. This 
centromere is therefore called a point centromere (Figure 5 a). Fission yeast 
Schizosaccharomyces pombe and other higher eukaryotes establish a larger, regional 
centromere (Figure 5 b+c). These regional centromeres range from ~5 kb in yeast to 
megabases in humans and incorporate many centromeric CENP-A nucleosomes. 
Regional centromeres are flanked by pericentric heterochromatin (Bernard et al., 
2001). In humans the centromere is also named as satellite centromere, since the 
underlying DNA sequence consists of arrays of 171 bp α-satellite DNA (Figure 5 c). 
Another specialized centromere strategy is established by some nematodes, like 
Caenorhabditis elegans. So called holocentromeres are spread along the whole 
chromosome and CENP-A nucleosomes are incorporated into several positions along 
the chromosome arm (Figure 5 d) (Steiner and Henikoff, 2014).  
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The only centromere described, that has a specific underlying DNA sequence, is that 
of S. cerevisiae. In all other centromeres any sequence similarity is missing despite 
sharing common features like repetitive DNA and embedding into pericentric 
heterochromatin. This led to the hypothesis, that there is no genetic basis of 
centromere identity but an epigenetic model for centromere identity inheritance. 
 
 CENP-A determines centromere identity 1.4.2
 
Three different indications support the hypothesis for an epigenetic model of 
centromere inheritance. First, the missing sequence similarity between organisms, 
described in chapter 1.4.1. Second, in chromosomes containing two centromeres, 
called dicentric chromosomes, one can be inactivated and still maintain the α-satellite 
Figure 5: Schematic representation of different centromeres 
a) Budding yeast point centromere, this centromere is sequence specific at centromere 
DNA Elements (CDEI-III)  
b+c) regional centromeres can span 4 kb to several megabases (also satellite 
centromere)  
d) some species, like in nematodes, form holocentromeres, centromeres spread over 
the whole chromosome. 
Modified from Steiner & Henikoff, Current Opinion in Genetics & Development (2015) 
(Steiner and Henikoff, 2015) 
Pericentric heterochromatin CENP-A containing chromatin 
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repetitive sequence (Warburton et al., 1997). Third, the observation that neo-
centromeres form de novo in chromosome regions lacking any sequence similarity to 
endogenous centromeric DNA (Amor et al., 2004).  
In 1985 it was discovered that CENP-A is essential at centromeres and that it is a 
major part in centromeric chromatin (Earnshaw and Rothfield, 1985; Palmer and 
Margolis, 1985). CENP-A is assembled at centromeres in almost all eukaryotic 
organisms with only a few exceptions. Hence, this centromere specific histone H3 
variant is the hallmark for epigenetic specification of centromere identity (Warburton 
et al., 1997). This hypothesis is confirmed by the presence of CENP-A at neo-
centromeres (Marshall et al., 2008) and the circumstance that artificial targeting of 
CENP-A to ectopic sites is sufficient to generate structures for microtubule 
recruitment during mitosis for chromosome segregation (Heun et al., 2006; 
Mendiburo et al., 2011). However it is still an open question how exactly the CENP-A 
chromatin propagates its identity over many generations.  
Since CENP-A is the most important factor for centromere inheritance; I will give an 
overview about its structure and function in section 1.5. 
 
1.5 The centromeric histone H3 variant CENP-A 
 
As already mentioned, the CENP-A (or Cse4 in yeast, CID in flies or CenH3 in 
plants) is a functionally highly conserved protein with distinct functions for 
kinetochore assembly and centromere identification. In centromeres the CENP-A 
nucleosomes replace canonical nucleosomes containing H3 and change chromatin 
structure and features to define the centromere identity (McKinley and Cheeseman, 
2016). In addition  CENP-A is a binding factor for kinetochore proteins and therefore 
serves as binding platform for microtubule attachment during mitosis (Schalch and 
Steiner, 2016). CENP-A consists of two major domains, the histone fold domain with 
62 % sequence similarity to H3 and the N-terminal tail with an even higher extent in 
sequence differences compared to H3 (Sullivan et al., 1994) (Figure 6). 
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 CENP-A structural domains 1.5.1
 
With significant structural and sequence differences compared to the canonical 
histone H3, CENP-A nucleosomes provide an environment for centromere 
establishment and centromere identity inheritance. The CENP-A targeting domain 
(CATD) is included in the histone fold domain and contains the first loop (L1) and 
the second α-helix (α2) (Figure 6). This sequence is sufficient for centromere targeting 
when introduced into H3 histones and therefore the most important domain for 
defining CENP-A (Black et al., 2007). Targeting and correct localization of CENP-A 
via the CATD is mediated by its histone chaperone HJURP (holliday junction 
recognition protein) (Foltz et al., 2009). CATD binds to the N-terminal part of HJURP, 
whereas the C-terminus of HJURP protects the CENP-A/H4 heterodimer for the 
formation of a (CENP-A/H4)2 tetramer by binding the DNA-binding region of the 
dimer (Hu et al., 2011). 
 
 
 
 
 
 
 
The CATD is not only important in targeting CENP-A to centromeres, but also in 
recruitment of the CCAN proteins, CENP-C and CENP-N.  
First it was shown that CENP-C recognizes the C-terminal part of CENP-A in frog 
egg extracts and that this is sufficient to assemble the kinetochore (Guse et al., 2011). 
Further studies indicated that CATD is important for CENP-C recruitment 
Figure 6: Primary sequence and secondary structure of CENP-A 
Conservation of CENP-A with H3 is shown in green and non-identical sequence is 
shown in red. CENP-A has several interaction domains. CATD domain is important 
for HJURP, the CENP-A chaperone, and CCAN protein recruitment. CENP-C 
specifically interacts with C-terminal part of CENP-A.  
Modified from McKinley & Cheeseman, Nature Reviews, Molecular Cell Biology (2016) 
(McKinley and Cheeseman, 2016) 
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(Westhorpe et al., 2015) and the N-terminal tail of CENP-A is involved in enhancing 
CENP-A/CENP-C interaction (Logsdon et al., 2015). 
Not only the CENP-A protein, also CENP-A nucleosomes show significant structural 
differences compared to canonical H3-containing nucleosomes, which will be 
described in the following. 
 
 CENP-A nucleosome 1.5.2
 
Newly synthesized CENP-A/H4 heterodimers are bound and specifically targeted to 
centromeres by HJURP (Hu et al., 2011). The same conformation of CENP-A/H4 is 
kept in nucleosome environment (Tachiwana et al., 2011), demonstrating that HJURP 
is responsible for preventing tetramer formation and DNA association by binding the 
DNA interactions site.  
CENP-A nucleosomes are stabilized by binding of CENP-C into the acidic patch 
(Kato et al., 2013; Tachiwana et al., 2011). After binding of CENP-C the CENP-A 
nucleosomes become flattened and more rigid and CENP-A turnover at centromeres 
is limited (Falk et al., 2015; Falk et al., 2016).  
The crystal structure reported in 2011 by Tachiwana et al. (Tachiwana et al., 2011) 
revealed an octameric structure of CENP-A nucleosomes and summarized four 
important features of CENP-A nucleosomes. First, the DNA is wrapped left-handed 
around the histone core. Second, the αN-helix of CENP-A is shorter and therefore the 
DNA exit and entry is not fixed equally to H3 nucleosomes (compare Figure 7). 
146 bp wrap around H3 nucleosomes (Luger et al., 1997), whereas only ~ 120 bp are 
tightly wrapped around CENP-A nucleosomes (Sekulic and Black, 2012). Third, the 
L1 loop, part of the CATD domain is exposed to the surface of the nucleosomes. And 
fourth, the entire CENP-A nucleosome has a similar overall shape and dimension 
compared to H3 nucleosomes (Sekulic and Black, 2012). 
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In summary, the (CENP-A/H4)2 tetramer is more rigid, because the                     
CENP-A/CENP-A interface is rotated compared to H3 nucleosomes, leading to a 
more compact structure (Sekulic et al., 2010). The CENP-A/CENP-A axis is similar to 
the H3/H3 axis (Falk et al., 2015) and finally CENP-A nucleosome structure is re-
shaped and stabilized upon CENP-C binding (Falk et al., 2015; Falk et al., 2016). This 
specific CENP-A nucleosome structure influences the centromeric chromatin 
architecture. 
 
1.6 Human centromeric chromatin 
 
As already described in 1.4.1, Figure 5 c, the human centromere is separated into two 
regions, the centromere core and pericentromeric heterochromatin flanking the 
centromere core. Disruption of one of these regions leads to defects in chromosome 
segregation, as shown by functional studies summarized in the review of Schalch 
and Steiner, 2016 (Schalch and Steiner, 2016). However, it is not completely 
understood how both regions interact mechanistically and why both regions are so 
important. The most favored model is that both form a distinct three-dimensional 
structure of centromeric chromatin that enables microtubule attachment and 
supports and senses tension for proper chromosome segregation (Schalch and 
Steiner, 2016). 
Figure 7: Structural model of CENP-A and H3 nucleosome 
A) Less DNA is wrapped around CENP-A nucleosomes since exit and entry site of 
CENP-A differs from H3 (B). 
Adopted from http://www.yomiuri.co.jp/adv/wol/dy/news/news_110721.html 
23.06.2017 
A B CENP-A nucleosome H3 nucleosome 
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The centromere core contains the CENP-A nucleosomes and is exposed to surface in 
condensed mitotic chromosomes. Within the centromere core, the CENP-A 
nucleosomes are interspersed by H3 containing nucleosomes, shown by quantitative 
approaches (Bodor et al., 2014). This was also confirmed by super-resolution 
microscopy of stretched chromatin fibers (Blower et al., 2002). The CENP-A 
nucleosomes serve as anchoring platform for the kinetochore proteins.  
The pericentromeric region is responsible for elasticity and tension resistance 
generated by cohesin and condensin (Gerlich et al., 2006; Ribeiro et al., 2009). Further 
function of pericentromeric chromatin is tension sensing and signaling to mitotic 
checkpoint (Schalch and Steiner, 2016). 
The three-dimensional shape of centromere chromatin is dependent on CCAN 
proteins and centromere specific histone modifications. CCAN proteins, like CENP-
T, -W, -S, -X and CENP-B contribute to centromere chromatin architecture as they 
bind to DNA either sequence specific (CENP-B), to stabilize CENP-A nucleosomes 
(Fujita et al., 2015) or as nucleosome-like complex (CENP-TWSX) altering DNA 
conformation (Nishino et al., 2012).  
Post-translational histone modifications specify domains of centromere core and 
pericentromeric chromatin. Within the centromere and pericentromere are histone 
marks correlating with active chromatin and inactivating histone marks that lead to a 
more dense packing of DNA respectively. 
As represented in Figure 8 (green box), the pericentromeric heterochromatin is 
highly associated with histone marks leading to inactive chromatin. 
Hypermethylated H3K9 (H3K9me2/3) and methylated DNA, which both mediate a 
strong compaction of DNA (Peters et al., 2003), are enriched in pericentromeric 
chromatin. In addition it is reported that the H4K20 methyltransferase Suv4-20h2 
mediates the recruitment of cohesins (Hahn et al., 2013) and loss of H3K9 
methylation and HP1 binding increases the separation of major satellites in 
metaphase (Schalch and Steiner, 2016). H3K27me3 modifications also contribute to 
inactive chromatin. 
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In contrast, the centromere core is more associated with active chromatin marks 
(Figure 8, blue box). The interspersed H3 nucleosomes are modified on histone 3, 
lysine 4 with demethylation (H3K4me2) (Blower et al., 2002; Ribeiro et al., 2010; 
Sullivan and Karpen, 2004). This H3K4me2 modification is functionally important, 
since HJURP recruitment and CENP-A assembly is dependent on this modifications 
in a synthetic human kinetochore system (Bergmann et al., 2011). Also the H3K36 
dimethylation (H3K36me2) is found at centromeric chromatin in stretches of 
chromatin fibers and by ChIP analysis (Bergmann et al., 2011). 
Furthermore CENP-A nucleosomes themselves are also modified with certain 
histone marks (Figure 8, red box). For example temporal CENP-A phosphorylations 
regulate the incorporation of CENP-A histones into centromeric chromatin 
(McKinley and Cheeseman, 2016). The major modification of CENP-A nucleosomes 
Figure 8: Model of epigenetic modifications on centromeric chromatin 
Pericentromeric chromatin has different post-translational histone modifications 
than nucleosomes in centromere core and CENP-A nucleosomes themselves. CENP-
A nucleosome modifications directly influence centromere function. In several 
organisms an active transcription of centromere DNA is suggested to be important 
for centromere function and maintenance. 
Adopted from McKinley & Cheeseman, Nature Reviews, Molecular Cell Biology (2016) 
(McKinley and Cheeseman, 2016) 
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is the H4K20 monomethylation (H4K20me1), a histone mark that is essential for 
kinetochore assembly (Hori et al., 2014). 
The CENP-A incorporation into existing centromeres is well known. However, de 
novo centromere establishment and maturation of the centromeric chromatin 
environment mentioned before are largely unknown. Approaches to study de novo 
centromere establishment are explained in further detail below. 
 
1.7 De novo centromere formation 
 
Neo-centromeres are centromeres that form at atypical sites on chromosomes, such 
as chromosome arms or telomeres, and underlying DNA sequences differ from 
endogenous centromeres (Scott and Sullivan, 2014). Spontaneous de novo centromere, 
or neo-centromere, formation on chromosomes is a relatively rare event, because it 
results in genomic instability. However, neo-centromeres were described in 1993, 
associated with abnormal phenotypes, like in cancer cells. Since neo-centromere 
formation is associated with cancer, several approaches exist to investigate de novo 
centromere formation from scratch. 
For example, massive overexpression of CENP-A leads to incorporation of CENP-A 
throughout the chromosome arm. After an initial pulse of CENP-A expression and its 
incorporation, CENP-A is removed from most chromosome regions again. In regions 
where CENP-A stays incorporated, kinetochore proteins are recruited during mitosis 
and a neo-centromere has formed (Heun et al., 2006). Another method for centromere 
establishment is artificial targeting of CENP-A to defined DNA loci to induce 
centromere formation (Mendiburo et al., 2011). By targeting the CENP-A chaperone 
HJURP to operator sites in human cells, establishment of an ectopic centromere was 
also achieved (Barnhart et al., 2011). 
All these approaches have in common, that the artificial centromere is able to recruit 
CCAN proteins and the KMN complex. In addition, spindle microtubules are 
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attached and CENP-A is recruited to these centromeres. However, the major 
disadvantage of these techniques is that chromosomes are genetically instable after 
targeting and recruiting CENP-A to ectopic sites, because of chromosome miss-
segregation and chromosome break during mitosis (Sekulic and Black, 2012). 
Therefore, more suitable approaches for investigation of de novo centromere 
establishment, maturation and propagation are the human artificial chromosomes 
and artificial targeting of CENP-A to plasmids. 
 
 Human artificial chromosomes (HACs) 1.7.1
 
Besides of being interesting vectors for gene delivery and gene therapy (Basu and 
Willard, 2005), human artificial chromosomes (HACs) are suitable tools to investigate 
centromere establishment and inheritance. HACs mimic endogenous chromosomes 
in small scale, since they assemble kinetochores and segregate actively during 
mitosis (Nakashima et al., 2005). HACs used for centromere studies contain the 
“alphoidtetO array” to enable manipulation of centromeric chromatin in HACs by 
targeting chromatin modifying enzymes to tetO sites (Nakano et al., 2008). 
Centromere formation on HACs is dependent on the presence of CENP-B boxes 
within the alphoid sequences to recruit CENP-B proteins for de novo incorporation of 
CENP-A nucleosomes into the alpha-satellite DNA of the human artificial 
chromosomes (Masumoto et al., 2004; Ohzeki et al., 2002). 
These HACs are used to manipulate chromatin status and to investigate its influence 
on centromere stability. It was observed that inactive chromatin flanking centromere 
region is important for HAC formation (Nakashima et al., 2005). By targeting a HAT 
(histone acetyl-transferase) to tetO within the HACs, Ohzeki et al. found that the 
balance of H3K9 methylation and acetylation is associated with centromere 
specification (Ohzeki et al., 2012). 
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Therefore HACs provide a suitable model system to study and manipulate 
centromeric chromatin and its influence on kinetochore assembly. However, human 
artificial chromosomes are huge extrachromosomal DNAs and they have a low 
transduction efficacy. 
 
 Centromere formation at ectopic sites on chromosomes 1.7.2
 
Observations, that overexpression of CENP-A leads to establishment of neo-
centromeres and recruitment of kinetochore proteins, gave already hints that CENP-
A is sufficient for centromere establishment. However, only a few sites generated 
ectopic centromeres with this approach, and the direct correlation of CENP-A 
incorporation and centromere formation was still missing (Heun et al., 2006). To 
verify the hypothesis that CENP-A generates centromeres, the group of Patrick Heun 
generated an artificial targeting system. Therefore, a LacO array was introduced into 
a chromosome of Drosophila melanogaster Schneider S2 cells and a CID:GFP:LacI was 
artificially targeted by pulse induction. CID is the Drosophila melanogaster homologue 
of human CENP-A. Targeting of CID leads to the recruitment of kinetochore 
proteins, as represented in Figure 9. 
 
 
 
 
 
 
 
 
Figure 9: Schematic representation of CENP-A (CID) targeting to 
LacO sites in chromosomes 
Targeting of CID:GFP:LacI to ectopic sites on chromosomes leads to 
recruitment of kinetochore proteins to these sites. 
Modified from Mendiburo et al., Science (2011) (Mendiburo et al., 2011) 
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The recruitment of CCAN protein CENP-C and outer kinetochore protein Ndc80 was 
validated by immune fluorescence of mitotic chromosomes (Mendiburo et al., 2011). 
As reported in 1941 (McClintock, 1941), dicentric chromosomes cause chromosome 
break and segregation defects. Since the induction of ectopic centromeres lead to 
dicentric chromosomes, this method is not suitable to further study centromere 
maturation and centromere inheritance. 
To prevent the genetic instability of Drosophila melanogaster Schneider S2 cells, the 
CID:GFP:LacI fusion protein was targeted to extrachromosomal plasmids harboring 
an array of 256 LacO sites. 
 
 De novo Centromere formation on LacO plasmids 1.7.3
 
The current epigenetic model for centromere inheritance is that CENP-A self-directs 
its loading after each cell division (Allshire and Karpen, 2008). To verify this and to 
investigate de novo centromere heritability, an episomal DNA element containing 256 
LacO sequences, a LacO plasmid, was utilized in Drosophila melanogaster Schneider S2 
cells, as depicted in Figure 10. 
 
 
 
 
 
 
 
 
Figure 10: Schematic representation of CENP-A (CID) targeting to LacO plasmids 
CID:GFP:LacI is targeted to LacO containing plasmids. This leads to the recruitment of 
kinetochore proteins and to self-propagation of artificial centromeres on plasmids. 
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Pulse induction of CID:GFP:LacI reveals recruitment of kinetochore proteins 
(Mendiburo et al., 2011). Expressing a HA tagged CID protein in parallel and 
performing immune fluorescence on HA and GFP indicated the recruitment of CID 
to LacO sites independent on LacI-LacO interaction. CID:HA was also represented at 
the plasmid LacO region. Therefore, by using the plasmids system, not only the de 
novo centromere establishment, but also the inheritance of centromere identity was 
analyzed.  
 
 
 
 
 
 
 
 
Plasmids that are targeted with CID:GFP:LacI establish a centromere identity, which 
results in the attachment of these plasmids to spindle microtubules during mitosis 
(Figure 11). This leads to stable maintenance of these plasmids in the cells by active 
segregation. 
In our study in close collaboration with María J. Mendiburo from Patrick Heun’s 
group, we demonstrated that centromeric chromatin identity is inherited after 
removal of CID:GFP:LacI expression (Mendiburo et al., 2011). In an immune 
fluorescence experiment episomal plasmids are depicted as CID/CENP-C positive 
foci during mitosis. Four weeks after transfection, episomal plasmids are still 
detectable and importantly these are only represented by CID/CENP-C immune 
fluorescent staining and no longer by CID:GFP:LacI. The conclusion is that initial 
Figure 11: Microtubules attach to plasmids 
Immunostaining demonstrates binding of 
microtubules to plasmids during mitosis. 
Modified from Mendiburo et al., Science (2011) 
(Mendiburo et al., 2011) 
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targeting of CID leads to the establishment of centromere identity. This centromere 
identity is inherited independently of CID targeting over many generations 
(Mendiburo et al., 2011). 
This capacity of self-propagating centromere identity and stable establishment and 
inheritance of extra-chromosomal DNA make this plasmid system a suitable gene 
therapy vector. Hence, we transferred the CENP-A targeting to plasmids into a 
human system. Our group established a tetO-DS reporter plasmid system based on 
the latent replication origin of the Epstein-Barr virus (EBV) and I investigated early 
centromere maturation and centromere inheritance. 
 
1.8 Development of the pCONCENP-A plasmid system 
 
The Epstein-Barr virus (EBV) is a γ-herpesvirus with a double-stranded DNA and a 
genome size of 172 kbp. It infects resting B-cells, establishes a lifelong persistent 
infection and is associated with tumor development, like Burkitt’s lymphoma or 
Hodgkin’s lymphoma. However, more than 90 % of world’s adult population is 
infected with EBV showing no symptoms of disease (Delecluse and Hammerschmidt, 
2000).  
Different DNA vectors were generated by cloning the latent replication origin of EBV 
into plasmids (Pich et al., 2008). First, the latent replication origin of EBV was cloned 
into bacterial plasmids and these were maintained stable in human cells. oriP consists 
of two cis-acting DNA-elements, the Dyad Symmetry (DS), mediating DNA 
replication and the Family of Repeats (FR), which is important for plasmid retention 
during mitosis. Both DNA elements harbor specific binding sites for their trans-
activator protein Epstein-Barr virus nuclear antigen 1 (EBNA1). EBNA1 is able to 
recruit the DNA replication machinery and binds chromosomal DNA for 
piggybacking EBV genomes during mitosis (Kirchmaier and Sugden, 1995). 
 
1 INTRODUCTION 
 
 
24 
 
 
 
 
 
 
 
 
 
 
EBV genomes are maintained in infected cells extra-chromosomally and oriP-based 
vectors are also suggested not to integrate and maintained autonomously (Ehrhardt 
et al., 2008). But other than human artificial chromosomes (HACs), explained in 
chapter 1.7.1, the oriP plasmids are not segregated by an active segregation 
mechanism during mitosis (compare Figure 12). EBNA1 binds to 20 specific binding 
sites within the FR and connects plasmids to host chromosome DNA via its DNA 
binding domain (Yates et al., 2000), a mechanism called piggybacking (Figure 12). 
The N-terminal part of EBNA1 mediates the binding to AT-rich DNA via the linking 
regions LR1 and LR2 (Figure 13 B) (Middleton and Sugden, 1992). In addition, the 
EBNA1 protein has a binding site that specifically detects and binds the DNA 
sequence present DS in its C-terminal domain (DNA binding domain). EBNA1 
binding to DS leads to the recruitment of the origin recognition complex (ORC) and 
DNA replication (Schepers et al., 2001).  
 
 
Human artificial 
chromosome (HAC) 
EBV or oriP 
plasmids 
Figure 12: HAC and oriP maintenance during cell division 
During mitosis HACs are segregated actively by attachment to microtubules 
(top), whereas oriP plasmids are associated to host chromosomes and segregated 
passively by piggybacking. 
Modified from Lufino et al, Molecular Therapy (2008) (Lufino et al., 2008) 
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Stable maintenance of oriP plasmids is dependent on selection pressure and these 
plasmids are rapidly lost if selection is removed. Therefore, the oriP based plasmid 
system was further developed to investigate DNA replication and segregation 
mechanisms independently. For example, our group is examining mechanisms of 
activating and establishing replication origins in an oriP-based plasmid where DS is 
replaced by a different targeting sequence (Brustel et al., 2017). 
Different plasmid segregation mechanisms are examined by the replacement of FR 
by tetO sites. First, tetO repeats were targeted by the high mobility group protein A 
(HMGA1). HMGA1a was suggested as a good candidate for plasmid maintenance 
since it was shown that it interacts with the origin recognition complex (Thomae et 
al., 2008) and has similar AT-hook domains like the EBNA1 protein. Our group 
developed a conditional gene vector by fusing HMGA1a to a dimeric singe chain (sc) 
tet transactivator (sctetR). Targeting of sctetR:HMGA1a to tet operator sites lead to 
Family of repeats (FR) Dyad symmetry element (DS) 
A B 
C 
Figure 13: oriP plasmid based on latent replication origin of EBV 
A) oriP reporter plasmid: DS element for plasmid replication, FR element for plasmid 
maintenance during mitosis via piggybacking to host chromosomes, GFP reporter 
gene and selection marker.  
B) EBNA1 protein binds to specific DNA sequence on EBV genome or oriP plasmids 
via N-terminal domain. DNA-binding and dimerization domain of EBNA1 binds to 
AT-rich sequences on host chromosomes for piggybacking EBV/oriP (Adopted from 
Pich et al., Nucleic acid research (2008) (Pich et al., 2008)  
C) bipartite structure of oriP: FR 20 binding sites for EBNA1 for plasmid retention and 
DS with 4 EBNA1 binding sites for plasmid replication via recruiting host replication 
machinery  
Modified from Schepers et al., EMBO (2001) (Schepers et al., 2001) 
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replication and nuclear retention of DS-tetO reporter plasmids. Plasmid loss was 
induced by an allosteric switch within sctetR with doxycycline (Pich et al., 2008). 
With this system, called pCONHMGA1a, our group was successful in demonstrating 
that HMGA1a has replicative potential and supports plasmid maintenance during 
cell division similar to EBNA1 by attaching plasmids to host chromosomes (Thomae 
et al., 2011; Thomae et al., 2008). However, this system is also dependent on selective 
pressure because plasmids are lost upon removal of selection (Pich et al., 2008). 
Therefore, a further development of this system was to target sctetR:CENP-A to tetO 
sites that replace the FR element in the oriP, similar to the LacO system, used in 
Drosophila melanogaster. 
Stefanie Fülöp, a former group member, investigated the plasmid maintenance  in 
human cells. Stefanie Fülöp demonstrated that just functional CENP-A supports 
plasmid maintenance. 
 
 
 
 
 
 
 
 
 
Stefanie Fülöp performed a plasmid maintenance experiment in three different cell 
lines. Cells either expressed sctetR:CENP-A, sctetR, sctetR:H3.3 and sctetR:CENP-
Amut, mutated in the CATD domain of CENP-A. After three or four weeks after 
Figure 14: tetO-DS plasmid maintenance 
A) Schematic representation of domain differences between H3.3, CENP-A and a mutated 
version of CENP-A in these experiments are indicated  
B) Maintenance of tetO-DS plasmids is dependent on functional CENP-A and does not 
work with H3.3, mutated CENP-A or sctetR targeting. oriP is maintained similar in all cell 
lines, independent of sctetR fusion protein  
Data: Stefanie Fülöp, Dissertation (2013) 
A B 
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transfection only the targeting of sctetR:CENP-A lead to plasmid maintenance of 
tetO-DS plasmids. oriP plasmids were used as control, since the maintenance of oriP 
plasmids is independent of targeting sctetR fusion proteins. The oriP plasmids were 
maintained in all cell lines, independent of the expression of different sctetR fusion 
proteins, sctetR:CENP-A, sctetR:H3.3, sctetR:CENP-Amut and sctetR. In contrast,   
tetO-DS reporter plasmids were only maintained after targeting of functional    
CENP-A. The tetO-DS reporter plasmids were not established in the cells when 
targeted with sctetR:H3.3, sctetR:CENP-Amut or sctetR because no centromere 
identity was established there. 
 
 
 
 
 
 
 
 
To further develop the tetO-DS sctetR:CENP-A plasmid system towards potential 
gene therapy usage, Stefanie Fülöp analyzed if the expression of the sctetR:CENP-A 
fusion protein in cis influences plasmid maintenance. Hence, our group generated an 
“all-in-one” sctetR:CENP-A plasmid and compared its maintenance to oriP and the 
tetO-DS reporter plasmid with sctetR:CENP-A expressed in trans by stable cell lines. 
There was no difference in plasmid rescue efficiency between the tetO-DS reporter 
plasmids with sctetR:CENP-A expression in trans and the all-in-one plasmid (Figure 
15). This “all-in-one” tetO-DS sctetR:CENP-A plasmid system we named   
pCONCENP-A (Figure 16). 
Figure 15: Plasmid maintenance of different reporter plasmids 
Maintenance of plasmids with targeting of sctetR:CENP-A expressed from 
plasmids (All-in-one) is similar to plasmids where sctetR:CENP-A is stably 
expressed. No plasmid was maintained when sctetR alone was targeted. 
Data: Stefanie Fülöp, Dissertation (2013) 
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This pCONCENP-A plasmid system is an improved vector functional in human cells 
with potential use for gene therapy approaches. Plasmid maintenance during cell 
cycle is ensured by active plasmid replication via DS-EBNA1 and the segregation is 
actively mediated by targeting CENP-A.  
During this project our group was investigating the long-term plasmid maintenance 
and gene expression capacity for using these plasmids for gene therapy approaches. 
I used this plasmid system to examine the inheritable centromere established after 
CENP-A targeting in its functional and epigenetic details. 
 
 
Figure 16: All-in-one pCONCENP-A reporter plasmid 
sctetR:CENP-A reporter plasmid is based on oriP. FR element was replaced 
by 20 tet operator targeting sites. sctetR:CENP-A is encoded on the plasmid 
under CMV promoter. 
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 AIM OF THE THESIS 2
 
In humans, centromere localization is not determined by the underlying DNA 
sequence. Consequently, its inheritance is specified epigenetically. The major 
hallmark for centromere identity is the centromere specific histone H3 variant  
CENP-A. However, the parameters defining centromere identity and its inheritance, 
such as histone modifications or CENP-A itself, are unclear.  
The pCONCENP-A plasmid system is a suitable tool for analyzing centromere-
dependent mechanisms, as site-specific targeting of CENP-A to the plasmid leads to 
the formation of a functional neo-centromere. It is stably maintained in human cells 
because CENP-A targeting leads to active plasmid segregation during mitosis, which 
makes it a potential tool for gene therapy. 
Using the pCONCENP-A plasmid system, I aim to understand the molecular 
mechanisms that lead to the establishment of centromere identity and its inheritance. 
I am addressing three distinct aspects: 
I) Do pCONCENP-A plasmids segregate by a CENP-A-dependent active 
plasmid segregation mechanism? 
II) What is the minimal plasmid establishment time required for long-term 
maintenance and CENP-A self-propagation? 
III) Are histone modifications present on a mature plasmid centromere? 
I) Established pCONCENP-A plasmids segregate actively during cell division. To 
visualize and follow this process, live cell imaging of cells containing pCONCENP-A 
will be performed. Furthermore, I will analyze artificial centromeres of pCONCENP-A 
for their capacity to recruit kinetochore components by immune fluorescence.  
II) My laboratory already showed that CENP-A targeting leads to stable plasmid 
maintenance after an initial plasmid establishment of three weeks. This plasmid 
maintenance becomes independent of CENP-A targeting. I aim to examine the 
minimal timeframe of centromere maturation in which centromeres begin to self-
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propagate. Additionally, immune fluorescence experiments will show incorporation 
of targeting-independent CENP-A.  
III) To investigate the histone modifications present on matured artificial 
centromeres, I will develop a Cas9-dependent targeting system to purify plasmids 
with matured centromeres from human cells. By Western Blot and mass 
spectrometry, I aim to reveal histone modifications that are established at 
centromeres during its maturation. 
 
In conclusion, I aim to understand the molecular mechanisms leading to the 
establishment of an inheritable centromere and the functional relevance of these 
artificial centromeres on plasmids for potential gene therapy vectors. 
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 MATERIALS & METHODS 3
3.1 Materials 
 
In the following the materials, like devices, chemicals, enzymes and buffers, which 
were used during this work are listed. Buffers were mixed from stock solutions, 
prepared from the listed chemicals. 
 
 Devices and consumables 3.1.1
 
In Table 1 devices and consumables are listed in alphabetical order with reference to 
the distributor. Cell culture devices, like cell culture dishes, cryotubes or 6-well plates 
were used from Nunc (Nunc GmbH, Germany). 
 
Table 1 Devices and consumables used in this work 
Devices Distributor 
Axiovert 10 fluorescence microscope Carl Zeiss AG, Germany 
CEA Blue sensitive X-ray film Agfa HealthCare GmbH, Germany 
Cell counting chamber 
Neubauer improved 
Brand GmbH & Co KG, Germany 
Cell Strainer (70 µm) BD FalconTM, USA 
Centrifuge Tubes (15 ml, 50 ml) Greiner Bio-One International AG, Austria 
Centrifuge Rotina 38R Hettich GmbH & Co. oHG, Germany 
Coverslip Carl Roth GmbH & Co KG, Germany 
Developer machine 
Optimax® 
Typon Röntgen-Film GmbH, Germany 
Electroporation cuvettes 1mm Peqlab Biotechnologie GmbH, Germany 
Electroporation device 
Gene pulser II 
Bio-Rad Laboratories GmbH, Germany 
FACS tubes 
5 ml polypropylene tubes 
BD FalconTM, USA 
Film cassettes Fujifilm Holdings K.K., Japan 
Flip-cap tubes Sarstedt AG & Co, Germany 
Flow Cytometry Analyzer 
FACSCalibur 
BD BiosciencesTM, USA 
Freezer (-20 °C) Liebherr-International Deutschland GmbH, Germany 
Freezer (-80 °C) Azbil Telstar, S.L.U., Spain 
Freezing box 
Nalgen Nunc Cryo 1 °C Freezing 
Container 
Nunc GmbH, Germany 
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French Pressure Cell Press 
French Press FA-078A 
With 40K standard cell (diameter 3’’) 
Thermo Electron GmbH, Germany 
Fridge (4 °C) Liebherr-International Deutschland GmbH, Germany 
Gel electrophoresis system peqlab GmbH, Germany 
Gene Amp PCR System 2400 PerkinElmer Inc., USA 
High-speed centrifuge 
Avanti J-26XP 
Beckman Coulter GmbH, Germany 
Hotplate/ magnetic stirrer RH basic IKA Labortechnik GmbH & Co KG, Germany 
Incubator 37 °C, 5 %CO2 
Mammalian cells 
UniEquip Laborgerätebau- und Vertriebs GmbH, 
Germany 
Incubator 37 °C 
Bacteria 
Heraeus GmbH, Germany 
Laminar flow 
LaminAir Hb 2448 
Heraeus GmbH, Germany 
Leica confocal microscope 
Leica TCS SP2 
Leica Microsystems GmbH, Germany 
Leica inverted motorized live cell 
fluorescence microscope 
Leica DMi8 (BMC Munich) 
Leica Microsystems GmbH, Germany 
Light-Cycler® Roche Diagnostics GmbH, Germany 
Live cell imaging chamber 
µ-Slide 8 Well; ibiTreat 
Ibidi GmbH, Germany 
Microscopy slide 
SuperFrost® 
Carl Roth GmbH & Co KG, Germany 
Millipore Water purification system 
Milli-RO 60 plus 
Merck Millipore, Merck KGaA, Germany 
NanoDrop® ND-1000 spectrometer Thermo Fisher Scientific Inc., USA 
Nitrocellulose ECL blotting membrane, 
Amersham 
GE Healthcare GmbH, Germany 
Orbital shaker 
Innova 4400 
New Brunswick Scientific GmbH, Germany 
Parafilm® M Brand GmbH & Co KG, Germany 
Photometer Eppendorf AG, Germany 
Pipet-boy IBS Integra Biosciences GmbH, Germany 
Pipet tips 
10 µl, 200 µl, 1000 µl 
Gilson Inc., USA 
Qubit-Fluorometer Invitrogen GmbH, Germany 
SemiDry Blotting System Hoefer Scientific Instruments, USA 
Sterile filter 0.45 µm, syringe filter Sartorius AG, Germany 
Sonifier 
Covaris S220 
Covaris Inc., Great Britain 
Sonifier tubes 
AFA Fiber & Cap tubes (12x12 mm) 
Covaris Inc., Great Britain 
Syringe (1 ml to 50 ml) Norm-Ject, Henke-Sass, Wolf GmbH, Germany 
Table centrifuge 5415R Eppendorf AG, Germany 
Table centrifuge A. Hartenstein GmbH, Germany 
Thermomixer comfort Eppendorf AG, Germany 
Vortex Genie 2 Scientific Industries Inc., USA 
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 Software 3.1.2
 
Software-programs and their developers are listed in Table 2. 
 
Table 2 Software used during this work 
Software Developer 
EndNote X7 Clarivate Analytics, USA 
FACSDIVATM V6.1.1 BD BiosciencesTM, USA 
Fiji ImageJ, USA 
FileMaker Pro 15 FileMaker Inc., USA 
FlowJo 10.0.8r1 FlowJo LLC, USA 
Leica Application Suite Leica Microsystems GmbH, Germany 
LightCycler® 480 Software 1.5.162 SP2 Roche Diagnostics GmbH, Germany 
MacVector 13.5.5 MacVector Inc., USA 
MS Office 2010 Microsoft Corporation, USA 
Prism 6.0c GraphPad Software Inc., USA 
 
 Enzymes and antibodies 3.1.3
 
In Table 3 enzymes are specified. Restriction enzymes used for cloning and DNA 
fragmentation for the STREP pull down (chapter 3.2.9) were purchased from New 
England Biolabs Inc., Great Britain.  
 
Table 3 Enzymes used in this work 
Enzyme Distributor 
Alkaline Phosphatase,  
Calf Intestine (CIP) 
New England Biolabs Inc., Great Britain 
MNase Roche Diagnostics GmbH, Germany 
Proteinase K Roche Diagnostics GmbH, Germany 
Pwo Polymerase peqlab GmbH, Germany 
RNase A, DNase free Roche Diagnostics GmbH, Germany 
T4 DNA ligase Affymetrix Inc., USA 
 
Antibodies, their specification and their application and dilution during this work 
are given in Table 4 (ChIP, Co-IP and Western Blot) and Table 5 (Immune 
fluorescence).  
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Table 4 Antibodies used in ChIP, Co-IP and Western Blot 
Antibody Origin Application Dilution Distributor 
α-tetR (31B3) Mouse ChIP; Co-IP 
WB 
See text 
1:20 
Helmholtz Center Munich 
α-HA (12CA5) Mouse ChIP 
WB 
See text 
1:20 
Helmholtz Center Munich 
α-H3 (ab1791) Rabbit WB 1:5000 Abcam plc, Great Britain 
α-H2B (ab1790) Rabbit WB 1:1000 Abcam plc, Great Britain 
α-strep (12B8) Rat WB 1:20 Helmholtz Center Munich 
α-H3K4me1 
(ab8895) 
Rabbit WB 1:500 Abcam plc, Great Britain 
α-H3K4me2 
(ab7766) 
Rabbit WB 1:1000 Abcam plc, Great Britain 
α-H3K4me3 
(ab8580) 
Rabbit WB 1:1000 Abcam plc, Great Britain 
α-H3K9me2 
(ab1220) 
Mouse WB 1:200 Abcam plc, Great Britain 
α-H3K9me3 
(ab8898) 
Rabbit WB 1:1000 Abcam plc, Great Britain 
α-H3K27me1 (07-
448) 
Rabbit WB 1:2000 Merck Millipore, Merck 
KGaA, Germany 
α-H3K27me2 (07-
425) 
Rabbit WB 1:1000 Merck Millipore, Merck 
KGaA, Germany 
α-H3K27me3 
(#9733) 
Rabbit WB 1:500 Cell signaling Technology 
Inc.,  USA 
α-H4K20me1 
(C15410034) 
Rabbit WB 1:1000 Diagenode Inc., USA 
α-H4K20me2 
(9759S) 
Rabbit WB 1:1000 Cell signaling Technology 
Inc.,  USA 
α-H4K20me3 
(C15410057) 
Rabbit WB 1:1000 Diagenode Inc., USA 
α-mouse HRP Goat WB 1:10000 Cell signaling Technology 
Inc.,  USA 
α-rat HRP Goat WB 1:10000 Jackson ImmunoResearch 
Laboratories Inc., USA 
α-rabbit HRP Goat WB 1:10000 Jackson ImmunoResearch 
Laboratories Inc., USA 
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Table 5 Antibodies used for immune fluorescence in this work 
Antibody Origin Application Dilution Distributor 
α-EBNA1 (1H4) Rat IF 1:20 Helmholtz Center Munich 
α-CENP-C 
(ab50974) 
Mouse IF 1:100 Abcam plc, Great Britain 
α-HEC1 (Ndc80) 
(ab3613) 
Mouse IF 1:100 Abcam plc, Great Britain 
α-rat Cy3 Goat IF 1:100 Jackson ImmunoResearch 
Laboratories Inc., USA 
α-rat A647 Goat IF 1:100 Jackson ImmunoResearch 
Laboratories Inc., USA 
α-mouse Cy5 Goat IF 1:100 Jackson ImmunoResearch 
Laboratories Inc., USA 
 
 Chemicals 3.1.4
 
In Table 6 chemicals and substances used during this work and their corresponding 
distributor are listed in alphabetical order. 
 
Table 6 Substances used in this work 
Substance Distributor 
Agarose, UltraPure Invitrogen GmbH, Germany 
Ammoniumperoxidisulfate (APS) Carl Roth GmbH & Co KG, Germany 
Ampicillin sodium salt Carl Roth GmbH & Co KG, Germany 
ATX Ponceau S 
red staining solution 
Fluka® Analytical , Germany 
Bio-Rad Protein Assay Bio-Rad Laboratories GmbH, Germany 
Bovine Serum Albumin, BSA Sigma-Aldrich Chemie GmbH, Germany 
Calcium chloride (CaCl2) Merck-Eurolab GmbH, Germany 
Chlorophorm Merck-Eurolab GmbH, Germany 
Complete protease inhibitor EDTA free Roche Diagnostics GmbH, Germany 
Hydrogen peroxide solution Sigma-Aldrich Chemie GmbH, Germany 
Dimethylpimelimidate (DMP) Sigma-Aldrich Chemie GmbH, Germany 
Dimethylsulphoxide (DMSO) Carl Roth GmbH & Co KG, Germany 
Dithiothreitol (DTT) Sigma-Aldrich Chemie GmbH, Germany 
Deooxycholic acid (DOC) Sigma-Aldrich Chemie GmbH, Germany 
dNTPs  Roche Diagnostics GmbH, Germany 
Doxycycline Sigma-Aldrich Chemie GmbH, Germany 
Dulbecco’s Eagle Modified Medium Gibco, Thermo Fisher Scientific Inc., USA 
Ethylenediaminetetraacetic acid (EDTA) Carl Roth GmbH & Co KG, Germany 
Ethylenglycol-bis(β-aminoethylether)-
tetraacetic acid (EGTA) 
Carl Roth GmbH & Co KG, Germany 
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Ethanol Panreac AppliChem GmbH, Germany 
Ethanolamine Carl Roth GmbH & Co KG, Germany 
Ethidiumbromide Carl Roth GmbH & Co KG, Germany 
Fetal bovine serum (FBS) Lot BS225160.5, Bio&SELL GmbH, Germany 
Formaldehyde 16 %, methanol-free Thermo Fisher Scientific Inc., USA 
G418/ Geneticin Carl Roth GmbH & Co KG, Germany 
GeneRuler™ 1 kb DNA Ladder Thermo Fisher Scientific Inc., USA 
GeneRuler™ DNA Ladder Mix Thermo Fisher Scientific Inc., USA 
Glycerol AppliChem GmbH, Germany 
Glycin Panreac AppliChem GmbH, Germany 
HEPES 100x solution Gibco, Thermo Fisher Scientific Inc., USA 
Hygromycin PAA-Laboratories, Austria 
Immersion oil 
TypeF Immersion liquid n=1.5180 
Leica Microsystems GmbH, Germany 
Isoamyl alcohol Merck-Eurolab GmbH; Germany 
Isopropanol (2-Propanol) Merck-Eurolab GmbH; Germany 
Kanamycin Carl Roth GmbH & Co KG, Germany 
Light-Cycler®Fast-Start-DNA-Master-
SYBR-Green-I 
Roche Diagnostics GmbH,Germany 
Lipofectamine 2000 Invitrogen GmbH, Germany 
L-α-lyso-lecitine Calbiochem, EMD Biosciences Inc., USA 
Manganese chloride (MnCl2) Fluka® Analytical, Germany 
2-Mercaptoethanol Carl Roth GmbH & Co KG, Germany 
Methanol Merck-Eurolab GmbH; Germany 
Milk powder Merck KGaA, Germany 
NP-40 (Igepal CA-630) Sigma-Aldrich Chemie GmbH, Germany 
NEB Buffer 
1.1; 2.1; 3.1 and Cut Smart 
New England Biolabs Inc., Germany 
Opti-MEM® Gibco, Thermo Fisher Scientific Inc., USA 
Orange G Sigma-Aldrich Chemie GmbH, Germany 
PageRuler Plus Prestained 
Protein Ladder 
Thermo Fisher Scientific Inc., USA 
Penicillin/Streptomycin 100x Gibco, Thermo Fisher Scientific Inc., USA 
Phenol Carl Roth GmbH & Co KG, Germany 
piperazine-N,N′-bis(2-ethanesulfonic 
acid) (PIPES) 
Sigma-Aldrich Chemie GmbH, Germany 
Polyacrylamide Carl Roth GmbH & Co KG, Germany 
Polyethylenimin (PEI) Polyscience Europe GmbH, Germany 
Poly-L-Lysine Sigma-Aldrich Chemie GmbH, Germany 
Potassium chloride ICN Biomedicals Inc., Germany 
protein G Sepharose 4 Fast Flow GE Healthcare, Germany 
Puromycin AppliChem GmbH, Germany 
Salmon Sperm Invitrogen GmbH, Germany 
Select Agar Invitrogen GmbH, Germany 
SiR-tubulin Spirochrome AG, Switzerland 
Sodium acetate Merck-Eurolab GmbH, Germany 
Sodium azide Sigma-Aldrich Chemie GmbH, Germany 
Sodium borate Sigma-Aldrich Chemie GmbH, Germany 
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Sodium dodecylsulfate (SDS) Serva Electrophoresis GmbH; Germany 
Sodium chloride Merck-Eurolab GmbH, Germany 
Sodium hydroxide Carl Roth GmbH & Co KG, Germany 
Strep-Tactin® Sepharose® Iba GmbH, Germany 
T4 DNA Ligase Buffer (10x) Affymetrix Inc., USA 
Thymidine Sigma-Aldrich Chemie GmbH, Germany 
TEMED Carl Roth GmbH & Co KG, Germany 
Tris-Base AppliChem GmbH, Germany 
Tris-EDTA pH 8.0 Carl Roth GmbH & Co KG, Germany 
Triton-X100 Sigma-Aldrich Chemie GmbH, Germany 
Trypsin-EDTA Gibco, Thermo Fisher Scientific Inc., USA 
Tween-20 AppliChem GmbH, Germany 
VectaShieldTM Mounting Medium Vector Laboratories Inc., USA 
XfectTM transfection reagent Clontech, Takara Bio USA Inc., USA 
 
 Kits 3.1.5
 
Kits used during this project are listed in Table 7. 
 
Table 7 Kits used in this work 
Kit Distributor 
JetStar 2.0 plasmid purification kit Genomed GmbH, Germany 
NucleoSpin Gel and PCR Clean-up kit Macherey-Nagel GmbH & Co KG, Germany 
CloneJET PCR Cloning Kit 
MBI Fermentas, Thermo Fisher Scientific Inc., 
Germany 
 
 Buffer 3.1.6
 
Buffer compositions of protocols performed during this work are indicated from 
Table 8 to Table 13. 
 
Table 8 Buffer for generation of chemical competent DH5α 
Buffer name Buffer composition 
Inoue Wash Buffer 55 mM MnCl2, 15 mM CaCl2, 250 mM KCl, 10 mM PIPES 
Inoue Buffer Inoue Wash Buffer, DMSO 
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Table 9 Buffer for plasmid rescue assay 
Buffer name Buffer composition 
TEN Buffer 10 mM Tris-HCl pH 7.5, 1 mM EDTA, 150 mM NaCl 
2xHIRT Buffer 20 mM Tris-HCl pH 7.5, 20 mM EDTA, 1.2 %SDS 
 
Table 10 Buffer for cell lysis and Western Blot 
Buffer name Buffer composition 
RIPA extract Buffer 50 mM Tris-HCl pH 7.9, 150 mM NaCl, 1 % NP-40, 0.2 % SDS 
5xLaemmli Buffer 
250 mM Tris pH 6.8, 10 % SDS, 500 mM DTT, 25 % Glycerol, 0.5 % 
Bromphenolblue 
8 % polyacrylamide 
separation gel 
8 % polyacrylamide, 3.4 mM SDS, 375 mM Tris pH 8.8 
13 % polyacrylamide 
separation gel 
13 % polyacrylamide, 3.4 mM SDS, 37  mM Tris pH 8.8 
Stacking gel 4 % polyacrylamide, 3.4 mM SDS, 125 mM Tris pH 6.8 
1xRunning Buffer 192 mM Glycine, 3.4 mM SDS, 24 mM Tris pH 7.4 
Blotting Buffer 1xRunning Buffer, 20 % MeOH 
ECL developing solution 1 ml solution A (100 mM Tris pH 8.8, 200 mM p-cumaric acid, 
1.25 mM Luminol), 3 µl solution B (3 % (v/v) H2O2) : 
 
Table 11 Buffer for covalent coupling of antibodies to protein A/G sepharose beads 
Buffer name Buffer composition 
Sodium borate Buffer 0.2 M sodium borate pH 9.0 
DMP Buffer Sodium borate Buffer, 20 mM DMP 
Ethanolamine Buffer 0.2 M ethanolamine pH 8.0 
Sodium azide Buffer PBS, 0.01 % sodium azide 
 
Table 12 Buffer for Co-precipitation 
Buffer name Buffer composition 
Permeabilizing buffer 50 mM Tris pH 7.9, 10 mM NaCl, 2 mM CaCl2, 150 mM sucrose 
Lysis buffer 
10 mM Tris pH 6.8, 5 mM EDTA, 600 mM NaCl, 1x complete protease 
inhibitor 
Dilution buffer 10 mM Tris pH 6.8, 5 mM EDTA, 1x complete protease inhibitor 
LiCl 
250 mM LiCl, 0.1 % SDS, 0.5 % DOC, 1 % NP-40, 50 mM Tris pH 8.0, 
1 mM EDTA 
RIPA-300 
300 mM NaCl, 0.1 % SDS, 0.5 % DOC, 1 % NP-40, 50 mM Tris pH 8.0, 
1 mM EDTA 
RIPA-150 
150 mM NaCl, 0.1 % SDS, 0.5 % DOC, 1 % NP-40, 50 mM Tris pH 8.0, 
1 mM EDTA 
1xTE Tris-EDTA pH 8.0 
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Table 13 Buffer for ChIP and STREP pull down 
Buffer name Buffer composition 
2% Formaldehyde PBS, 2 % Formaldehyde 
LB3(+) Buffer 
25 mM Hepes pH 7.5, 140 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 
0.5 % Sarcosyl, 0.1 % DOC, 0.5 % Triton-X-100, 1x complete protease 
inhibitor 
Blocking Solution 
0.5 mg/ml BSA, 30 µg/ml salmon sperm, 1x complete protease 
inhibitor, 0.1 % Triton-X-100 in LB3(-) buffer (without detergents) 
LiCl 
250 mM LiCl, 0.1 % SDS, 0.5 % DOC, 1 % NP-40, 50 mM Tris pH 8.0, 
1 mM EDTA 
RIPA-300 
300 mM NaCl, 0.1 % SDS, 0.5 % DOC, 1 % NP-40, 50 mM Tris pH 8.0, 
1 mM EDTA 
RIPA-150 
150 mM NaCl, 0.1 % SDS, 0.5 % DOC, 1 % NP-40, 50 mM Tris pH 8.0, 
1 mM EDTA 
1xTE Tris-EDTA pH 8.0 
 
 Plasmids 3.1.7
 
Plasmids used for ChIP, IF and plasmid maintenance experiments are given in Table 
14. 
 
Table 14 Reporter plasmids used for ChIP, IF and plasmid maintenance experiments 
Plasmid  
(AGV identification) 
Plasmid description 
3279 CMV-EBNA1∆GA 
3230 FR-DS + GFP; oriP 
3293 40xtetO-DS + GFP 
3448 20xtetO-DS + GFP + sctetR:HMGA1a 
6083 20xtetO-DS + GFP + CMV-sctetR:CENP-A; pCONCENP-A 
5600 40xtetO-DS + sctetR:GFP:CENP-A; pCONCENP-A 
5602 40xtetO-DS + sctetR:GFP 
4292 20xtetO-DS + GFP + miniEcad-sctetR:CENP-A; pCONCENP-A 
6437 
20xtetO-DS-40xCas9 targ. + GFP + sctetR:CENP-A; 
pCONCENP-A + Cas9 targeting 
6359 
40xtetO-DS-10xCas9 targ. + sctetR:GFP:CENP-A;  
pCONCENP-A + Cas9 targeting 
 
Plasmids used for cloning the CRIPR/Cas9 targeting system are listed in Table 15. 
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Table 15 Plasmids used for CRISPR/Cas9 cloning 
Plasmid  
(AGV identification) 
Plasmid description 
6350 sgRNA A66407 expressing plasmid 
6351 10xCas9 targeting sequence (GeneScript) 
6372 20xCas9 targeting sequence 
6378 40xCas9 targeting sequence 
6339 CMV-Cas9:3xmCherry (addgene #64108) 
4202 MiniEcad promoter 
6367 MiniEcad-Cas9:3xmCherry 
6395 CMV-Cas9:mCherry:TAP 
 
3.2 Methods 
 
In this chapter detailed information about experimental procedures during this work 
is given. 
 
 Molecular biological methods 3.2.1
 
This chapter deals with cloning techniques, PCR amplification and plasmid 
purification from bacteria. 
 
 Cloning strategies 3.2.1.1
 
Multimerization of Cas9 targeting sites 
 
For multimerization of Cas9 targeting sites the decamer plasmid (6351, see Table 15) 
was digested with BamHI and BglII. The same plasmid was digested with BamHI for 
linearization (= vector) and with BamHI + BglII for isolating the 10x Cas9 targeting 
sequence (= insert). Ligation of the decamer sequence and the linearized plasmid 
with the decamer sequence led to the 20x Cas9 targeting sequence plasmid. 30x and 
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40x Cas9 targeting sequence was generated by BamHI and BglII digest as well. After 
generating different numbers of repeats, those were cloned into reporter plasmids by 
restriction sites SpeI, KpnI or BssHII next to tetO repeats. 
 
Cloning of Cas9:mCherry:TAP  
 
The Cas9:3xmCherry plasmid was ordered from addgene (addgene #64108). It was 
used for multicolor imaging of chromosomal loci by Ma et al. (Ma et al., 2015). The 
TAP tag, consisting of a tandem STREP and a Flag tag, was cloned onto the Cas9 
protein of this Cas9:3xmCherry plasmid. Final fusion protein was generated as 
depicted in Figure 17. 
 
 
 
 
 
 
 
For cloning STREP-STREP-Flag onto Cas9:mCherry a PCR was performed to amplify 
STREP-STREP-Flag with specific restriction sites (see Table 16), NotI and XhoI. 
 
Table 16 Primer for PCR for cloning Cas9:mCherry:TAP 
Primer name Sequence 
Cas9_for (783) gagagcggccgcagctggagccaccctcagttc 
Cas9_rev (785) tctcctcgagatttcgaaattcatttatcatcatcatctttataatcctctcc 
 
Figure 17 schematic representation of Cas9:mCherry:TAP fusion 
protein 
The Cas9 fusion protein consists of a nuclear localization signal (NLS) to 
be transported into the nucleus for binding DNA. Cas9 domain binds, 
together with sgRNA, the target DNA. mCherry is for visualization of 
the protein within the nucleus. TAP tag consists of tandem STREP and 
Flag. 
3 MATERIALS & METHODS 
 
 
42 
After PCR, pJET1.2 ligation and bacterial amplification of pJET1.2 plasmid with PCR 
product, the vector plasmid, Cas9:3xmCherry plasmid (6339, Table 15), was digested 
with NotI + XhoI and the insert plasmid, STREP-STREP-Flag in pJET1.2 was also 
digested with NotI + XhoI. Both were ligated and transformed into bacteria. 
 
 Polymerase Chain Reaction (PCR) 3.2.1.2
 
Polymerase chain reaction (PCR) is used for specific amplification of DNA fragments 
(Mullis et al., 1986). Specific primer pairs, designed to amplify the TAP tag from a 
template plasmid were used. The reaction with pwo polymerase was performed in 
50 µl total volume and with 50 pg template DNA according to manufacturer’s 
instructions. Temperature profile used for the reaction is shown in Table 17. 
 
Table 17 PCR program for cloning Cas9:mCherry:TAP 
 Temperature Duration Cycles 
Pre-incubation 94 °C 5 min 1 
Amplification 
94 °C 30 sec 
25 59 °C 30 sec 
68 °C 45 sec 
Amplification 68 °C 5 min 1 
Cooling 4 °C ∞ 1 
 
The annealing temperature was calculated according to the respective primer 
melting temperature. PCR products were gel purified by the NucleoSpin Gel and 
PCR clean up kit and cloned into the pJET1.2 vector according to manufacturer’s 
instructions.  
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 Generation of chemical competent DH5α bacteria 3.2.1.3
 
Generation of chemical competent DH5α was done as described in Cold Spring 
Harbor protocol of Sambrook et al. (Sambrook and Russell, 2006) 
In brief, a stock of previously prepared competent DH5α was used to inoculate a new 
25 ml starting culture. Bacteria were incubated on an orbital shaker for six to eight 
hours at 37 °C and 200 rpm. Overnight incubation of a 250 ml culture was performed 
by inoculation 1 ml of the starting culture in 250 ml pre-cooled LB medium and 
keeping them on an orbital shaker at 18 °C and 200 rpm. The next day the culture 
was diluted to an OD600 of 0.05 in a total volume of 400 ml. After another overnight 
incubation at 18 °C and 200 rpm, OD600 measurement was performed continuously 
until an OD600 of 0.55 was reached. Bacteria were kept on ice-water for 10 min and 
then harvested by centrifugation at 2500 g for 10 minutes at 4 °C. Medium was 
discarded and cells were resuspended in 80 ml ice-cold Inoue wash buffer. Cells 
were centrifuged as described before and resuspended in 20 ml of ice-cold Inoue 
buffer supplemented with 1.5 ml DMSO. After incubation for 10 min at 4 °C aliquots 
of 500 µl bacteria suspension were prepared. Bacteria were stored at -80 °C until use 
after snap-freezing the aliquots in liquid nitrogen. 
 
 Transformation 3.2.1.4
 
For transformation chemical competent Escherichia coli strain DH5α were thawed on 
ice and 100 μl of bacteria were mixed with plasmid DNA. The mixture was incubated 
30 minutes on ice, transferred to 42 °C for 90 seconds and stored on ice for five 
minutes. Samples were diluted in 1 ml LB medium and incubated on the 
thermomixer for 45 minutes at 37 °C. After centrifugation for 5 min at 250 g 
supernatant was discarded and pelleted bacteria were resuspended in 200 µl fresh LB 
medium. Bacteria were plated on selective ampicillin (100 mg/ml) agar plates and 
incubated for 16 h at 37 °C.  
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 DNA preparation (Mini-prep.) 3.2.1.5
 
Single colonies grown on selective agar plates were selected and inoculated into 3 ml 
LB medium containing ampicillin (100 mg/ml). The cultures were incubated for 16 h 
at 37 °C at 200 rpm in an orbital shaker. 3 µl of bacterial culture was plated on 
selective agar plates; 2 ml culture was used to extract plasmid DNA.  
Bacteria were pelleted by centrifugation for 10 min at 1500 g and 4 °C and 
resuspended in 100 µl E1 resuspension buffer (all “E” buffers were from JetStar 2.0 
plasmid purification kit). By adding 100 µl E2 and inverting three times, cells were 
lysed by alkaline lysis for 5 min at room temperature. Adding 100 µl E3 buffer leads 
to precipitation of bacterial DNA and proteins. After centrifugation for 20 min at 
16100 g and 4 °C, the supernatant was transferred into 900 µl ice-cold 100 % Ethanol. 
Plasmid DNA is precipitated by centrifugation for 30 min at 16100 g and 4 °C. After 
sequential wash with 500 µl 70 % and 100 % Ethanol the pellet was air-dried for 
15 min and resuspended in 30 to 50 µl 1xTE. 
 
 Sequencing 3.2.1.6
 
Samples were prepared from purified plasmid DNA in a concentration of 50 -
 100 ng/µl in a total volume of 15 µl. For sequencing a general pJET1.2 primer was 
added by Eurofins Genomics, Germany. 
Sequences obtained from Eurofins were compared to in silico sequences generated 
with MacVector by the ClustalW alignment tool. Plasmids with matching sequences 
were re-transformed into DH5α and inoculated into 400 ml LB medium. After 
overnight incubation at 37 °C and 200 rpm bacteria were harvested and plasmid 
DNA was extracted (see chapter 3.2.1.7). 
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 High amount DNA preparation (Maxi-prep.) 3.2.1.7
 
A 400 ml LB bacteria culture was incubated 16 h at 37 °C and 200 rpm in an orbital 
shaker. Plasmid DNA was extracted with the JetStar 2.0 plasmid purification kit 
according to manufacturer’s instructions. 
After centrifugation for 15 min at 2800 g and 4 °C, cells were resuspended in 10 ml E1 
buffer. Lysis was done by adding 10 ml E2 buffer and incubating for 5 min at room 
temperature. For neutralization E3 buffer was added and after inverting the 
suspension a centrifugation for 30 min at 20000 g and 4 °C followed. Supernatant was 
filled into an equilibrated column. Bound DNA was washed with 60 ml E5 buffer 
end eluted from the column with 15 ml elution buffer E6 into a 50 ml tube. By adding 
10.5 ml 2-propanol and centrifugation for 45 min and 2800 g plasmid DNA was 
precipitated. Pellet was washed with 70 % and 100 % Ethanol, air-dried for 15 min 
and resuspended in 500 to 1000 µl 1xTE buffer. DNA concentration was determined 
with NanoDrop® ND-1000 spectrometer and samples were stored at -20 °C. 
 
 Restriction digest and dephosphorylation 3.2.1.8
 
For control digest of mini-plasmid preparations 2-5 units restriction enzyme for 1-
2 µg DNA were used. Sample was diluted to 20 µl total volume in the appropriate 
buffer (NEB 1.1, 2.1, 3.1 or CutSmart). In restriction digests for further cloning (vector 
and insert digest) 4 µg plasmid was digested in higher volume. After incubation for 
1 h at 37 °C enzymes were heat inactivated by incubating for 20 min at 65 °C or 80 °C 
according to manufacturer’s instructions. 
After heat inactivation of restriction digest, 1 unit CIP was added to the sample to 
prevent re-ligation of vector DNA. Directly after incubation for 30 min at 37 °C 
samples were loaded into an agarose gel. 
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 Agarose gel electrophoresis 3.2.1.9
 
DNA was separated according to expected fragment size in a 1-1.5 % agarose gel 
supplemented with 3 µl/100 ml ethidium bromide. 6xOrange G was added to the 
samples before loading them onto the gel. GeneRuler DNA Ladder Mix was used to 
determine fragment sizes. Electrophoresis was done at 100 V and 400 mA for 1 h.  
Separated DNA fragments were either extracted for ligation and further cloning 
(chapter 3.2.1.10) or analyzed by UV excitation in a gel documentation system. 
 
 Gel extraction 3.2.1.10
 
DNA fragments were cut from agarose gel and purified with the NucleoSpin Gel and 
PCR Clean-up kit according to manufacturer’s instructions. 
In brief, agarose containing DNA was dissolved in 200 µl NT buffer per 100 µg gel for 
5-10 min at 50 °C. This sample was loaded onto a SpinColumn and centrifuged for 
30 sec at 11000 g. After washing two times with 700 µl NT3 buffer and drying column 
membrane by centrifugation for 1 min at 11000 g, DNA was eluted twice with 15 µl 
water. Eluted DNA concentration was ascertained with NanoDrop® ND-1000 
spectrometer.  
 
 Ligation 3.2.1.11
 
Ligation was performed to covalently combine the digested insert with the digested 
vector fragment, both having compatible ends according to restrictions enzymes. 
Ligases were used as enzymes to build phosphodiester bounds between 3’-OH and 
neighboring 5’-phosphate groups. Two controls were conducted. Re-ligation control 
was performed without insert. Incomplete digest control for vector DNA digest was 
3 MATERIALS & METHODS 
 
 
47 
conducted without the insert and the ligase. Ligation reaction mix was composed as 
following: 
0.5 µl T4 DNA ligase 
1.5 µl 10x T4 DNA ligase buffer 
x µl Vector 
y µl Insert 
1 µl 10 mM ATP 
2 µl 50 % PEG 6000 
ad 15 µl H2O 
 
The molar ratio of Vector:Insert was between 1:5 to 1:10, calculated from molecular 
weight and concentration of fragments. After mixing, reactions were incubated for 
12-16 h at 16 °C. Transformation of ligated plasmids was done with 4 µl of ligation 
reaction in chemical competent DH5α cells. 
 
 Cell culture 3.2.2
 
For all my experiments I used HEK293 cell lines. In Table 18 a short description of the 
cell line, the AGV internal identification and the information about cultivation 
conditions is listed. 
 
 Cultivation of HEK293 cell lines 3.2.2.1
 
HEK293EBNA1+ cells were cultivated at 37 °C and 5 % CO2 in DMEM medium 
supplemented with 8 % FBS, 220 µg/ml G418 and 1x Pen/Strep (100 units/ml 
Penicillin and 100 µg/ml Streptomycin). Cells were grown to 80 % confluence on 
15 cm dishes and split 1:4 to 1:6 every three to four days. To split cells they were 
washed with 10 ml PBS and treated with 2 ml 0.25 % Trypsin-EDTA for 5 min at 
room temperature. After incubation cells were resuspended in new growth medium 
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and partly transferred to a new cell culture dish. For cell lines expressing additional 
sctetR fusion proteins, puromycin was added according to Table 18. 
Table 18 Essential cell line information 
Cell lines  
(AGV identification) 
Description Medium 
HEK293  
(#43) 
Human embryonic kidney 
cells transformed with 
adenovirus 5 
DMEM, 8 % FBS, 
1 % Penicillin/Streptomycin 
HEK293EBNA1+ 
(#1803) 
Human embryonic kidney 
cells, stably expressing 
EBNA1 
DMEM, 8 % FBS, 
1 % Penicillin/Streptomycin, 
220 µg/ml G418 
HEK293EBNA1+ + sctetR 
(#1456) 
Human embryonic kidney 
cells, stably expressing sctetR 
DMEM, 8 % FBS, 
1 % Penicillin/Streptomycin, 
700 ng/ml Puromycin 
HEK293EBNA1+ + 
sctetR:H3.3 
(#2126) 
Human embryonic kidney 
cells, stably expressing 
sctetR:H3.3 
DMEM, 8 % FBS, 
1 % Penicillin/Streptomycin, 
300 ng/ml Puromycin 
HEK293EBNA1+ + 
sctetR:CENP-A 
(#2419) 
Human embryonic kidney 
cells, stably expressing 
sctetR:CENP-A 
DMEM, 8 % FBS, 
1 % Penicillin/Streptomycin, 
300 µg/ml Puromycin 
HEK293EBNA1+ + 
sctetR:CENP-Amut 
(#2506) 
Human embryonic kidney 
cells, stably expressing 
sctetR:CENP-Amut 
DMEM, 8 % FBS, 
1 % Penicillin/Streptomycin, 
300 µg/ml Puromycin 
HEK293EBNA1+  
(#2901) 
Generated from cell line #43 
by integrating expression 
plasmid 3279 
DMEM, 8 % FBS, 
1 % Penicillin/Streptomycin, 
400 µg/ml G418 
 
 Determination of cell number 3.2.2.2
 
To count the cells, they were trypsinized and resuspended in growth medium as 
described before. Cell suspension was transferred into a falcon tube and 10 µl were 
used to spot on a Neubauer cell counting chamber. Total cell number was 
determined by following equation:  
 
𝑡𝑜𝑡𝑎𝑙 𝑐𝑒𝑙𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 =
𝐶𝑒𝑙𝑙 𝑐𝑜𝑢𝑛𝑡
𝑐𝑜𝑢𝑛𝑡𝑒𝑑 𝑠𝑞𝑢𝑎𝑟𝑒𝑠
 𝑥 104  𝑐𝑒𝑙𝑙𝑠 𝑚𝑙⁄ 𝑥 𝑣𝑜𝑙𝑢𝑚𝑒 [𝑚𝑙]  
Cells were seeded according to the calculated cell concentration after counting. 
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 Generation of stable cell lines 3.2.2.3
 
For generation of stable cell lines expressing EBNA1 from the CMV promoter, cells 
were seeded in a 6-well to a density of 2x 105 and transfected with 2 µg linearized 
expression plasmid 3279 (see Table 14) using Lipofectamine2000 according 
manufacturer’s instructions (detailed information about transfection procedure is 
given in 3.2.2.5). Transfected cells from one 6-well were plated in medium with 300, 
400 and 500 µg/ml G418 on three 15 cm culture dishes the next day. After two to 
three weeks, single colonies from the 400 µg/ml G418 selected cells were separated 
and expanded in 6 well plates. Expression of EBNA1 was verified by Western Blot 
and immune fluorescent staining. 
 
 Cryoconservation 3.2.2.4
 
HEK293EBNA1+ cells were grown to confluence and three vials were frozen from 
one 15 cm cell culture dish. Cells were pelleted and resuspended in a suspension of 
90 % FBS mixed with 10 % DMSO. They were frozen to – 80 °C and after a few days 
cells were transferred to the liquid nitrogen tank for long-term storage. 
For thawing, cells were quickly warmed to 37 °C, washed with 10 ml fresh medium 
to remove remaining DMSO and plated on a new 15 cm cell culture dish in 20 ml of 
fresh growth medium. 
 
 Transfection for plasmid maintenance experiments 3.2.2.5
 
Transfections for plasmid maintenance experiments with Lipofectamine 2000 were 
performed according to manufacturer’s instructions. In brief, 4x 105 cells were seeded 
per well into a 6-well plate and transfected 24 h later. 2 μg of plasmid DNA and 4 μl 
of Lipofectamine2000 were diluted separately with Opti-MEM medium to a final 
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volume of 50 μl each and incubated for five minutes. Subsequently, both solutions 
were mixed and incubated for 20 min at room temperature. The resulting 100 μl 
transfection solution was applied to the cells drop-wise. 24 hours after transfection 
cells were transferred to a 15 cm cell culture dish in fresh DMEM growth medium 
containing 120 µg/ml hygromycin.  
 
 Transient transfection 3.2.2.6
 
Transient transfections were carried out with the transfection reagent 
polyethylenimin (PEI) in 6-well plates. 4x 105 cells were seeded per well into a 6-well 
plate and transfected 24 h later. 2 µg DNA of corresponding plasmid were mixed 
with 300 µl DMEM-FBS (DMEM without FBS but supplemented with 
Penicillin/Streptomycin and 1 % HEPES). PEI transfection reagent was also mixed 
with 300 µl DMEM-FBS in a ratio of 3 µg PEI per 1 µg DNA. Both solutions were 
combined and vortexed for 10 sec. Reaction was incubated for 20 min at room 
temperature and drop-wise distributed onto the cells. After four hours incubation, 
the medium was replaced by normal cell growth medium and cells were incubated 
for 16 h at 37 °C in the incubator.  
The next day, cells were plated on 10 cm (1 well) or 15 cm (2 wells) for further 
experiments. 
 
 Cell synchronization with thymidine block 3.2.2.7
 
Synchronization was done by a double thymidine block and release. Thymidine 
blocks cells during S-phase by influencing the formation of a regulatory dCTP pool, 
which is important for DNA synthesis (Bjursell and Reichard, 1973). 
Cells were seeded in 6-wells, 2x 105 cells per well, in 1 ml normal growth medium 
and incubated for 8 h at 37 °C and 5 % CO2. 1 ml thymidine medium (8 mM 
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thymidine in normal DMEM growth medium) was added and incubated for 16 h. 
Cells were released from block by washing twice with PBS and coating them with 
1 ml growth medium. Second block was done 8 h later by adding again 1 ml 8 mM 
thymidine medium for 16 h. Final release followed by washing twice with PBS and 
coating cells with 2 ml growth medium for 8 h, until mitosis. 
 
 Transient transfection of synchronized cells 3.2.2.8
 
Cells from three 6-well plates were released from block as described in chapter 
3.2.2.7. After 8 h incubation at 37 °C and 5 % CO2, cells were transfected according to 
PEI transfection protocol (described in detail in chapter 3.2.2.6) with three different 
reporter plasmids, the tetO-DS sctetR:CENP-A reporter plasmid, the tetO-DS 
sctetR:HMGA1a control and the oriP control. 
I replaced normal growth medium by 1 ml DMEM without serum. One 6-well plate 
was transfected with one reporter plasmid. To each well 600 µl transfection reaction 
mix, containing 200 ng reporter plasmid and 1.8 µg fill-up plasmid (LacO plasmid), 
was added drop-wise after incubation of transfection mixture for 20 min at room 
temperature. Cells were incubated for 4 h at 37°C and 5 % CO2. Afterwards medium 
was replaced by normal growth medium containing FBS and placed into the 
incubator. One well each also contained also 2 µg/ml doxycycline (day0). On the 
next day wells were transferred to 10 cm cell culture dishes. Doxycycline was added 
to one additional plate as well (day1). On day2 and day4 medium of one plate each 
was replaced by medium containing 2 µg/ml doxycycline. Cells were split every 
three to four days and doxycycline medium was replaced every second day. On day9 
cells were harvested for FACS analysis (see chapter 3.2.4). 
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 Transient transfection for live cell imaging 3.2.2.9
 
In total 5 µg plasmids were transfected with XfectTM Polymer as transfection reagent 
according to manufacturer’s instructions. A short description about procedure is 
given in the following. 4x 105 HEK293EBNA1+ cells were seeded in 6-wells the day 
before transfection. Reporter plasmid carrying sctetR:GFP:CENP-A, tetO-DS and the 
Cas9 targeting sites (1.5 µg) (6359, Table 14) was mixed with CMV-Cas9:3xmCherry 
(0.5 µg) and the sgRNA expression plasmid (3 µg) in 100 µl XfectTM reaction buffer 
total volume. This mixture was vortexed for 5 sec. Afterwards 1.5 µl XfectTM Polymer 
was added to the diluted plasmids and vortexed again for 10 sec. After incubation for 
10 min at room temperature and brief centrifugation, the 100 µl transfection solution 
was added drop-wise to the cell culture medium. Cells were incubated overnight at 
37 °C in the incubator. The next day cells were transferred on 10 cm dishes and 
grown for additional three days. On day four after transfection cells were counted 
and seeded into ibidi® live cell imaging slides. Depending on the experiment, cells 
were stained with live cell tubulin dye, SiR-tubulin (for further details see chapter 
3.2.10). 
 
 Plasmid rescue assay 3.2.3
 
For the analysis of long-term plasmid maintenance reporter plasmids were 
transfected and selected for two weeks. After two weeks selection pressure was 
either removed or cells were kept further under selection as controls. Every two 
weeks a plasmid rescue assay was performed. Therefore, cells were lysed and 
plasmid DNA was enriched according to the HIRT protocol (Hirt, 1966). 
In detail, after washing confluent cells with 10 ml PBS on the dish, cells were 
equilibrated in 5 ml TEN buffer. TEN was removed and cells were coated with 1.5 ml 
TEN buffer and an equal volume of 2xHIRT buffer was added for cell lysis. Cell lysis 
was performed on the dish by tilting the plate for 1 min. The lysate was collected in a 
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flip-cap tube and genomic DNA and proteins precipitated at 4 °C for 16 h, in the 
presence of 1 M NaCl. After centrifugation for 45 min at 4 °C and 20000 g, DNA was 
purified by phenol-chloroform extraction, precipitated with ethanol and 
resuspended in 100 µl 1xTE buffer. 
DNA samples were digested with 40 units DpnI in presence of 0.5 µl RNase. 350 ng 
digested DNA was electroporated into Electromax DH10β competent cells. For 
electroporation all buffers and cuvettes were cooled throughout the procedure. 100 μl 
of bacteria were diluted with 500 µl ice-cold water and 100 μl of this diluted 
suspension were mixed with 50 μl DNA (350 ng) sample. Electroporation was 
performed in 1 mm cuvettes at 25 μF and 2.5 kV. After electroporation cells were 
transferred in 3 ml of LB medium and incubated on a shaker at 37 °C for 45 min. 
Afterwards cells were pelleted, plated on selective ampicillin agar plates and 
incubated overnight at 37 °C. The ampicillin-resistant colonies, representing the 
number of recovered plasmids, were counted the next day. For calculations the 
colony number obtained at the first plasmid rescue, one week after removal of 
selection pressure, was used for normalization. 
 
 Flow cytometry 3.2.4
 
Cells for flow cytometry were harvested by trypsinization and resuspending in 5 ml 
PBS containing 2 % FBS. After centrifugation at 250 g and 4 °C for 7 min cell pellet 
was resuspended in 1 ml PBS and transferred into FACS tubes. These tubes were 
kept on ice during measurement time. Cells were diluted that only 1000 to 1500 
events per second were measured in BD FACSCalibur device. Measurement stopped 
after counting 105 events. Gating for living, intact cells was done afterwards by 
analysis in the FlowJo program. Therefore, only cells having defined size (forward 
scatter) and defined granulation profile (side scatter) were gated. Out of this 
population the percentage of gfp positive cells was determined.  
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 Western Blot 3.2.5
 
RIPA protein extraction was performed by harvesting HEK293 cells with trypsin and 
transferring into falcon tubes. After washing twice with ice-cold PBS cell suspension 
was centrifuged (600 g, 7 min, 4 °C). Pellet was resuspended in two pellet volumes 
RIPA extract buffer supplemented with 1x complete protease inhibitor and incubated 
for 20 minutes on ice. Lysate was vortexed for 15 sec and centrifuged at 16100 g, 
20 min, 4 °C. The protein concentration of the supernatant was determined using 
Bradford reagent and 20 to 50 µg protein extract with 1x Laemmli buffer was loaded 
on the SDS gel after boiling for 5 min at 95 °C. The remaining supernatant was stored 
at -20 °C for long time storage. 
Depending on predicted proteins size extracts were separated on an 8 % or 13 % 
SDS-polyacrylamide gel and blotted on Amersham Hybond ECL membrane using 
semiDry blotting system. Protein separation and transfer onto the membrane was 
verified by ponceau stain and the membrane was blocked for 1 h in 5 % milk in PBS, 
0.1 % Tween-20. Incubation with primary antibody (dilution see Table 5), was 
performed in 2.5 %milk in PBS, 0.1 % Tween-20 for 16 h at 4 °C. Afterwards, 
membrane was washed 3x 5 min with PBS, 0.1 % Tween-20 and incubated with 
secondary HRP coupled antibody 1:10000 in 2.5 % milk in PBS, 0.1 % Tween-20 for 
1 h at room temperature. After repeated washing steps (3x 10 min in PBS, 0.1 % 
Tween-20), revelation was done using ECL containing H2O2 on CEA Blue Sensitive 
X-ray films. 
 
 Co-Immune precipitation of sctetR fusion proteins 3.2.6
 
For co-immune precipitation 5x 107 cells were harvested. Cells were trypsinized and 
resuspended in ice-cold PBS supplemented with 5 % FBS. After centrifugation (250 g, 
4 °C, 7 min) cell pellet was washed with 50 ml PBS and transferred into an eppendorf 
tube with 1 ml PBS. Cells were permeabilized by lysolecithin. Therefore, cell pellet 
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was resuspended in 1 ml permeabilizing buffer and 100 µl pre-warmed 1 % 
lysolecithin solution was added. Suspension was incubated for 5 min at 37 °C and 
70 units MNase were added and mixed by inverting 5 times. Samples were incubated 
for 30 min at 37 °C. MNase reaction was stopped by adding 50 µl 0.5 M EGTA (final 
concentration 20 mM). Nuclei were pelleted by centrifugation (400 g, 3 min, 4 °C) and 
was performed in 500 µl lysis buffer on ice for 30 min. By high speed centrifugation 
at 16100 g for 15 min at 4 °C, cell fragments and aggregates were precipitated. 
Supernatant was used for co-immune precipitation. Two 50 µl aliquots were taken 
for MNase digest analysis and as input control for Western Blot. MNase digest 
control was treated with proteinase K and RNase A and DNA was extracted by 
phenol-chloroform extraction (as described in chapter 3.2.9.4). The supernatant for IP 
was transferred into 15 ml tubes and diluted with dilution buffer to a final 
concentration of 150 mM NaCl. IP buffer was supplemented with 0.5 % Sarcosyl, 
0.1 % DOC and 0.8 % Triton X-100. After pre-clearing with protein G beads 
(3x washed with PBS) for 2 h, 100 µl tetR antibody coupled beads (see appendix for 
coupling procedure) were added and incubated overnight at 4 °C on orbital shaker. 
A sequential wash with 1 ml RIPA-300, RIPA-150 and 1xTE followed. Elution was 
performed with 2x50 µl of 1xTE+1 % SDS for 5 min at room temperature on an 
orbital shaker. Elutions were combined and supplemented with 5xLaemmli buffer. In 
an 8 % PAGE IP of tetR was approved, in a 13 % PAGE co-precipitation of histone 
proteins was investigated.  
 
 Chromatin Immune Precipitation (ChIP) 3.2.7
 
For chromatin immune precipitation HEK293EBNA+ cells were transfected with the 
tetO-DS sctetR:HMGA1a (3448) and sctetR:CENP-A (6083) reporter plasmids in 
presence and absence of 2 µg/ml doxycycline were used. 
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 Cross-link 3.2.7.1
 
Cells were trypsinized, washed twice in 10 ml PBS with and without 4 µg/ml 
doxycycline and after centrifugation (250 g, 4 °C, 7 min) cell pellet was resuspended 
in 10 ml PBS with and without 4 µg/ml doxycycline. An equal volume of PBS 
supplemented 2 % methanol-free formaldehyde was added and cells were fixed for 
5 min on a roller at room temperature. The cross-link reaction was quenched with 
glycine (1.25 M). After incubation for one minute on the roller and 5 min on ice, cells 
were washed with once with ice-cold PBS. Nuclei preparation was performed in 
10 ml ice-cold PBS, 0.5 % NP-40 for 10 min on ice. After pelleting, nuclei were 
resuspended in PBS containing 10% glycerol, pelleted as 2x 107 cell aliquots and snap 
frozen in liquid nitrogen. 
 
 Sonication 3.2.7.2
 
Cross-linked cell pellets were thawed on ice and resuspended in 1 ml LB3+ buffer to 
a final concentration of 2x 107 cells/ml. Sonication was performed in AFA Fiber & 
Cap tubes (12x12 mm) at an average temperature of 5 °C to 7 °C. For sonication the 
Covaris S220 was used. Settings were established for HEK293EBNA1+ cells in a 
concentration of 2x 107 cells/ml at 100 W, 150 cycles/burst, 10 % duty factor for 
10 min. 
 
 Immune precipitation 3.2.7.3
 
After sonication, chromatin concentration was measured by NanoDrop® ND-1000 
Spectrometer and aliquots of 250 µg chromatin were prepared. Sheared chromatin 
was pre-cleared with 50 µl protein G beads (washed 3x in PBS, 50 % bead slurry 
prepared) for 2 h. 250 µg chromatin was incubated for 16 h at 4 °C with 50 µl of the 
31B3 α-tetR monoclonal antibody supernatant and as IgG control 50 µl α-HA 12CA5 
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monoclonal antibody supernatant was used. BSA-blocked protein G beads 
(incubated beads 16 h on roller in blocking solution at 4°C) were added (50 µl/ 250 µg 
chromatin) and incubated for 4 h on orbital shaker at 4 °C. Sequential washing steps 
with LiCl, RIPA-300, RIPA-150 buffer and finally twice in 1xTE (pH 8.0) buffer were 
performed. Immuno-precipitated chromatin fragments were eluted from the beads 
by shaking twice at 1200 rpm for 10 min at 65°C with 100µl of TE, 1 % SDS. The 
elution was treated with 80 µg RNAse A for 2 h at 37 °C and with 8 µg proteinase K 
at 65 °C for 16 h. DNA was purified using the NucleoSpin Gel and PCR Clean-up kit 
(and NTB binding buffer for SDS containing samples) according to manufacturer’s 
instructions. Quantitative PCR analysis was performed as described in 3.2.8 and 
quantitative PCR values were represented as fold enrichment relative to isotype IgG 
control or % input calculated relative to an input standard curve. Chromatin sizes 
were verified by loading 1-2 µg eluted DNA on a 1.5 % agarose gel.  
 
 Quantitative PCR (qPCR) 3.2.8
 
Quantitative PCR was performed with the Roche LightCycler® 480 System and the 
Light-Cycler®Fast-Start-DNA-Master-SYBR-Green-I (2xSYBR). 2 µl of ChIP elution 
were mixed with 8 µl master mix containing 5 µl 2xSYBR, 2.5 µl H2O, 0.5 µl 5 µM 
primer mix. Amplification was performed using the Roche SYBR standard program 
depicted in Table 19. qPCR primers are listed in Table 20.  
Table 19 Roche SYBR Green qPCR standard program 
 Temperature [°C] Duration [s] Cycles Detection 
Pre-incubation 95 300 1  
Amplification 
95 1 
45 
 
60 10  
72 10  
75 3 single 
Melting curve 
97 1 
1 
 
67 10 
(heat to 97°C) 
 
97 continuous 
Cooling 37 15   
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Primer pairs, listed in Table 20, detected specific fragments on plasmid DNA. These 
fragments resulted from sonication and precipitation in ChIP experiments or resulted 
from restriction enzyme digest during STREP pull down protocol.  
 
Table 20 qPCR primer 
Primer 
(Schepers group internal identification) 
Sequence [5’  3’]  
DS_for (284) TGTCATAGCACAATGCCACCAC 
DS_rev (285) GGTCAGGATTCCACGAGGGTAG 
FR_for (276) CGTGCTCTCAGCGACCTCG 
FR_rev (277) TCAAACCACTTGCCCACAAAAC 
Sc4_for (280) TCGGCGTCCACTCTCTTTCC 
Sc4_rev (281) CAGTAAGGTGTATGTGAGGTGCTCG 
tetO_for (383) GGGGGTGTTAGAGACAACCAGTG 
tetO_rev (384) GGCAGGGACCAAGACAGGTG 
reference_for (756) CGGCAACATCCTGGGGC 
reference_rev (757) CTGCTGGTAGTGGTCGGCG 
AseI_for (758) CACCACGATGCCTGTAGCAATG 
AseI_rev (759) AGCAATAAACCAGCCAGCCG 
AflIII_for (764) CAGTCAGAGAACCCCTTTGTGTTTG 
AflIII_rev (765) GACCACTAACCTTCGCTCCATACC 
Cas9_for (791) TTACTCTCTTCCCAAAGGATGTGC 
Cas9_rev (792) AAACCTGTCGTGCCAGAACTTG 
 
Digest efficiencies were calculated according to Hagege et al. (Hagege et al., 2007) as 
following:  
% 𝑟𝑒𝑠𝑡𝑟𝑖𝑐𝑡𝑖𝑜𝑛 =  100 −
100
2[(𝐶𝑡(𝑟𝑒𝑠)−𝐶𝑡(𝑐𝑜𝑛𝑡𝑟))𝑑𝑖𝑔 − (𝐶𝑡(𝑟𝑒𝑠)−𝐶𝑡(𝑐𝑜𝑛𝑡𝑟))𝑢𝑛𝑑]
 
 
 STREP pull down with Cas9:mCherry:TAP 3.2.9
 
HEK293EBNA1+ cells were transfected with 2 µg reporter plasmids tetO-DS + 
sctetR:CENP-A either with or without Cas9 targeting sites and selected for two 
weeks with 120 µg/ml hygromycin. These cells were seeded again and transfected 
with the sgRNA expression plasmid (1 µg) together with the Cas9:mCherry:TAP 
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expression plasmid (1 µg). After four days 108 cells were harvested by trypsinization 
and resuspension in PBS+5 %FBS. 
 
 Cross-link 3.2.9.1
 
Cells were washed 2x with 20 ml PBS. After second wash cell pellets were 
resuspended in 10 ml PBS and equal volume of PBS supplemented with 2 % 
formaldehyde was added. Cross-link was stopped after 5 min incubation at room 
temperature on the roller by adding 2.2 ml 1.25 M glycine and incubation for 5 min at 
room temperature. Cells were washed in 10 ml ice-cold PBS. Nuclei preparation 
followed by 30 min incubation in 20 ml PBS + 0.5 % NP-40 on ice. Nuclei were 
centrifuged at 600 g for 10 min and 4 °C. After washing in ice-cold PBS, cells were 
resuspended in 5 ml 3.1 buffer (concentration 2x 107 cells/ml). 
 
 
 French Press 3.2.9.2
 
To re-solubilize proteins and chromatin of interest, the 5 ml cell suspension in 
3.1 buffer was loaded into the French Press cell. Suspension was stored on ice and 
pressed three times with a pressure of 13000 psi in a pre-cooled 40000 K cell. After 
applying high pressure, lysate was aliquoted into 1 ml aliquots and frozen at -80 °C. 
Two aliquots were directly used for STREP pull down. 
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 Restriction digest 3.2.9.3
 
Two different restriction enzymes were selected to fragment plasmids for STREP pull 
down. The combination of AflIII and AseI (Figure 18) led to a higher probability for 
separation of exactly the fragment of interest, tetO array + Cas9 targeting sequence. 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the digest, 120 units AflIII and 120 units AseI were added to 2x 107 cells. The 1 ml 
aliquots were distributed into 5 aliquots and incubated for 2 h at 37 °C with 
1200 rpm. After incubation, aliquots were combined into one tube and centrifuged 
for 5 min at 500 g and 4 °C. 50 µl Controls were taken at each step to control re-
solubilization, digest efficiency and IP success by qPCR and Western Blot. 
 
Figure 18 Representation of tetO-DS 
sctetR:CENP-A + Cas9 plasmid 
tetO-DS sctetR:CENP-A reporter plasmid with Cas9 
targeting sites. AseI and AflIII restrictions sites are also 
depicted, together with qPCR products covering 
restriction sites. 
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 Pull down 3.2.9.4
 
Supernatant obtained after restriction digest was supplemented to final 
concentrations of 150 mM NaCl, 0.5 % Sarcosyl, 0.1 % DOC, 0.5 % Triton X-100 and 
1x complete protease inhibitor with these stock solutions. Pre-clearing was 
performed by adding 100 µl protein G sepharose beads (3x washed with PBS) for 1 h 
at 4 °C. Beads were removed by centrifugation for 5 min at 300 g and 4 °C. 
Supernatant was incubated with 150 µl STREP-tactin® bead slurry (equilibrated 3x 
with 3.1 buffer) for 16 h at 4 °C by constantly rotating on orbital shaker. Beads were 
sequentially washed with RIPA-300 buffer, RIPA-150 buffer and 1x TE buffer. 
Elution was performed by incubating the beads two times for 5 min at room 
temperature with 100 µl 1x TE + 0.5 % SDS. For Western Blot analysis, the cross-link 
war reverted for 1 h at 65 °C, 5x Laemmli was added and samples were boiled for 
5 min at 95 °C. 
qPCR controls were incubated for 1 h with RNase A at 37 °C and subsequently for 
16 h with proteinase K at 65 °C in 400 µl total volume. DNA was extracted by adding 
400 µl Phenol and incubation for 5 min at room temperature on orbital shaker. After 
centrifugation at 16100 g for 20 min and 4 °C, water-phase was transferred into new 
tube. 400 µl Chlorofom-Isoamylalcohol was added and incubated for 5 min on the 
orbital shaker. This step was repeated after centrifugation at 16100 g, 15 min, 4 °C. 
Water-phase was transferred into new tube and 2.5 volumes (1000 µl) 100 % ethanol 
and 40 µl Sodium-acetate were added. DNA precipitated overnight at -20 °C. 
Pelleting DNA was done by centrifugation at 16100 g, 30 min, 4 °C. After washing 
DNA pellet with 70 % and 100 % ethanol, it was resuspended in 50 µl 1xTE buffer. 
DNA concentration was determined using the NanoDrop® ND-1000 Spectrometer. 
Digestion and re-solubilization efficiency was investigated by loading 10 µl samples 
into a 1.5 % agarose gel and qPCR was performed as described in chapter 3.2.8. 
 
3 MATERIALS & METHODS 
 
 
62 
 Live cell imaging with Cas9:3xmCherry 3.2.10
 
HEK293EBNA1+ cells were transfected with pCONCENP-A plasmids containing Cas9 
targeting sites and co-transfected with the sgRNA and Cas9:3xmCherry expression 
plasmids as described in chapter 3.2.2.9. Four days after transfection cells were 
trypsinized and collected in a 15 ml tube. Cells were counted and 300 µl suspension 
were seeded into ibidi® live cell imaging slides in a concentration of 5 to 8x 104 cells. 
Cells settled for 6 h at 37 °C in the incubator. 50 µl medium was removed and 
replaced with 50 µl medium supplemented with SiR-tubulin to a final concentration 
100 nM. This concentration was constantly maintained during imaging.  
 
 Immune fluorescence 3.2.11
 
HEK293EBNA1∆GA+ cells were transfected with pCONCENP-A plasmids expressing the 
sctetR:GFP:CENP-A fusion protein and incubated for four days in the incubator. 
 
 CENP-C/Ndc80 and EBNA1 co-staining 3.2.11.1
 
Four days after transfection 2x 105 cells were seeded onto Poly-L-Lysine coated cover 
slips. (Cover slips were coated by washing with 80 % ethanol and incubating with 
2 ml 0.01 % Poly-L-Lysine solution for 20 min at room temperature in 6-wells. After 
incubation Poly-L-Lysine solution was removed and cover slips were air dried for 
20 min.) Seeded cells were settled for 8 h at 37 °C in the incubator in 1 ml growth 
medium. 1 ml 8 mM thymidine containing growth medium was added and cells 
were blocked for 16 h in the incubator. By washing 2x with PBS and adding 2 ml 
growth medium the thymidine block was released. 8 h after release cells were fixed 
in mitosis. Cells were fixed for 8 min in 4 % formaldehyde in PBS + 0.1 % Triton X-
100. After washing with PBS + 0.1 % Triton for 5 min at room temperature, cells were 
blocked with PBS + 0.1 % Triton containing 5 % FBS for 1 h at room temperature. 
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Subsequently, 30 µl of the first primary antibody in PBS + 0.1 % Triton containing 
2.5 % FBS, CENP-C or Ndc80, was dropped onto the cells (concentration see Table 5) 
and incubated overnight at 4 °C. After washing 3x 5 min with PBS + 0.1 % Triton, the 
incubation with 30 µl secondary antibody, α-mouse Cy5 1:100 in PBS + 0.1 % Triton 
containing 2.5 % FBS, for 1 h at room temperature was performed. From this step of 
protocol all further steps were performed in the dark. After washing 3x 5 min with 
PBS + 0.1 % Triton, cells were incubated with 30 µl EBNA1 antibody, 1:10 diluted in 
PBS + 0.1 % Triton containing 2.5 % FBS for 1 h at room temperature. Subsequently, 
cells were washed 3x 5 min and the secondary antibody, α-rat Cy3 1:100, was added 
and incubated for 1 h at room temperature. Counter staining of DNA was done with 
50 µl of 250 ng/ml DAPI solution for 2 min after washing 3x 5 min. After a finial 
wash step in PBS + 0.1 % Triton, cells were mounted in vecta shield on a microscope 
slide and sealed with nail polish. Slides were stored at 4 °C in the dark until imaging. 
 
 EBNA1 staining 3.2.11.2
 
HEK293EBNA1∆GA+ cells were co-transfected with pCONCENP-A plasmids expressing 
the sctetR:GFP:CENP-A fusion protein and a RFP:CENP-A expression plasmid. Two 
and four days after transfection, 4x 105 cells were seeded on Poly-L-Lysine covered 
cover slips. Fixation and blocking was done as described in chapter 3.2.11.1. After 
blocking 30 µl EBNA1 antibody, 1:10 diluted in PBS + 0.1 % Triton containing 2.5 % 
FBS for 1 h at room temperature, and after washing 3x 5 min the secondary antibody, 
α-rat Alexa647 1:100, was added and incubated for 1 h at room temperature in the 
dark. Counter staining of DNA with DAPI and mounting cells onto microscope 
slides was performed as described above. 
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 Microscopy 3.2.12
 
For microscopy of fixed samples I used the confocal laser scanning microscope 
(CLSM), Leica TCS SP2.  
For live cell imaging I used a fluorescence microscope without confocal scanning. I 
collaborated with Steffen Dietzel and Andreas Thomae of the Biomedical center in 
Munich (BMC) and used the Leica inverted motorized live cell fluorescence 
microscope, Leica DMi8.  
 
 Fixed samples 3.2.12.1
 
Fixed samples were imaged at the confocal laser scanning microscope (CLSM), Leica 
TCS SP2 with a 63x oil objective. The pinhole was set to 0.9 AU and a 63x oil objective 
with a numerical aperture of 1.4 was used. Argon laser intensity was set to 30 % and 
DPSS 501 nm, HeNe 594 nm and HeNe 633 nm were also used. Excitation intensity of 
DAPI was kept below 10 % UV to avoid bleaching of other fluorescent dyes. GFP was 
excited with 488 nm (~ 15 %), mCherry and Cy3 were excited with 550 nm (~ 25 %) 
and Cy5 or Alexa647 was excited with 633 nm (~ 25 %). Gain of PMTs was set 
between 700 and 1000 V as recommended in Leica TCS SP2 instructions. Imaging 
was done in stacks of around 15 to 20 µm height with a z-step size of 500 nm. The 
pixel size was around 100 nm and a frame average of 3 frames was performed for 
each color to improve signal to noise ratio. 
 
 Live cell Imaging 3.2.12.2
 
Live cell imaging was performed at the BMC at the Leica inverted motorized live cell 
fluorescence microscope, Leica DMi8. I used a 40x dry objective with a numerical 
aperture of 0.6. Microscope stage was surrounded by dark chamber and was heated 
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to 37 °C and the CO2 concentration was set to 6 %. The LED quad filter SpX-Q was 
used for excitation and emission detection. Excitation wavelengths generated by the 
spectrax light engine® (Lumencor® Inc., USA) and filtered by the LED quad were 
390/22 nm, 470/24 nm, 550/15 nm and 640/30 nm. For imaging settings were used 
as shown in Table 21. 
 
Table 21 Settings for live cell imaging 
Signal Excitation 
wavelength 
illumination 
intensity 
illumination 
time 
Bin Gain 
bright field BF lamp 30 100 ms 3x3 1.0 
gfp 470 nm (7 %) 100 % 200 ms 3x3 5.0 
rfp 550 nm (6 %) 100 % 200 ms 3x3 5.0 
SiR-tubulin 640 nm (4 %) 100 % 200 ms 3x3 2.0 
 
In each experiment I chose ten positions to image every 4 minutes. At each position a 
stack of 7.5 µm with a z-step size of 1.5 µm was recorded. Total imaging time was set 
to 24 h. 
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 RESULTS 4
 
Human centromeres are functionally defined regions on chromosomes that regulate 
kinetochore assembly during mitosis. It is known that centromere identity is not 
genetically determined. Centromere positioning is rather specified epigenetically by 
CENP-A, the centromere specific H3 histone variant (Black et al., 2007; Mendiburo et 
al., 2011; Warburton et al., 1997). However, little is known about other potential 
epigenetic modifications contributing to centromere inheritance. 
We demonstrated, in collaboration with Patrick Heun’s group, that artificial targeting 
of CENP-A to plasmids is sufficient to establish neo-centromere activity on plasmids 
in Drosophila Schneider S2 cells (Mendiburo et al., 2011). With the pCONCENP-A vector, 
we transferred the CENP-A targeting system into human cells and I investigated 
centromere establishment and maturation. 
Detailed information about the pCONCENP-A plasmid is given in chapter 1.8. In brief, 
the pCONCENP-A contains the replication element (DS) of EBV’s latent replication 
origin (oriP) and a tetO array as cis-acting elements. Plasmid replication is initiated 
by EBNA1 binding to DS. Segregation is mediated by CENP-A targeting to tetO thus 
inducing centromere activity. oriP plasmids served as reference in the plasmid 
maintenance analyses.  
In order to investigate the stability of centromeres established by targeting of   
CENP-A and the resulting epigenetic inheritance of these centromeres, we first 
examined the plasmid maintenance for more than 20 weeks. Plasmids were 
transfected into HEK293 cells and plasmid abundance was analyzed weekly by 
measuring gfp-reporter gene expression and plasmid rescue experiments. In the 
following, I will describe the experimental setup, the observations of long-term 
plasmid maintenance and their functional relevance. 
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4.1 Long term pCONCENP-A maintenance  
 
We assumed, that the establishment of an inheritable centromere identity leads to 
stable maintenance of pCONCENP-A over many cell generations independent of 
selective pressure. In previous experiments, a stable and inheritable centromere was 
established at the pCONCENP-A plasmid after targeting CENP-A. These plasmids were 
maintained for three or four weeks under selective pressure (Figure 14 and Figure 
15). In order to investigate long-term maintenance, we decided to follow plasmid 
abundance in HEK293 cells after an establishment time of two weeks in selective 
medium for around 20 weeks without selection. 
Therefore, Lara Schneider transfected HEK293EBNA1+ cells with oriP and 
pCONCENP-A. After the initial establishment time the selection medium was replaced 
by normal cell culture growth medium. Every seven days, plasmid maintenance was 
monitored by FACS (see Figure 19 A). In FACS analysis (fluorescence activated cell 
sorting/scanning) cells are scanned according to their size, granulation level and 
fluorescence intensity. Living cells were defined according to size and granulation of 
reference untransfected HEK293 cells. Within this cell population, the proportion of 
gfp+ expressing cells was determined. Every second week, the plasmid abundance 
was also measured more directly by plasmid rescue assays. In this experiment, cells 
are lysed and low molecular weight DNA is extracted. To discriminate between 
bacterial “input” DNA that was initially transfected on the one hand and replicated 
and segregated DNA on the other, a DpnI digest was performed. The transfected 
DNA that was initially purified from bacteria is dam methylated. DpnI is a dam 
methylation sensitive enzyme that digests DNA that carries a methylated A in the 
GATC-motif. After DpnI digest, only replicated plasmid DNA is intact and can be re-
transformed into bacteria to represent the amount of plasmids that were present in 
the cells. 
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oriP plasmids were lost within three to five weeks after removal of selective pressure 
(Figure 19 B, red line). A similar plasmid loss rate was observed by measuring the 
gfp+ level, expressed as destabilized GFP on the reporter plasmids (Figure 19 C, red 
line). In contrast, the pCONCENP-A plasmid was stably maintained after a copy 
number stabilization phase at a level between 30 and 50 % relative to the starting 
amount (Figure 19 B+C, yellow line).  
In conclusion, targeting of CENP-A to the tetO array on pCONCENP-A leads to stable 
plasmid maintenance for a long time frame over 5 months. It is very likely that an 
inheritable centromere identity is established on the plasmid within two weeks 
establishment time under selective conditions. 
plasmid rescue FACS 
Figure 19: Plasmid rescue and FACS analysis of plasmid maintenance  
A) Timeline of experimental setup. Establishment of plasmids is under selection 
pressure for 14 days. After two weeks selection is removed and plasmid 
maintenance is analyzed every two weeks by plasmid rescue and weekly FACS 
counts.  
B) pCONCENP-A plasmids are maintained stable over 5 months. oriP is lost already 5 
weeks after selection removal. 
Data: Lara Schneider ( n=4, Mean+SD) 
A 
C B 
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Long-term stability is an appropriate prerequisite for the use of pCONCENP-A as gene 
therapy vector. However, before developing clinical applications with pCONCENP-A it 
is essential to functionally characterize it. 
As a first step, I decided to investigate the targeting of sctetR:CENP-A to the tetO 
array and its segregation mechanism.   
 
4.2 sctetR:CENP-A is site specifically targeted to tetO sites 
 
The artificially induced neo-centromere is established after targeting sctetR:CENP-A 
to a tetO array on a plasmid system. Besides the tetO, the reporter plasmid harbors 
the EBV latent replication origin DS. To address the question if sctetR:CENP-A is site 
specific targeted to the tetO array on pCON, two different approaches were used. A 
ChIP experiment verified the sctetR:CENP-A fusion protein binding to tetO. Immune 
fluorescence was employed to study the co-localization between sctetR:GFP:CENP-A 
and the plasmids by overlapping signals resulting from confocal microscopy and its 
resolution limitations. 
 
 ChIP directly demonstrates interaction with tetO 4.2.1
 
For the functional characterization of pCONCENP-A it was important to know if 
sctetR:CENP-A is site-specifically targeted to the tetO array on the plasmids. The 
binding of sctetR:CENP-A to tetO was determined in a ChIP experiment, since ChIP 
is a sensitive method to identify DNA-protein interactions. For ChIP the chromatin 
and chromatinized plasmids were fixed with formaldehyde and fragmented by 
sonication. After immune precipitation using a tetR-specific antibody, the tetR 
protein interacting DNA fragments were quantified by qPCR. The enriched DNA 
fragments at the region next to the tetO repeats and a reference region that is located 
approximately 5 kb apart from tetO were compared. 
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To perform a tetR specific ChIP, I first had to generate a suitable α-tetR antibody in 
collaboration with the Monoclonal Antibody Core Facility of the Helmholtz Center 
Munich. Detailed information about antibody validation is given in the appendix. 
 
 
 
 
 
 
 
 
 
 
 
sctetR:CENP-A was specifically bound to the tetO sequence, comparing the eluted 
plasmid amount after tetR IP at tetO sites and the reference site (Figure 20). In 
addition, the tetR pull down with the newly generated α-tetR antibody is specific, 
since the control IP with an equivalent IgG subtype only shows background level 
with the tetO and reference primer pair.  
Since I aimed to demonstrate kinetochore protein recruitment by immune 
fluorescence in the following, I also needed to investigate sctetR:CENP-A targeting to 
plasmids with this method. I know from ChIP experiments, that sctetR:CENP-A is 
site specifically targeted to the tetO array on the plasmids. Therefore, I assume that 
sctetR:GFP:CENP-A co-localizes with the plasmids if they show an overlapping 
signal with confocal microscopy resolution. 
Figure 20: ChIP with α-tetR monoclonal antibody 
A) Representation of tetO-DS sctetR:CENP-A reporter plasmid with primer binding sites 
for qPCR analysis indicated in magenta (tetO, DS and reference region)  
B) ChIP of the tetR fusion protein reveals binding at tetO sites whereas the plasmid region 
around 5 kb away from tetO is not co-precipitating with sctetR:CENP-A. There is a 
significant enrichment of sctetR:CENP-A at tetO compared to the reference region. (n=5, 
Mean+SD, p-value: unpaired t test with Welch’s correction, two-tailed) 
B 
A 
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 sctetR:GFP:CENP-A co-localizes with plasmids 4.2.2
 
In order to illustrate sctetR:GFP:CENP-A targeting to pCONCENP-A in an immune 
fluorescence approach, I needed to visualize the plasmids. Therefore, the plasmid 
DNA was represented by the immune fluorescent staining of EBNA1, which interacts 
with DS, the replication element of the plasmids (Figure 21 B). 
 
 
 
 
 
 
 
 
 
The co-localization of sctetR:GFP:CENP-A signals and EBNA1 fluorescence staining 
reveals a close proximity of sctetR:GFP:CENP-A with the plasmids, which suggests 
the binding of sctetR:GFP:CENP-A to the plasmids. In collaboration with Evelyne 
Barrey, a PhD student in Patrick Heun’s group, HEK293EBNA1+ cells were 
transfected with pCONCENP-A plasmids expressing the sctetR:GFP:CENP-A fusion 
protein (Figure 21 A). Four days post transfection, the cells were fixed and stained for 
the EBNA1 protein using the EBNA1 specific monoclonal 1H4 antibody and a 
fluorescently labeled secondary antibody raised against the rat IgG subtype of the 
primary α-EBNA1 antibody. Co-staining of the sctetR:GFP:CENP-A with EBNA1 
was approved by confocal laser scanning microscopy. 
 
Figure 21: Illustration of EBNA1 immune fluorescence staining 
A) pCONCENP-A reporter plasmid encoding sctetR:GFP:CENP-A  
B) Representation of reporter plasmid with immune fluorescence staining of EBNA1. 
EBNA1 binds to the DS element of pCONCENP-A and is recognized by an EBNA1 
specific antibody. This EBNA1 antibody is recognized in turn by fluorescently 
labelled secondary antibody that recognizes the rat IgG subtype of the EBNA1 
specific antibody. 
B A 
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These representative images suggest the binding of sctetR:GFP:CENP-A to the 
plasmids (Figure 22, white arrows). Quantification of overlapping signals revealed 
that almost 95 % of the EBNA1 signals overlap with sctetR:GFP:CENP-A spots (see 
Figure 29 B and Figure 30 B). 
The site-specific targeting of CENP-A to the tetO is the major prerequisite for the 
establishment of centromere inheritance. In this chapter, I presented that CENP-A is 
efficiently targeted to pCONCENP-A by ChIP and immune fluorescence. The next 
hypothesis was that the formation of a neo-centromere on plasmids leads to an active 
segregation mechanism during mitosis. In order to verify this hypothesis, I 
visualized the plasmids during one cell cycle by live cell imaging.  
 
 
Figure 22: Immune fluorescence of EBNA1 and sctetR:GFP:CENP-A  
Co-localization of EBNA1 (representing plasmids) and sctetR:GFP:CENP-A 
is marked with white arrows. Almost 95 % of EBNA1 signals overlap with 
sctetR:GFP:CENP-A  
Images from Evelyne Barrey (MPI Immunology and Epigenetics, Freiburg) 
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4.3 Dynamics of pCONCENP-A during cell cycle 
 
For the visualization of plasmid DNA in a live cell imaging approach, the staining of 
EBNA1 is not suitable. In fixed cells, during the immune fluorescence, EBNA1 
signals were amplified by sequential binding of EBNA1 antibodies and even more 
secondary antibodies that were fluorescently labeled. In live cell imaging, EBNA1 
signals are not amplified by sequential antibody staining. In addition, the DS only 
contains four EBNA1 binding sites and thus the signals resulting from a fluorescently 
labeled EBNA1 protein are too weak. For that reason, I developed a targeting system 
to specifically visualize plasmid DNA in live cell settings. Suitable systems are 
artificial targeting systems, like the prokaryotic LacI-LacO targeting. During this 
project, I decided to generate an innovative CRISPR/Cas9-dependent visualization 
method because the CRISPR/Cas9 was demonstrated to visualize specific genomic 
loci in living cells (Chen et al., 2013). 
 
 CRISPR/Cas9 targeting system 4.3.1
 
The CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 
(CRISPR-associated) system, utilized during this project, is derived from 
streptococcal defense mechanisms against their pathogens. If foreign DNA enters the 
cell, it is recognized by the Cas9-crRNA-tracrRNA complex and cleaved by the 
endonuclease activity of the Cas9 protein. crRNA (CRISPR RNA) is expressed from 
the CRISPR repeats, containing protospacer sequences. This crRNA interacts with 
tracrRNA (trans-activating crRNA), which builds a secondary RNA structure that 
binds to Cas9. After unwinding the foreign DNA, the complementary crRNA binds it 
and the Cas9 protein cleaves the DNA. (Figure 23 A) 
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This naturally occurring CRISPR/Cas9 system was engineered to target specific 
sequences for genome editing or protein targeting. Nuclease active or nuclease 
deficient Cas9 proteins are used and in both cases, the sgRNA (single guide RNA) is 
utilized in the same way. The crRNA and the tracrRNA were fused together and 
thus, the complementary sequence to DNA is directly bound to the RNA forming 
secondary structure for Cas9 interaction (Figure 23 B). Stable binding of the sgRNA-
Cas9 protein complex to DNA occurs if the first 20 nucleotides of sgRNA are 
complementary to DNA and if the DNA harbors the protospacer adjacent motif 
(PAM) (Jinek et al., 2012).  
Figure 23: Naturally occurring and engineered CRISPR-Cas9 systems 
A) Natural CRISPR-Cas9 pathway: foreign DNA sequences are incorporated 
into CRISPR arrays, which then produce crRNAs including regions that are 
complementary to the foreign DNA sequence (protospacer). These crRNAs 
hybridize to tracrRNAs (also encoded in the CRISPR system). This RNA 
complex associates with the Cas9 nuclease. crRNA/tracrRNA/Cas9 complexes 
recognize and cleave foreign DNA also complementary to protospacer 
sequences.  
B) Engineered CRISPR-Cas9 system: fusion between a crRNA and part of the 
tracrRNA sequence (= sgRNA). This sgRNA builds a complex with Cas9 to 
mediate cleavage of target DNA sites that are complementary to the first (5′) 
20 nt of the gRNA and that lie next to a PAM sequence.  
(Sander and Joung, 2014)  
A B 
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The system, I developed for this project, consisted of a nuclease deficient Cas9 
protein fused to three mCherry proteins and a sgRNA that did not have 
complementary sequences in the human genome. The sgRNA was expressed from a 
lentiviral vector (clone A66407) and cloned from the library mouse GeCKOv2 library 
A_2 by Kai Höfig. I generated a sequence consisting of a complementary sequence to 
the sgRNA, a PAM and a 20 nucleotide spacer region (Figure 24). 
 
 
 
 
 
 
Spacer region was inserted to reduce interference of neighboring Cas9 proteins that 
bind to multimers of the sgRNA targeting sequence, since Cas9:3xmCherry is a huge 
protein. The PAM and the spacer region were chosen from Chen et al. (Chen et al., 
2013), supplemental information. A decamer of the sgRNA-PAM-spacer sequence 
was designed with MacVector and ordered as GeneScript plasmid. For further 
multimerization to 20, 30 and 40 repeats and cloning into reporter plasmids, the 
decameric sequence was equipped with specific restrictions sites (Figure 25). 
 
 
 
 
The live cell imaging application of Cas9:3xmCherry targeting and the dynamics of 
pCONCENP-A during the cell cycle are described in the following. 
Figure 25: sgRNA targeting sequence with restriction sites 
Decamer of sgRNA targeting, PAM and spacer region was equipped with specific 
restriction sites for further multimerization (BamHI, BglII) and final cloning into 
reporter plasmids (SpeI, KpnI, BssHII) 
Figure 24: sgRNA targeting sequence and spacer monomer 
sgRNA complementary sequence for targeting Cas9 fusion proteins for live cell 
imaging and plasmid purification. For multimerization of this sequence a spacer region 
of 20 nucleotides was included to avoid interference of neighboring Cas9 proteins. 
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 Cas9:3xmCherry is suitable to visualize pCONCENP-A plasmids 4.3.2
 
In order to use Cas9:3xmCherry targeting in live cell imaging microscopy, I first 
demonstrated specific targeting of Cas9:3xmCherry proteins to the binding sites on 
the plasmids. Therefore, I co-transfected HEK293EBNA1+ cells with the 
Cas9:3xmCherry and the sgRNA expression plasmids together with pCONCENP-A 
with and without the specific sgRNA complementary sequence. After four days, I 
fixed those cells and performed EBNA1 immune fluorescent staining to represent the 
plasmids, like in chapter 4.2.2.  
 
 
 
 
 
 
 
 
pCONCENP-A plasmids containing Cas9 specific targeting site, represented by EBNA1 
signals, overlapped with the Cas9:3xmCherry fluorescence. In addition, many signals 
arising from sctetR:GFP:CENP-A co-localized with Cas9:3xmCherry if the plasmids 
harbored complementary sgRNA sequence repeats (Figure 26 A). In contrast, if 
pCONCENP-A does not contain the targeting sites, the Cas9 fusion protein was 
distributed equally in the whole nucleus (Figure 26 B). 
Only the presence of specific targeting sites for the sgRNA leads to the specific 
localization of the Cas9:3xmCherry fusion protein to plasmids. This makes the Cas9 
A B 
Figure 26: Cas9:3xmCherry is specifically targeted to plasmids in IF 
A) sctetR:GFP:CENP-A and Cas9:3xmCherry co-localize with plasmid signals  
B) No co-localization of Cas9:3xmCherry with plasmids and sctetR:GFP:CENP-A, if 
plasmid does not contain Cas9 targeting sites. Cas9:3xmCherry is distributed in the 
whole nucleus.  
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artificial targeting system a suitable tool to investigate plasmid dynamics in living 
cells by live cell imaging. 
 
 pCONCENP-A localization in living cells 4.3.3
 
To understand the pCONCENP-A segregation mechanism in mitosis and plasmid 
localization during interphase, live cell imaging was performed. Imaging living and 
proliferating cells has to deal with some critical aspects. Excitation with energetic 
wavelengths and high intensities leads to increased cell death. In addition, oxygen 
and CO2 concentration and humidity need to be optimized for imaging conditions of 
proliferating cells. For that reason I decided to collaborate with Andreas Thomae and 
Steffen Dietzel from the Biomedical Center Munich, since they were experienced and 
equipped for live cell imaging. With LED driven fluorescence excitation, I performed 
live cell imaging in a suitable time resolution. By keeping excitation intensities low, 
cells survived and proliferated under imaging conditions, even though imaging up 
to three different fluorescent colors.  
For live cell imaging I transfected a HEK293EBNA1+ cell line stable expressing 
Cas9:3xmCherry with the pCONCENP-A reporter plasmid, already used in the fixed 
cells. After four days establishment time, the cells were transferred onto an imaging 
slide and imaged at a fluorescence live cell microscope in cooperation with Andreas 
Thomae. Every four minutes an image stack was taken from bright field illumination, 
the sctetR:GFP:CENP-A and the Cas9:3xmCherry channel for 24 hours in total. 
Signals of sctetR:GFP:CENP-A were too weak to follow over one cell cycle and only 
the dynamics of Cas9:3xmCherry were analyzed. 
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During interphase the plasmid signals were highly dynamic. The bright 
Cas9:3xmCherry signal representing plasmids that was followed in Figure 27, moved 
from one end of the nucleus to another and back. Consequently, the plasmids are not 
immobilized within any specific environment, but rather move through the whole 
nucleus.  
Even if the cell prepared for mitosis, the plasmid localization was not static.  
During mitosis the plasmid signal localized in between the future daughter cells 
during anaphase (Figure 28, 18.8 h). After cell division the plasmid signal, 
represented by Cas9:3xmCherry, was observed in one of both daughter cells. This 
means that in this example shown here, it seems that plasmids are segregated 
asymmetrically during mitosis. 
 
 
 
Figure 27: Highly dynamic localization of pCONCENP-A in interphase 
Plasmids are stained by Cas9:3xmCherry. Images were taken every 4 min for 24 
hours. Different time points during interphase are selected here 
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In several other experiments I aimed to further characterize segregation of plasmids 
having an artificial centromere, but unfortunately I couldn’t manage to visualize 
living cells expressing Cas9:3xmCherry anymore. In additional experiments I stained 
living cells with the live-cell tubulin dye to demonstrate attachment of microtubules 
to plasmids. Because of technical issues and limited time, I was not able to reveal the 
exact segregation mechanism by live cell imaging during this project.  
In summary, the Cas9-dependent targeting system is specifically targeted to the 
plasmids, demonstrated by the co-localization to pCONCENP-A plasmids in fixed cells. 
Therefore, it is a suitable tool for live cell investigations of plasmid dynamics. 
Nevertheless, the segregation mechanism of the reporter plasmids was not clarified 
with this method. 
However, we supposed active plasmid segregation because of the establishment of a 
neo-centromere on the pCONCENP-A plasmids. To verify this, I examined recruitment 
of inner and outer kinetochore components since the kinetochore assembly is the 
prerequisite of microtubule mediated active segregation. If the kinetochore is 
assembled on plasmids it is likely that these are segregated actively during mitosis. 
Figure 28: plasmid segregation in mitosis is asymmetric 
Same imaging time series as in Figure 28. Cell imaged during mitosis. In 
this cell plasmid aggregate is asymmetrically distributed to just one 
daughter cell. 
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4.4 Recruitment of kinetochore proteins 
 
We observed that centromere establishment on plasmids after CENP-A targeting led 
to maintenance of these plasmids as independent genetic entities by centromere 
regulated segregation. An active plasmid segregation mechanism implies the 
recruitment of kinetochore proteins to the plasmids, as they mediate the interaction 
of centromeric chromatin with the microtubules.  
I investigated the CENP-A dependent recruitment of kinetochore proteins to the 
artificial centromere on the plasmid by immune fluorescence. In the following I 
delineate the inner kinetochore protein CENP-C and the outer kinetochore protein 
Ndc80 recruitment to neo-centromeres after CENP-A targeting.  
 
 Recruitment of inner kinetochore proteins (CENP-C) 4.4.1
 
In an immune fluorescence approach I studied if the recruitment of the inner 
kinetochore protein CENP-C to pCONCENP-A is dependent on CENP-A targeting. 
CENP-C has some important functions at endogenous centromeres. It is involved in 
the assembly, formation and maintenance of kinetochores (Tomkiel et al., 1994). 
CENP-C is directly recruited and bound by CENP-A cell cycle independently and it 
reshapes and stabilizes CENP-A nucleosomes (Falk et al., 2015). To fulfil these 
functions on pCONCENP-A as well, CENP-C has to be recruited to the plasmids after 
CENP-A targeting.  
To verify the recruitment of CENP-C to reporter plasmids immune fluorescence 
staining of EBNA1 and CENP-C were performed. HEK293EBNA1+ cells were 
transfected with the pCONCENP-A plasmid expressing sctetR:GFP:CENP-A, as 
described in 4.2.2. Four days after transfection, cells were fixed and stained for 
EBNA1 and CENP-C with specific antibodies. Confocal microscopy images were 
taken of 20 cells. Interphase as well as mitotic cells were used to quantify the co-
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localization of CENP-C with the plasmids, since CENP-C is constitutively bound to 
CENP-A. 
 
 
 
 
 
 
 
 
 
 
 
sctetR:GFP:CENP-A targeting and formation of centromeres on pCONCENP-A led to 
recruitment of CENP-C, since sctetR:GFP:CENP-A, plasmids, represented by EBNA1, 
and CENP-C fluorescence depicts overlapping signals in immune fluorescence 
microscopy (Figure 29 A). 
Artificial targeting of sctetR:GFP:CENP-A and recruitment of CENP-C to the 
plasmids was quantified from 20 cells (Figure 29 B). In order to quantify the targeting 
of CENP-A and the co-localization of CENP-C with the artificial centromeres, EBNA1 
signals were determined first. Second, the signal overlap of sctetR:CENP-A with the 
EBNA1 signals was analyzed. As represented in Figure 29 B (green representation) 
on average 95 % of EBNA1 signals co-localize with sctetR:GFP:CENP-A. These 95 % 
of overlapping signals, were then scanned for CENP-C co-staining. It turned out that 
55 % of plasmids recruit CENP-C (Figure 29 B, magenta representation). No co-
Figure 29: Recruitment of the inner kinetochore protein CENP-C 
A) A representative image is shown for the recruitment of CENP-C to plasmids with 
targeted sctetR:GFP:CENP-A. Enlarged spots demonstrate overlapping CENP-C signals 
with plasmids, represented by EBNA staining.  
B) Quantification of CENP-C/EBNA1 co-localization on plasmids. First EBNA1 spots were 
marked then CENP-C and sctetR:GFP:CENP-A overlap on these spots was analyzed. 20 
cells were used for quantification and sctetR:GFP:CENP-A or CENP-C signals were 
calculated relative to the EBNA1 signals (Mean+SD). 
A B 
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staining of CENP-C and EBNA1 was observed when sctetR:GFP:CENP-A signal was 
not present. 
By immune fluorescence microscopy I demonstrated a recruitment of CENP-C to 
pCONCENP-A that is dependent on CENP-A targeting. CENP-C is one major factor for 
the assembly of the outer kinetochore complex during mitosis. Since, this protein was 
present at the neo-centromeres on plasmids, we suggested that also outer 
kinetochore components assemble during mitosis. 
 
 Recruitment of outer kinetochore proteins (Ndc80) 4.4.2
 
As second example to confirm the hypothesis that centromere establishment on 
plasmids after CENP-A targeting leads to active plasmid segregation by kinetochore 
assembly on pCONCENP-A, I studied the co-staining of EBNA1 with the outer 
kinetochore component Ndc80 by immune fluorescence. Since, outer kinetochore 
proteins and microtubules are recruited to centromeres during mitosis, I had to 
analyze mitotic cells. HEK293EBNA1+ cells were transfected with the reporter 
plasmid and four days after transfection, cells were synchronized by thymidine 
block. Cells were released from block and 8 hours after release I fixed them during 
mitosis. After immune fluorescent staining of Ndc80 and EBNA1, the signal overlap 
of Ndc80 and EBNA1 of 20 cells was quantified as for the CENP-C recruitment. 
During mitosis the outer kinetochore protein Ndc80 was recruited to the plasmids 
(Figure 30 A). The co-localization of sctetR:GFP:CENP-A with EBNA1 in mitotic cells 
was similar to that in interphase cells. Around 95 % of plasmid signals overlap with 
sctetR:GFP:CENP-A fluorescence during mitosis (Figure 30 B, sctetR:GFP:CENP-A). 
On average 60 % of these plasmids recruit the outer kinetochore protein Ndc80 
(Figure 30 B, Ndc80). 
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In immune fluorescence experiments, I demonstrated the recruitment of inner and 
outer kinetochore components after artificial targeting of CENP-A. Since I observed 
that EBNA1 signals, not overlapping with sctetR:GFP:CENP-A, also do not recruit 
kinetochore proteins, I assume that recruitment of CENP-C and Ndc80 to plasmids is 
dependent on CENP-A targeting.  
 
 Recruitment of kinetochore proteins only if CENP-A is targeted 4.4.3
 
In order to demonstrate that the recruitment of kinetochore proteins to pCONCENP-A 
is dependent CENP-A targeting, a control experiment was performed. I transfected 
HEK293EBNA1+ cells with pCONCENP-A and a tetO-DS plasmid expressing the 
sctetR:GFP fusion protein. I quantified the overlap of plasmid signals, represented by 
the EBNA1-DS interaction, with sctetR:GFP and CENP-C or Ndc80 of 20 cells. 
Figure 30: Recruitment of the outer kinetochore protein Ndc80 
A) A representative image of the recruitment of Ndc80 to reporter plasmids with targeted 
sctetR:GFP:CENP-A during mitosis is shown. Enlarged spots demonstrate overlapping 
signals of Ndc80 and EBNA1 fluorescent staining.  
B) Quantification of Ndc80/EBNA1 co-localization on plasmids. First EBNA1 spots were 
marked then Ndc80 and sctetR:GFP:CENP-A overlap on these spots was analyzed. 20 cells 
were used for quantification and sctetR:GFP:CENP-A or Ndc80 signals were calculated 
relative to the EBNA1 signals (Mean+SD). 
A B 
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The recruitment of CENP-C and Ndc80 was dependent on the targeting of CENP-A, 
because artificial targeting sctetR:GFP to tetO-DS reporter plasmids did not result in 
co-staining of EBNA1, the sctetR fusion protein and kinetochore proteins. In contrast, 
if sctetR:GFP:CENP-A was targeted, a highly significant increase in signal overlap 
between EBNA1 and kinetochore proteins was observed.  
I conclude from these results that artificial CENP-A targeting leads to the 
establishment of a functional centromere identity on pCONCENP-A. Kinetochore 
components, represented by CENP-C and Ndc80, are recruited to neo-centromeres in 
a CENP-A dependent manner. During mitosis the outer kinetochore mediates active 
plasmid segregation and this in turn leads to long-term plasmid maintenance. 
To gain deeper understanding in the mechanisms that lead to establishment of 
centromere inheritance on pCONCENP-A, I investigated the capacity of sctetR:CENP-A 
fusion proteins to form centromeric nucleosomes. 
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Figure 31: Quantification of kinetochore protein co-localization 
after targeting sctetR:GFP:CENP-A or sctetR:GFP 
Comparison of quantification of CENP-C and Ndc80 co-localization 
with plasmids targeted by either sctetR:GFP:CENP-A or sctetR:GFP. 
Quantification was carried out as described in Figure 29.  
(n=20 cells, Mean+SD, p<0.0001, p-value: unpaired t test with Welch’s 
correction, two-tailed) 
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4.5 sctetR:CENP-A forms centromeric nucleosomes  
 
The sctetR:CENP-A fusion protein is targeted to the tetO array of pCONCENP-A 
plasmids by the interaction of the tet transactivator (tetR) and its target site. This 
interaction was already confirmed in previously described experiments (chapter 4.2). 
In addition, the recruitment of kinetochore components to the artificial centromere 
on plasmids by targeting CENP-A was demonstrated. This suggests that the CENP-A 
fusion protein is indeed forming a kinetochore complex at an artificial centromere. 
The following experiments aim to verify this hypothesis, by analyzing if the fusion 
protein is incorporated into nucleosomes. 
 
 sctetR:GFP:CENP-A is present at endogenous centromeres 4.5.1
 
To address the question, if sctetR:CENP-A is 
recruited to endogenous centromeres, a 
sctetR:GFP:CENP-A expression plasmid was 
transfected into HEK293EBNA1+ cells. Four days 
after transfection, cells were fixed and immune 
fluorescently stained against tubulin proteins. The 
attachment of microtubules to sctetR:GFP:CENP-A 
containing centromeres was detected by confocal 
microscopy. With this approach I demonstrated 
that the sctetR:GFP:CENP-A fusion protein was 
recruited to endogenous centromeres (Figure 32). 
During mitosis microtubules attached at 
endogenous centromeres and sctetR:GFP:CENP-A 
signals were present at microtubule ends.  
The actual incorporation of sctetR:CENP-A fusion proteins into centromeric 
nucleosomes was not shown by immune fluorescence. In order to clarify the ability 
Figure 32: Immune 
fluorescence of tubulin 
Binding of microtubules at 
endogenous centromeres where 
also sctetR:GFP:CENP-A is 
bound. 
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of sctetR:CENP-A to incorporate into nucleosomes, a co-immuno precipitation (co-IP) 
was performed by demonstrating interaction of sctetR:CENP-A fusion proteins with 
canonical histones. 
 
 sctetR:CENP-A nucleosomes 4.5.2
 
As already described in detail in chapter 
1.5.2, the centromeric CENP-A 
nucleosome varies in structure and 
composition from canonical nucleosomes. 
The CENP-A histone H3 variant 
dimerizes with histone H4 to a            
(CENP-A:H4)2 heterodimer. These are 
incorporated, together with two H2A and 
H2B histones  into centromeric DNA. This 
complex builds an octameric nucleosome 
within the centromeres (Figure 33). 
Other than canonical nucleosomes, centromeric nucleosomes contain two CENP-A 
histone H3 variants instead of canonical H3 (Dunleavy et al., 2013). 
To analyze whether sctetR:CENP-A is incorporated into centromeric nucleosomes an 
immuno precipitation (IP) of the tetR fusion protein was performed and the co-
precipitation of canonical histones was investigated. 
Mono-nucleosomes (Figure 34 B) were extracted from three different cell lines 
(HEK293EBNA+ + sctetR, sctetR:H3.3 or sctetR:CENP-A). sctetR fusion proteins were 
precipitated with the tetR specific 31B3 antibody covalently coupled to protein G 
beads. After stringent washing steps, precipitates were examined for co-precipitation 
of canonical H3 and H2B. 
Figure 33: schematic representation of 
H3 and CENP-A nucleosomes 
Canonical histone only contains H3 histones, 
whereas CENP-A nucleosomes only contain 
CENP-A histones 
Adopted from Dunleavy & Karpen, Nature 
structural and molecular biology (2013) 
(Dunleavy et al., 2013) 
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If sctetR:CENP-A is incorporated correctly into CENP-A nucleosomes, a co-
precipitation of H2A, H2B and H4 but not H3 is expected. In contrast, in cells 
expressing sctetR without fusion, no histone co-precipitates after a tetR IP of mono-
nucleosomes. In case of sctetR:H3.3 cell line, histones H2A, H2B, H4, endogenous H3 
but not CENP-A are expected to co-precipitate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
I obtained a comparable sctetR fusion protein amounts after the tetR-IP of sctetR, 
sctetR:H3.3 and sctetR:CENP-A from the respective cell lines (Figure 34 A). For the IP 
of sctetR alone no co-precipitation of endogenous histone proteins was observed 
(Figure 34 C, D; sctetR). In contrast, in case of sctetR fused to H3.3, endogenous H3 
and H2B were co-precipitating from MNase digested extract (Figure 34 C, D; 
sctetR:H3.3). This indicates that the sctetR:H3.3 fusion protein is incorporated into 
canonical nucleosomes. With the sctetR:CENP-A fusion protein only H2B, but almost 
Figure 34: tetR IP and co-IP of endogenous histones 
A) IP analysis of tetR IP from different cell lines sctetR, sctetR:H3.3 and sctetR:CENP-A  
B) MNase digest, in all cell lines DNA is digested to mono-nucleosomes  
C) Western Blot of eluted fractions against histone H3. Only in sctetR:H3.3 cell line H3 
is co-precipitating. (n=1) 
D) Western Blot of eluted fractions against H2B. H2B co-precipitates with sctetR:H3.3 
and sctetR:CENP-A. (n=1) 
A 
B 
C 
D 
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no H3 was co-precipitated (Figure 34 C, D; sctetR:CENP-A). This result confirms that 
the sctetR:CENP-A complexes with H2A, H2B and H4 to form centromere-like 
nucleosomes.  
The results described in this chapter demonstrate that the sctetR:CENP-A fusion 
protein is incorporated into centromeric nucleosomes. The fusion protein interacts 
with the other histones and forms centromere specific nucleosome particles, revealed 
by co-precipitation. Furthermore, the sctetR:GFP:CENP-A fusion protein is present at 
endogenous centromeres, where microtubules are associated during mitosis.  
Since the kinetochore is assembled on pCONCENP-A as well, and plasmid maintenance 
is stable over several months, I assume that sctetR:CENP-A is incorporated as 
centromere-like nucleosome into the plasmids. This incorporation leads to the 
establishment of an inheritable and self-propagating centromere. To verify that 
hypothesis, I studied the dependence of plasmid maintenance on constitutive 
targeting of CENP-A. 
 
4.6 Establishment of centromere inheritance 
 
In Drosophila cells our group demonstrated, together with our collaboration partner 
Patrick Heun, that initial CENP-A targeting induces an inheritable centromere on 
plasmids that becomes independent on CENP-A targeting within three weeks 
(Mendiburo et al., 2011). Since we know that artificial CENP-A targeting in human 
cells also leads to the recruitment of kinetochore proteins and therefore to the 
establishment of a neo-centromere, we studied the establishment of the centromere 
inheritance in more detail. We aimed to ascertain the dependence of plasmid 
centromeres on CENP-A targeting, the timeframe of de novo centromere 
establishment on plasmids and its ability to self-propagate. 
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 Targeting of sctetR:CENP-A after 5 days but not after 3 weeks 4.6.1
 
In order to analyze if plasmid maintenance is dependent on constitutive CENP-A 
targeting we performed a chromatin immuno precipitation (ChIP) of sctetR:CENP-A 
at different time points after transfection. 
Stefanie Fülöp, a former group member, transfected HEK293EBNA1+ cells with oriP 
and pCONCENP-A and harvested the cells five and 21 days after transfection. EBNA1 
binding to DS and FR on oriP and to DS on pCONCENP-A was determined five days 
after transfection, the binding of sctetR:CENP-A to tetO was compared five and 21 
days after transfection by ChIP. 
 
 
 
 
 
 
 
 
 
 
Analysis of EBNA1 ChIP revealed that the EBNA1 protein was bound to the DS 
element, present on both reporter plasmids, with high affinity. As expected, the same 
enrichment of EBNA1 was found at the FR element of oriP. Whereas no enrichment 
of EBNA1 at the tetO and FR primer region on the sctetR:CENP-A plasmid was 
detected. Since the reference region is several kilo base pairs away from EBNA1 
Figure 35: ChIP of EBNA1 and sctetR:CENP-A in oriP and pCONCENP-A plasmid 
A) EBNA1 is bound to DS and FR in the oriP plasmid and it is bound to DS in the pCONCENP-A 
plasmid system.  
B) sctetR is bound to tetO sites 5 days after transfection. It is not bound to other regions of 
plasmid. Three weeks after transfection, there is no binding of sctetR:CENP-A to tetO.  
Data: Stefanie Fülöp (unpublished) 
A B 
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binding sites, no significant enrichment of EBNA1 was observed in this region 
(Figure 35 A). In addition, tetR ChIP identified background level enrichment at DS, 
tetO and the reference regions on oriP (Figure 35 B, red bars). 
sctetR:CENP-A enrichment at tetO and reference regions (DS and reference) was 
determined five days and three weeks after transfection (for primer positions see 
Figure 20). Quantification of sctetR:CENP-A binding to tetO five days after 
transfection revealed an enrichment of sctetR:CENP-A at tetO repeats (Figure 35 B, 
yellow, filled bars). In contrast, analyzing sctetR:CENP-A binding after three weeks, 
no sctetR:CENP-A enrichment at the tetO array was detected (Figure 35 B, yellow, 
dashed bars).  
This observation is a first hint, that after initial targeting of sctetR:CENP-A 
maturation of the centromere identity takes place on the plasmid leading to a 
sctetR:CENP-A targeting independent maintenance. 
The time needed for establishment of centromere identity and the maturation of 
centromeric chromatin on the artificial plasmid centromere is addressed in the 
following. 
 
 Centromere inheritance is established within 7 days 4.6.2
 
In our previous experiments, we investigated plasmid maintenance after an 
establishment phase of two to four weeks under selective pressure. Since we 
observed the recruitment of kinetochore proteins takes place earlier, I performed, in 
close collaboration with Lara Schneider, plasmid maintenance experiments analyzing 
the establishment of centromere identity after seven days. 
For this purpose, we made use of doxycycline, that inhibits binding of sctetR to the 
tet operator sequence by changing the conformation of the tet transactivator dimer. 
We analyzed plasmid maintenance after a shortened establishment time of seven 
days and after adding doxycycline to the cells. To determine whether plasmid 
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maintenance of the sctetR:CENP-A plasmids is dependent on sctetR:CENP-A 
targeting, we also compared it with two different controls. The oriP plasmid 
maintenance is only dependent on EBNA1 and thus not influenced by doxycycline. 
In contrast, the maintenance of sctetR:HMGA1a plasmids, introduced in chapter 1.8, 
is strictly dependent on constitutive targeting on sctetR:HMGA1a and therefore the 
plasmid loss is inducible by doxycycline (Pich et al., 2008). This doxycycline 
inducible system served as control for doxycycline activity. In the “+dox” condition 
the sctetR:HMGA1a plasmids show an increased plasmid loss compared to the         
“-dox” condition.  
HEK293EBNA1+ cells were transfected with the different reporter plasmids (oriP, 
sctetR:HMGA1a tetO-DS and pCONCENP-A) and incubated for seven days. After this 
incubation time (= establishment phase) cells were FACS sorted according to gfp 
expression. Only gfp positive cells were re-plated and cultivated in presence and 
absence of 2 µg/ml doxycycline in cell growth medium. Plasmid maintenance was 
then analyzed by FACS count for gfp+ at different time points after the FACS sort 
(Figure 36 A). 
As expected oriP plasmid loss was independent of doxycycline treatment. A 
doxycycline inducible plasmid loss was observed for the sctetR:HMGA1a plasmid 
system. Plasmid loss rates of oriP and sctetR:HMGA1a tetO-DS without doxycycline 
were similar, whereas the inhibition of sctetR:HMGA1a binding to tetO by 
doxycycline led to a significant increase in plasmid loss after seven days 
establishment time. Within 18 days only low levels of gfp+ cells were detectable. In 
contrast the pCONCENP-A plasmids were maintained at a stable level in both tested 
conditions (“+dox” and “-dox”). About 15 % gfp+ cells were the stable threshold for 
maintaining pCONCENP-A plasmids after an initial plasmid loss, independent of 
doxycycline.  
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We found that initial targeting of CENP-A for seven days is sufficient to establish 
inheritable centromeres on pCONCENP-A. The same experimental setup was then 
performed with four days establishment phase (see Appendix). Four days of 
establishment showed the same plasmid maintenance as seven days (compare Figure 
36 and Appendix Figure 5). These results raised the question if the establishment of 
an artificial centromere can be even faster than four days. 
Figure 36: Targeting independent plasmid maintenance 7 days 
after establishment 
A) Timeline of experimental setup. 7 days after transfection cells are 
sorted according to gfp expression and then splitted into condition with 
and without doxycycline. Plasmid maintenance was analyzed by FACS 
count every 4 to 6 days.  
B) Plasmid maintenance after 7 days establishment time. (n=3, Mean+SD) 
A 
B 
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 Establishment of centromere inheritance after 4 days 4.6.3
 
To dissect even shorter centromere maturation time, I transfected synchronized 
HEK293EBNA1+ cells with either sctetR:HMGA1a tetO-DS or pCONCENP-A plasmids 
during mitosis and added doxycycline at different time points to repress the binding 
of tet transactivator to the operator elements (Figure 37 A). Since endogenous   
CENP-A incorporation is known to take place from late mitosis to G1 phase 
(McKinley and Cheeseman, 2016), I transfected the cells during mitosis to prevent 
CENP-A incorporation during the first cell cycle.  
HEK cells were released from a thymidine block for 16 hours by washing with PBS 
and adding cell growth medium. Eight hours after release, when most cells entered 
mitosis, cells were transfected with the tetO-DS reporter plasmids expressing either 
sctetR:HMGA1a or sctetR:CENP-A. Doxycycline was added to one plate immediately 
after transfection (day0) and to other plates one, two or four days later as shown in 
Figure 37 A. At day1 after transfection the initial amount of transfected plasmids was 
quantified by FACS measurement of gfp positive cells. On day9 after transfection the 
plasmid maintenance under different conditions was determined (Figure 37 A). 
Transfected cells without doxycycline treatment were also analyzed and set as 100 % 
reference. 
The relative plasmid maintenance for the sctetR:HMGA1a plasmids analyzed on 
day9 after transfection was not significantly different if doxycycline was added on 
day2 or day4. The slight differences in plasmid maintenance, if day0 and day4 were 
compared, resulted from the time of doxycycline present in the medium. If 
doxycycline was added on day0 and analyzed on day9, the plasmids were not 
established in the cells. If the treatment started at day4, plasmids were initially 
established and then lost within five days. Contrary to the sctetR:HMGA1a plasmids, 
the pCONCENP-A plasmids were stably maintained in the HEK293EBNA1+ cells if the 
sctetR:CENP-A targeting was inhibited at day4. The artificial centromere was 
established within four days, which led to maintenance of these plasmids in presence 
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of doxycycline. Relative plasmid maintenance was significantly reduced if 
doxycycline was added already two days after transfection or earlier.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
These results indicate, that four days are sufficient for the establishment of 
centromere activity on pCON, whereas two days are not. It is likely that recruitment 
of CENP-A is independent on CENP-A targeting because of a self-propagation 
mechanism for CENP-A incorporation. To further verify that, a ChIP experiment in 
presence and absence of doxycycline was performed. There is no difference in 
binding of sctetR:CENP-A to tetO sites in both conditions expected. In contrast, the 
sctetR:HMGA1a binding to tet operators in presence of doxycycline is anticipated to 
be reduced.  
Figure 37: Two days of establishment are not enough 
A) Timeline of experimental setup. Cells are transfected during mitosis and 
then spitted into conditions with and without doxycycline on day0, 1, 2 and 4.  
B) tetO-DS sctetR:HMGA1a reporter plasmid loss is not significantly different 
when doxycycline is added.  
C) tetO-DS sctetR:CENP-A is established within four days. If doxycycline is 
added after two days, plasmids are lost significantly more. (n=3, Mean+SD, 
**p=0.0074, p-value: unpaired t test with Welch’s correction, two-tailed) 
A 
B C 
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For this tetR ChIP, I transfected HEK293EBNA1+ cells with either sctetR:HMGA1a 
tetO-DS or pCONCENP-A reporter plasmids. Four days after transfection, I added 
2 µg/ml doxycycline for 24 h. After cross-linking in presence of doxycycline a tetR 
immuno precipitation was performed. Quantitative PCR revealed a 4-fold reduced 
binding of sctetR:HMGA1a to tetO in presence of doxycycline. In contrast, binding of 
sctetR:CENP-A to tetO was not influenced by inhibiting the binding capacity of 
sctetR to tetO with doxycycline (Figure 38). 
 
 
 
 
 
 
 
 
 
 
 
It is confirmed that within four days the centromere inheritance is established on the 
pCONCENP-A plasmids (Figure 37), whereas two days are no sufficient for centromere 
establishment. Maintenance of neo-centromeres is independent of CENP-A targeting, 
demonstrated by ChIP of tetR fusion proteins. In addition, the sctetR:CENP-A fusion 
proteins are incorporated into centromeric nucleosomes (Figure 34). The hypothesis 
resulting from these observations is that endogenous CENP-A is also recruited to the 
Figure 38: ChIP in presence and absence of 
doxycycline 
Binding of sctetR:HMGA1a to tetO is significantly 
reduced in presence of doxycycline. Binding of 
sctetR:CENP-A to tetO is not significantly affected by 
doxycycline. (n=4, Mean+SD, p-value: unpaired t test 
with Welch’s correction, two-tailed)  
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plasmids and this leads to the targeting-independent and self-propagating 
centromere inheritance on pCONCENP-A. 
 
4.7 Recruitment of CENP-A 
 
To test the hypothesis, if endogenous CENP-A is recruited to pCONCENP-A 
centromeres after establishment, I performed immune fluorescence microscopy. The 
endogenous and targeting-independent CENP-A protein was represented by a 
RFP:CENP-A fusion protein. 
I transfected HEK293EBNA1+ cells with the sctetR:GFP:CENP-A expressing 
pCONCENP-A reporter plasmid and analyzed the recruitment of a RFP:CENP-A 
protein two and four days after transfection by co-staining of plasmid signals and 
RFP:CENP-A. According to the result depicted in Figure 37 a recruitment of 
endogenous CENP-A, represented by RFP:CENP-A, was expected on day4, but not 
on day2. 
 
 
 
 
 
 
 
 
 
Figure 39: Recruitment of RFP:CENP-A to plasmids 
RFP:CENP-A co-localizes with sctetR:GFP:CENP-A and EBNA1 on day 4 
after transfection. 2 days after transfection RFP:CENP-A is not recruited to 
plasmids. 
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Indeed, what was observed in this immune fluorescence analysis was, that 
RFP:CENP-A was recruited to the plasmids four days, but not two days after 
transfection. Two days of centromere maturation were not sufficient to incorporate 
endogenous CENP-A (represented by RFP:CENP-A) into plasmid chromatin, 
whereas after four days RFP:CENP-A was loaded into the artificial centromeres on 
the plasmids (Figure 39). 
In order to investigate if recruitment of RFP:CENP-A to the plasmids is independent 
on the targeting of sctetR:GFP:CENP-A, doxycycline was added to the cells. 
HEK293EBNA1+ cells were transfected with either sctetR:GFP:CENP-A expressing 
pCONCENP-A plasmids or, as reference, with sctetR:GFP expressing tetO-DS reporter 
plasmids and incubated for four days. Then, the RFP:CENP-A expression plasmid 
was transfected and cells were split into two conditions: presence and absence of 
2 µg/ml doxycycline.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 40: Recruitment of RFP:CENP-A to plasmids in presence of doxycycline 
RFP:CENP-A co-localizes with tetO-DS plasmids in presence and absence of doxycycline 
when sctetR:GFP:CENP-A is targeted. RFP:CENP-A is not recruited when sctetR:GFP is 
targeted. In presence of doxycycline sctetR:GFP is not co-localized to plasmids, whereas 
sctetR:GFP is co-localized with plasmids when no doxycycline is present. 
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As already demonstrated in Figure 39, RFP:CENP-A was recruited to plasmids in 
absence of doxycycline. In addition a co-staining of RFP:CENP-A, sctetR:GFP:CENP-
A and EBNA1 in presence of doxycycline was detected. By highlighting this 
observation, it indicates that not only endogenous or RFP:CENP-A but also 
sctetR:GFP:CENP-A is incorporated into pCONCENP-A by endogenous mechanisms.  
In contrast, initial targeting of sctetR:GFP did not recruit RFP:CENP-A to tetO-DS 
reporter plasmids. The control experiment also illustrated that applying doxycycline 
led to decreased tetR-tetO interaction, because the sctetR:GFP signal was distributed 
in the whole nucleus after adding doxycycline, whereas it co-localized with EBNA1, 
representing plasmids, in absence of doxycycline (Figure 40). 
In summary, we found out that after establishment of centromere identity on 
plasmids, these were maintained stable and independent on CENP-A targeting. 
Recruitment of kinetochore proteins led to the active segregation of the plasmids 
during mitosis. In addition my results showed that it takes only four days to 
establish an inheritable centromere on plasmids in human cells. All these findings 
indicate that the inheritable centromere establishes epigenetic modifications to self-
propagate and maintain its identity.  
Therefore, the next aim was to reveal the epigenetic characteristics of the plasmid 
centromeric chromatin that lead to its inheritance. For that purpose, I utilized the 
CRISPR/Cas9 targeting system, introduced in chapter 4.3.1, to purify plasmids with 
matured centromeres out of the human cells. After purification of the plasmids, 
several histone modifications were analyzed, since these are potential candidates for 
epigenetic inheritance of centromere identity. 
 
 
 
4 RESULTS 
 
 
99 
4.8 CRISPR/Cas9 targeting system to analyze histone modifications on the 
artificial centromere 
 
To purify plasmid centromeres, established after CENP-A targeting, and analyze 
their epigenetic histone modification pattern, I needed a system to isolate the 
plasmid DNA from human cells. The master student Alejandro Freyermuth 
compared a LexA dependent targeting system, where a LexA:TAP fusion protein 
was targeted to LexA sites on plasmids with an innovative CRISPR/Cas9-dependent 
purification method during his master thesis project.  
CRISPR/Cas9 is a new tool to target and modify DNA systematically and easily. It is 
a bacterial system altered and engineered to use also in mammalian cells. Cas9 is an 
endonuclease that cuts double stranded DNA after specific targeting by a guide 
RNA. This guide RNA is complementary to the DNA sequence where Cas9 should 
cut the DNA. In the engineered system the nuclease activity leads to homologous 
recombination of the DNA strands and results in either deletion of a DNA fragment 
or in the insertion or replacement by co-transfecting a target DNA-sequence (Sander 
and Joung, 2014).  
In our system it turned out that the CRISPR/Cas9 targeting method was more 
specific than the LexA system. We used the nuclease deficient Cas9 protein that was 
tagged with a tandem affinity purification (TAP) tag, consisting of a twin-STREP tag 
and a Flag tag (see Figure 17, chapter 3.2.1.1). 
Since this Cas9 dependent plasmid purification system was not used before, we 
characterized it in its targeting specificity to plasmids and optimized a purification 
protocol to analyze epigenetic histone modifications established on the plasmid by 
targeting CENP-A.  
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 Specific binding of Cas9 to the targeting sites in the plasmid system 4.8.1
 
In order to investigate binding efficiency of Cas9:mCherry:TAP to the targeting sites 
on the reporter plasmids, I performed a STREP pull down according to the ChIP 
protocol (see chapter 3.2.7).  
HEK293EBNA1+ cells, stable expressing Cas9:mCherry:TAP, were transfected with 
the pCONCENP-A plasmid with and without a repeat of 40 Cas9 targeting sites. 
Readout of this pull down was a qPCR with primer locations several (kilo) bases 
away from the targeting sites (Figure 41 C tetO; reference) and in close proximity to 
the targeting sites (Figure 41 C Cas9).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 41: ChIP of plasmid with and without targeting sites 
A) Representation of tetO-DS sctetR:CENP-A reporter plasmid with Cas9 targeting sites. 
B) Representaion of tetO-DS sctetR:CENP-A reporter plasmid  
C) qPCR of plasmid sites located at tetO and Cas9 sites. Targeting of Cas9:TAP is highly 
specific to Cas9 targeting sites, if those are present on reporter plasmid. (n=2, Mean+SD) 
A B 
C 
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Figure 42: High digest efficiency in 
un-cross-linked and heavily cross-
linked sample 
AseI digest (red bars) is a little less 
efficient than AflIII digest (blue bars). 
Overall digest efficiency of plasmid DNA 
is very high with more than 80 %  
Data: Alejandro Freyermuth (n=1)  
Specific binding of the Cas9:mCherry:TAP fusion protein was observed after STREP 
ChIP. Significant enrichment of Cas9 was found at the Cas9 targeting sites on the 
plasmid that contains these sites, whereas no Cas9 is bound to reference regions or to 
the plasmid without any specific targeting sites (Figure 41 C). 
Hence, this system is suitable for the specific purification of pCONCENP-A plasmids by 
a STREP pull down and to further characterize the epigenetic information established 
at the artificial centromere on the plasmids. 
 
 High digest efficiency of plasmid DNA 4.8.2
 
For the analysis of the matured centromeres only the region within and around the 
tetO array is of interest.  However, the pCONCENP-A including the Cas9 targeting sites 
has a size of around 13 kbp. The fragment of interest, with the matured centromere, 
is around 3 kbp in size.  
In order to reduce background signals, 
induced by the remaining plasmid, the 
plasmid DNA was digested by specific 
endonucleases. Combining an AseI and AflIII 
restriction enzyme digest of whole cell 
extract transfected with reporter plasmids 
led to fragmentation of genomic DNA and to 
site specific digest of plasmid DNA. The 
resulting fragment included centromeric 
nucleosomes at the tetO sites and the Cas9 
targeting sites for purification (Figure 18, 
chapter 3.2.9.3). 
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To verify the digest efficiency of AseI and AflIII on the plasmids a quantification by 
qPCR was performed by the master student Alejandro Freyermuth under my 
supervision. He transfected HEK293EBNBA1+ cells with pCONCENP-A plasmids 
containing the Cas9 targeting sites. Four to six days later, he prepared cell extracts 
either not or heavily (40 min) cross-linked. After double-digestion with AseI and 
AflIII, he extracted the DNA and quantified digest efficiencies by qPCR according to 
Hagege et al. (equation see chapter 3.2.8) (Hagege et al., 2007).  
The primer pairs covering the AseI or AflIII digest region included one restriction site 
of AseI or AflIII respectively. AflIII restriction digest showed a slightly better digest 
efficiency depicted in Figure 42 (blue bars). However, in general a high digest 
efficiency of 80 % for AseI and 95 % for AflIII was observed in un-cross-linked and 
cross-linked chromatin. These efficiencies were suitable to continue the purification 
protocol to investigate histone modifications established on the artificial centromere. 
 
 Re-Solubilization by high pressure in a French pressure cell press 4.8.3
 
To remove insoluble proteins and protein aggregates, which would interfere with the 
STREP-beads during purification, Alejandro centrifuged the cell lysate. By doing 
that, we observed that almost all material was pelleted and no proteins remained 
soluble in the supernatant after centrifugation (Figure 43, not pressed). Hence, we 
decided to solubilize the cell lysate by disposing high pressure mediated by a French 
pressure cell press, like used in the PICh (Proteomics of Isolated Chromatin) protocol 
on the ribosomal RNA gene promoter developed in J. Déjardins group (Ide and 
Dejardin, 2015).  
 
 
 
 
4 RESULTS 
 
 
103 
 
 
 
 
 
 
 
 
 
 
As expected the protein solubility, as well as DNA solubility increased with rising 
pressure (see Figure 43 A for protein and Figure 44 for DNA). At a pressure of 
8700 psi only 20 % of protein was re-solubilized, whereas at a pressure of 21700 psi 
almost 80 % of protein was soluble (Figure 43 B). Do define the optimal pressure for 
re-solubilization of chromatin, one also has to take care about the DNA re-
solubilization and the fragmentation of DNA occurring by shearing in the French 
pressure cell press.  
Without pressing the lysate and loading extracted DNA on an agarose gel, a distinct 
band above the 10 kb marker was observed (Figure 44; not pressed, lysate). This 
DNA was insoluble (Figure 44; not pressed, insoluble) and therefore not accessible in 
our purification approach. After exposing the lysate to high pressure, the DNA was 
re-solubilized but also fragmented (Figure 44; 13000 psi-21700 psi). To ensure to have 
enough re-solubilization but not too much shearing to break the 3 kb plasmid 
fragment we were aiming to analyze, we used a pressure of 13000 psi (Figure 44 
marked by red rectangle). In this setting the DNA size of bulk soluble DNA was 
between 3 kb and 6 kb and the solubility was at 40 %. 
Figure 43: Protein re-solubilization by French Press 
A) Re-solubilization of proteins. Without French Press proteins are not 
soluble, with increasing pressure the protein solubilization is also rising.  
B) Representation of quantification of protein re-solubility.  
Data: Alejandro Freyermuth, Master thesis 
A B 
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The conditions for STREP pull down were established as the following: 5 minutes 
cross-link with 1 % formaldehyde; 13000 psi French press; 2 h digest with AseI and 
AflIII. 
By performing a STERP purification of Cas9:mCherry:TAP under these conditions, I 
investigated the histone modifications that establish on neo-centromeres after  
CENP-A targeting.  
 
 Efficient STREP pull-down of Cas9:mCherry:TAP fusion protein 4.8.4
 
With the Cas9 dependent STREP purification I analyzed the composition of a 
matured artificial centromere on the pCONCENP-A plasmid. We knew from previous 
experiments, described in chapter 4.6.3, that the centromere identity is established 
Figure 44: DNA re-solubilization by French Press 
DNA is re-solubilized but also fragmented by French Press. To pull down artificial 
centromere at tetO sites, fragment size needs to be more than 3 kb. At 13000 psi conditions 
are suitable for purification of plasmids. Fragment size is more than 3 kb and re-
solubilization is around 40 %. 
Data: Alejandro Freyermuth, Master thesis 
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already after four days. However, for technical reasons I analyzed modifications, 
possibly dictating the centromere inheritance, after a longer establishment time.  
Thus, I transfected HEK293EBNA1+ cells with the pCONCENP-A reporter plasmid 
either including Cas9 targeting sites or without Cas9 targeting sites. Both plasmids 
were stable established in the cells for three weeks under selection pressure. After re-
transfecting these cells with the Cas9:mCherry:TAP expression plasmid together 
with the sgRNA encoding plasmid and incubating them for additional five days, 
they were harvested and cross-linked. The readout of the STREP pull down after 
French Press and restriction digest was performed by Western Blot. 
 
 
 
 
 
 
As verified in the Western Blot (Figure 45), the Cas9:mCherry:TAP protein became 
soluble after exerting a pressure of 13000 psi by French press. The same amount of 
protein stayed soluble after restriction enzyme digest. The soluble fraction was then 
used for STREP pull down. Besides there was a lot unbound Cas9:mCherry:TAP 
remaining on the beads, the elution of the protein was sufficient to investigate co-
precipitation of histones and modified histones established on plasmid chromatin. 
 
 
 
Figure 45: STREP pull down after French press and digest  
Cas9:mCherry:TAP Western Blot for analysis of solubility and pull down efficiency with 
STREP beads. Before French Press almost no protein is soluble. After French Press and 
digest around 50 % proteins are soluble. This is the case for cells transfected with plasmids 
with and without targeting sites. 
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 Co-purification of modified histones  4.8.5
 
In order to determine which histones and possible histone modifications are present 
around tet operator sites after the establishment of an artificial centromere, different 
Western Blot analyses were performed after the STREP pull down depicted in Figure 
45. Equal amounts of eluted proteins of the STREP pull down of cell extracts 
containing the pCONCENP-A reporter plasmids with targeting sites were compared 
with extracts containing the reporter plasmids without the Cas9 targeting sites.  
 
 
 
 
 
 
 
 
 
 
 
The pull down of Cas9:mCherry:TAP proteins in cells containing the pCONCENP-A 
with targeting sites (+) and without targeting sites (-) was comparable (Figure 46,     
α-strep). However, the co-precipitation of histones and histones carrying specific 
modifications was higher when Cas9 targeting sites were present on the reporter 
plasmid (compare Figure 46 α-H3). Most prominent modifications were H3K9me3, 
H3K4me1 and H3K4me2. In addition H3K9me2, H3K27me2 and H3K27me3 were 
Figure 46: Co-purification of histones and specific modifications 
Elutions of STREP pull down analyzed in co-precipitation of histone H3 
and histone H4 modifications. Analyzed were plasmids without (-) and 
with (+) Cas9 targeting sites. (n=1) 
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enriched on plasmid chromatin after CENP-A targeting. Histone H4 showed a tri-
methylation state on lysine 20. No significant signal compared to pCONCENP-A 
without Cas9 targeting sites was observed for H4K20me1, H4H20me2 and H3K4me3. 
For H3K27me1, there was no signal obtained at all (Figure 46, α-H3K27me1; input 
analysis not shown).  
Most of these histone modifications, especially H3K4me2 and H3K9me3, are known 
to be present on human centromeric and pericentromeric chromatin (McKinley and 
Cheeseman, 2016). Finding these also in the plasmid system gives a hint, that initial 
targeting of CENP-A to a foreign DNA locus leads to the maturation of an inheritable 
centromere identity that is comparable to endogenous centromeres. 
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 DISCUSSION 5
 
I used the pCONCENP-A plasmid system as a suitable tool to analyze de novo 
centromere establishment and epigenetic maturation of artificial centromeres. Site-
specific targeting of CENP-A leads to the establishment of an inheritable centromere 
identity. With the pCONCENP-A plasmid system, I addressed three distinct aspects: 
I) The CENP-A dependent plasmid segregation mechanism by live cell imaging of 
cells containing pCONCENP-A. Furthermore, I analyzed their capacity to recruit 
kinetochore components by immune fluorescence.  
II) The minimal plasmid establishment time required for long-term maintenance and 
CENP-A self-propagation. Plasmid maintenance became independent of CENP-A 
targeting and I examined the minimal timeframe of centromere maturation in which 
centromeres begin to self-propagate. 
III) The histone modifications present on matured plasmid centromeres. Therefore, I 
developed a Cas9-dependent targeting system and purified plasmids with matured 
centromeres from human cells. 
 
5.1 Plasmid segregation mechanism after CENP-A targeting 
 
Initial targeting of sctetR:CENP-A to a tetO array of pCONCENP-A leads stable 
maintenance of pCONCENP-A plasmids within human cells (Figure 14), because of the 
formation of a functional neo-centromere on these plasmids. At endogenous 
chromosomes centromeres are the platform for kinetochore assembly and they 
mediate interaction of microtubules. Thus they regulate active segregation during 
mitosis. Since centromeres are formed on the plasmids as well, we hypothesize an 
active segregation mechanism for pCONCENP-A plasmids, like it is observed for 
endogenous chromosomes. 
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To adress that question, we investigated the capacity of pCONCENP-A to recruit 
kinetochore proteins. I chose the inner kinetochore protein CENP-C and the outer 
kinetochore protein Ndc80 as representative components. CENP-C is one of the most 
important inner kinetochore proteins, because it directly interacts with the CENP-A 
nucleosome and stabilizes it (Falk et al., 2015). In in addition CENP-C plays a role in 
self-propagation of centromere inheritance (McKinley and Cheeseman, 2016). 
Presence of CENP-C at artificial centromeres on plasmids already indicates that these 
are able to self-propagate and recruit CENP-A in a cell cycle dependent manner. On 
this account, I examined the recruitment of CENP-C to artificial neo-centromeres on 
the plasmids by immune fluorescence. The targeting of sctetR:GFP:CENP-A results 
in highly enriched localization of CENP-C signals at the plasmids compared to 
targeting of sctetR:GFP (Figure 31). 55 % of pCONCENP-A plasmid signals, represented 
by EBNA1 staining, overlap with CENP-C spots in a sctetR:GFP:CENP-A targeting 
dependent manner. If sctetR:GFP only is targeted, no overlap of CENP-C with 
EBNA1 is observed. This indicates that CENP-C recruitment is dependent on CENP-
A targeting and that the neo-centromeres are able to attract CCAN components. 
CCAN is constitutively bound to centromeres and provides a binding site for outer 
kinetochore proteins during mitosis. Ndc80 is the major sub-complex for active 
segregation during mitosis, because its HEC1 subunit directly interacts with spindle 
microtubules (Wei et al., 2007). Only if Ndc80 is recruited to plasmids, these will be 
able to actively segregate by microtubule interaction. I analyzed presence of HEC1 at 
neo-centromeres, also by immune fluorescence, in mitotic cells. Like for the CENP-C 
protein, recruitment of HEC1 is dependent on initial CENP-A targeting. Overlap 
between plasmid signals and HEC1 signals is with 60 % significantly higher if 
sctetR:GFP:CENP-A was targeted compared to sctetR:GFP targeting (Figure 31). 
These data suggest that neo-centromeres on pCONCENP-A are capable to recruit 
kinetochore components. However, the segregation mechanism is not resolved with 
these approaches. 
Immune fluorescence experiments in the Drosophila melanogaster system 
demonstrated the association of plasmid neo-centromeres to spindle microtubules 
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(Figure 11, in collaboration with P. Heun). We also observed that segregation of these 
plasmids is not timely regulated as segregation of chromosomes (Mendiburo et al., 
2011). Two models of plasmid segregation are conceivable, as represented in Figure 
47. 
 
 
 
 
 
 
 
 
 
 
 
First, plasmids are either bound by microtubules at two sites of centromere region, 
like in endogenous chromosomes (Figure 47, left). This leads to segregation of 
replicated plasmids and equal distribution to daughter cells. Alternatively, replicated 
plasmids are attached to microtubules from one direction and are segregated 
asymmetrically to the spindle poles (Figure 47, right). 
To clarify the segregation mechanism of plasmids that contain an artificial 
centromere, I performed live cell imaging experiments. I generated a CRISPR/Cas9 
dependent targeting system to specifically visualize pCONCENP-A plasmids in living 
cells. The Cas9:3xmCherry protein approach was already established in multicolor 
imaging of chromosomal loci (Ma et al., 2015). By counterstaining cells with a live cell 
Figure 47: Segregation mechanism of pCONCENP-A plasmids 
After replication plasmids are segregated by recruitment of spindle microtubules during 
mitosis. Plasmids can be attached at both sides and segregated equally to daughter cells 
like endogenous chromosomes (left). Or plasmids are attached by microtubules from just 
one direction and pulled towards one spindle pole asymmetrically (right). 
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tubulin dye, I aimed to detect microtubule-plasmid interaction during mitosis in 
living cells.  
Because of technical problems, I have not been able to finalize this project. In initial 
experiments, I followed one cell over the cell cycle and detected the Cas9:3xmCherry 
signal during cell division. In this experiment one plasmid spot localized towards 
just one spindle pole (Figure 28), indicating an asymmetric plasmid segregation for 
this cell. 
In conclusion, the molecular segregation mechanism of pCONCENP-A with neo-
centromeres is still unclear. Fly experiments indicate that segregation of plasmids 
might be earlier than segregation of endogenous chromosomes because plasmids are 
detected at spindle poles already at metaphase (Mendiburo et al., 2011). It is likely 
that plasmid segregation is not part of the spindle assembly checkpoint (SAC). Cells 
detect correct attachment of microtubules to both sites of chromosomes by 
generation of tension and tension signaling by kinetochores at the SAC. Only if 
kinetochores of all chromosomes detect tension, generated by cohesin proteins, 
mitotic progression takes place (Kim and Yu, 2015). In replicated plasmids, the 
centromeres are most likely not arranged as cohesin attached pairs, a prerequisite for 
the spindle checkpoint. It is well possible that plasmids are distributed 
asymmetrically in human cells (Figure 28). 
The composition of the minimal kinetochore complex and proteins recruited to 
plasmids once centromere is established, like cohesins, could be determined by a 
tandem affinity purification and subsequent mass spectrometric analysis. In contrast 
to in vitro assembly of purified proteins, like in the study of Guse et al. (Guse et al., 
2011), the pCONCENP-A system and its analysis after purification would reveal an in 
vivo assembled minimal kinetochore and might allow structural characterization of 
this huge protein complex by AFM (atomic force microscopy) studies. 
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5.2 Establishment of self-propagating centromeres on plasmids 
 
In the pCONCENP-A reporter plasmid, the sctetR:CENP-A fusion protein is targeted to 
plasmids by tetR-tetO interaction. The transactivator tetR is bound to the specific 
tetO sequence by dimerization of two tetR proteins. In the sctetR fusion protein both 
dimers are connected by a linker. Binding of tetR to tetO can be inhibited with 
doxycycline by changing tetR dimer structure that the interaction to tetO is 
interrupted. 
Site-specific targeting of sctetR:CENP-A was investigated by ChIP and immune 
fluorescence. Both techniques verified the site specific targeting of sctetR:CENP-A to 
plasmids (Figure 20 and Figure 22). Another important finding of the pCONCENP-A 
system was its stability in human cells. These plasmids showed long-term 
maintenance without selective pressure for five months (Figure 19). In collaboration 
we already reported, that targeting of CID, Drosophila CENP-A, is sufficient for 
establishment of an inheritable centromere identity in fly cells (Mendiburo et al., 
2011). With pCONCENP-A we observed that also this plasmid maintenance becomes 
independent of CENP-A targeting after a centromere has established on the plasmids 
(Figure 36). Hence, we presume an artificial neo-centromere established on the 
plasmids, that is self-propagating and regulates its CENP-A incorporation. 
In order to test this hypothesis, different experimental approaches were used. First 
hints about CENP-A targeting independent centromere inheritance were given by 
ChIP of sctetR:CENP-A at two different time points. Precipitation of sctetR:CENP-A 
after four days establishment revealed localization of the fusion protein at tet 
operator sites. In contrast, at the matured centromere after three weeks establishment 
time, no sctetR:CENP-A was detectable at the plasmid tetO array. To further validate 
targeting-dependency of centromere inheritance we used plasmid maintenance as 
readout. After an establishment time of seven days, we added doxycycline into the 
system and investigated pCONCENP-A maintenance when tetR-tetO interaction is 
inhibited (Figure 36). Even when the targeting of sctetR:CENP-A to the plasmids is 
interrupted, these were maintained several weeks. This implied a centromere 
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inheritance mechanism that is independent of CENP-A targeting. We already knew 
from Drosophila melanogaster experiments, that an epigenetic mark is established at 
artificial centromeres, which leads to its self-propagation and incorporation of 
additional CENP-A (Mendiburo et al., 2011). For that reason we analyzed 
recruitment of CENP-A, that was not mediated by the tetR transactivator. 
RFP:CENP-A was a representative for endogenous CENP-A, potentially recruited to 
the neo-centromeres. Two days after introducing pCONCENP-A into human cells, no 
RFP:CENP-A is incorporated into plasmid centromeres. In contrast, two days later, 
four days after transfection, RFP:CENP-A was present at pCONCENP-A, together with 
sctetR:GFP:CENP-A (Figure 39). In an additional experiment we revealed that not 
only RFP:CENP-A but also sctetR:GFP:CENP-A is recruited to plasmid by a targeting 
independent mechanism (Figure 40).  
These results demonstrate that CENP-A targeting is sufficient to establish an 
inheritable centromere identity on plasmids in the human system. These centromeres 
are self-propagating and regulate CENP-A incorporation. 
However, how the of CENP-A containing neo-centromere is restricted and how 
many CENP-A nucleosomes are needed for the establishment of an artificial 
centromere was not completely solved with our approaches. For endogenous 
centromeres it is known that expression of exogenous CENP-A leads to a 
downregulation of endogenous CENP-A in human cells (Jansen et al., 2007) and it 
was observed that CENP-A overexpression leads to spreading of CENP-A to 
chromosome arms (Gascoigne et al., 2011). This indicates that CENP-A restriction to 
centromere core is partly determined by CENP-A levels in the cells and the amount 
of CENP-A nucleosomes incorporated into chromatin. If threshold level of CENP-A 
nucleosomes is to low, for example at mis-incorporation in chromosome arms, 
CENP-A is evicted again. The minimum functional core for epigenetic inheritance of 
eukaryotic centromeres is 30 to 70 kb of alphoid DNA arrays (Okamoto et al., 2007). 
For the pCONCENP-A plasmid system only 6 CENP-A nucleosomes are sufficient for 
establishment of centromere inheritance, whereas 6 CENP-A nucleosomes within 
endogenous chromosomes are not sufficient. We conclude for pCONCENP-A, that only 
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a small number of CENP-A nucleosomes leads to the establishment of a neo-
centromere and that each CENP-A triggers new CENP-A incorporation only once, 
like in endogenous centromeres (Ross et al., 2016).  
 
5.3 Four days are sufficient for de novo Centromere inheritance 
 
The pCONCENP-A establish a stable maintenance in human cells without selective 
pressure (Figure 36) and targeting of CENP-A is sufficient to create an inheritable 
centromere identity on plasmids. In addition, already four days after transfection, 
RFP:CENP-A, is recruited to neo-centromeres by a targeting independent mechanism 
(Figure 39). The question that arises from these observations is: 
How fast is the inheritable centromere identity established on the plasmids? 
We knew from previous experiments that seven days of establishment lead to stable 
plasmid maintenance. Since already after four days RFP:CENP-A is present at 
artificial centromeres, we investigated plasmid maintenance after an establishment 
time of four days. We observed that the pCONCENP-A plasmids were as stable as after 
seven days when doxycycline inhibited tetR targeting four days after transfection 
(Appendix Figure 5). In conclusion this meant that only three to four cell cycles were 
sufficient for de novo formation of neo-centromeres. To ascertain if centromere 
formation on plasmids is also possible in less than four days, I further shortened the 
establishment time. CENP-A targeting was inhibited immediately (day0), one day, 
two days and four days after transfection (Figure 37 A) and plasmid maintenance 
after nine days was used as readout for centromere formation. Two days of 
establishment are not sufficient for de novo centromere maturation and plasmid 
maintenance (Figure 37 C), as indicated as well in the RFP:CENP-A immune 
fluorescence experiment (Figure 39). 
For maturation of centromeres, plasmids have to be chromatinized first. The process 
of chromatinization of plasmids was shown already in vivo (Riu et al., 2007). Since the 
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pCONCENP-A encodes the sctetR:CENP-A fusion protein, it also takes some time to 
express this fusion protein from plasmids, successfully target it and incorporate it 
into plasmid nucleosomes. After chromatinization, successful targeting of 
sctetR:CENP-A and its incorporation the centromeres are able to self-propagate its 
own CENP-A incorporation. The timeframe of these events taking place, which we 
identified in our experiments, is four days. Four days correspond to three to four cell 
cycles. We also demonstrated in an immune fluorescence approach that      
RFP:CENP-A and sctetR:GFO:CENP-A are recruited to plasmid centromeres in 
presence of doxycycline (Figure 40). This verifies that centromere inheritance and 
incorporation of CENP-A in plasmids is independent of targeting. In conclusion, we 
revealed that a short pulse of CENP-A targeting of only three to four cell cycles is 
sufficient to establish a self-propagating and inheritable centromere on  pCONCENP-A. 
However, our approach did not uncover the mechanism behind CENP-A 
incorporation and how centromere identity is determined on the plasmids. Since 
RFP:CENP-A or sctetR:CENP-A in presence of doxycycline are independent of the 
tetR targeting mechanism, it is likely that CENP-A incorporation into plasmids is 
mediated by HJURP. HJURP recognizes CENP-A present at artificial centromeres on 
plasmids and targets and incorporates new CENP-A via the endogenous CENP-A 
incorporation cycle. HJURP dependent CENP-A incorporation is dependent on the 
CATD domain of CENP-A (Bassett et al., 2012) and this explains, why only  
pCONCENP-A with functional CATD were maintained in our experiments (Figure 15). 
Therefore, it is likely, that new CENP-A is incorporated on plasmids by HJURP.  
 
5.4 Histone modifications at matured artificial centromeres 
 
The sctetR:GFP:CENP-A fusion protein is incorporated into endogenous 
centromeres, if no tetO containing plasmid is present in the cells (Figure 32). We also 
know that sctetR:CENP-A forms nucleosomes together with H2B and without 
canonical H3 (Figure 34). What we do not know from our experiments is, how 
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sctetR:CENP-A nucleosomes are assembled at plasmid centromeres. It is unclear if 
tetO repeats result in a different nucleosome conformation, since these are 
prokaryotic sequences. Therefore, it might be that sctetR:CENP-A nucleosomes as 
well as canonical nucleosomes establish differently at these prokaryotic DNA 
structures on pCONCENP-A. However, my expectation is that sctetR:CENP-A 
nucleosomes at tetO repeats on plasmids are similar to endogenous CENP-A 
nucleosomes. It was reported, that CENP-C reshapes and stabilizes CENP-A 
nucleosome structure (Falk et al., 2015). Since CENP-C is also recruited to plasmids 
(Figure 29) it is likely that it also influences the CENP-A nucleosome structure at 
plasmid nucleosomes. I assume that sctetR:CENP-A nucleosomes at the tetO array 
are similar to endogenous centromeric nucleosomes. In order to verify this 
hypothesis the Cas9-dependent tandem affinity purification system, I generated for 
the pCONCENP-A plasmids, could be used. After plasmid purification by Cas9:TAP, 
mono-nucleosomes containing sctetR:CENP-A could be enriched by a tetR-IP and 
further analyzed according to structure and composition. 
The question I addressed with the Cas9-dependent tandem affinity purification was 
how matured centromeres on pCONCENP-A are defined and if histone modifications 
are established at inheritable centromeres. It is known that at endogenous 
centromeres, CENP-A nucleosomes are interspersed with canonical H3 nucleosomes 
that show a centromere specific histone modification pattern (Fukagawa, 2017). In 
order to uncover histone modifications present on matured artificial centromeres on 
pCONCENP-A, I developed and investigated the Cas9:STREP:STREP:Flag targeting 
system for plasmid purification as a prerequisite for histone modification analysis by 
mass spectrometry. It was already shown that pull down of specific DNA by 
CRISPR/Cas9 and subsequent mass spectrometric analysis enables epigenome 
definition of a certain gene locus (Waldrip et al., 2014). We put a lot of effort into the 
establishment of the purification protocol. We first found, that proteins and DNA 
needed to be properly re-solubilized by French Press (Figure 43 and Figure 44) 
according to Ide et al. (Ide and Dejardin, 2015). Pull down of plasmids harboring 
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targeting sites was significantly increased compared to plasmids that do not contain 
targeting sites (Figure 41).  
My initial experiment after successful pull down of Cas9 protein bound to plasmids 
revealed several histone modifications (Figure 46). Di-methylation of histone H3 on 
lysine 4 (H3K4me2), was present at artificial centromeres. It is the most prominent 
modification of centromeres since it is required for HJURP targeting of CENP-A to 
centromeres (Bergmann et al., 2011). Another important modification is mono-
methylation of lysine 20 on histone H4 (H4K20me1) in CENP-A nucleosomes, which 
is needed for kinetochore assembly (Hori et al., 2014). However, H4K20me1 was not 
detectable at neo-centromeres on the plasmids. In contrast, typical modifications for 
pericentromeric chromatin, like di- and tri-methylation of histone H3 on lysine 9 
(H3K9me2/3), tri-methylation of lysine 27 on histone H3 (H3K27me3) and tri-
methylation of lysine 20 on histone H4 (H4K20me3) were detectable on the plasmid 
system within the centromere region. This pull down with subsequent histone 
modification analysis was done only once because of time limitations. However, it 
depicted a histone modification pattern that was different from endogenous 
centromeres. This may have several reasons: 
First, the Cas9 targeting system, I was using has off target effects. A first hint of off-
target binding was already given by immune fluorescence in fixed cells (Figure 26 B), 
where the Cas9 protein is distributed over the whole nucleus when the reporter 
plasmid does not contain targeting sites. It is essential to know if Cas9 is bound to 
any endogenous DNA in this setting before concluding histone modifications 
established on the plasmid with this method. Because H3K9me3 and H4K20me3 are 
abundant histone modifications and pulling down Cas9 proteins that bind to off-
target DNA, enriched in these modifications, leads to detection of these 
modifications in Western Blot. Therefore, the determination of possible off target 
effects of CRISPR/Cas9 by ChIP-seq is essential.  
Second, the digest efficiency represented in Figure 42 is not exactly determined for 
re-solubilized and purified plasmid fragments and whole plasmids, which also 
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establish pericentromeric chromatin marks, were pulled down. Analyzing Cas9:TAP 
precipitations of whole plasmids, reveals also histone modifications that are more 
specific for pericentromeres.  
Third possibility is that the epigenetic modification pattern of artificial centromeres is 
different from that of endogenous human centromeres.  
Since this experiment was done only once, it is not statistically significant.  
However, with the Cas9:STREP:STREP:Flag system, I generated a prerequisite for 
future investigations of artificial centromeres on pCONCENP-A. By tandem affinity 
purification of plasmids harboring inheritable centromeres that recruit minimal 
kinetochores, histone modifications of matured centromeres and the composition of 
minimal kinetochores could be uncovered. In addition, the timing of histone 
modification establishment during centromere maturation could be investigated with 
this method. And finally the structure of a whole kinetochore complex could be 
solved after pCONCENP-A purification by Cas9:TAP.  
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 CONCLUSION 6
 
Human centromeres are specific regions on chromosomes that are responsible for 
kinetochore assembly and correct sister-chromatid segregation during mitosis. Their 
localization is not determined by the underlying DNA sequence. Therefore, the 
inheritance of centromere identity is epigenetically specified. The major hallmark for 
defining centromeres is the centromere specific H3 variant CENP-A. Artificial 
targeting of CENP-A to plasmids leads to the establishment of neo-centromeres. I 
used this approach to functionally investigate centromere maturation on pCONCENP-A 
plasmids by microscopy, cell biological and biochemical methods. 
I demonstrated that artificial targeting of sctetR:CENP-A to tetO plasmids lead to the 
recruitment of inner and outer kinetochore components. The kinetochore at plasmid 
neo-centromeres distributed plasmids to daughter cells. The segregation mechanism 
I observed once by live cell imaging was asymmetrical, but it needs to be clarified 
more precise. 
However, sctetR:CENP-A targeting is sufficient to establish an inheritable 
centromere identity on pCONCENP-A in human cells, because plasmids were stable 
maintained over five months. In addition, the centromere maturation on plasmids is 
a very fast process since only three to four cell cycles were sufficient to generate 
stable plasmid maintenance. Within this timeframe targeting-independent CENP-A 
was incorporated into artificial plasmid centromeres.  
The mechanisms leading to matured and inheritable centromeres were not solved 
during this project. Nevertheless, I developed a CRISPR/Cas9 targeting system to 
purify pCONCENP-A plasmids carrying matured neo-centromeres. This tool serves as 
prerequisite for the analysis of epigenetic marks, like histone modifications, that 
establish during centromere maturation. In addition it facilitates the investigation of 
kinetochore complex composition and may provide an insight into kinetochore 
complex structure. 
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In conclusion, the pCONCENP-A plasmid is a suitable tool for investigating de novo 
centromere formation mechanisms with additional potential application in gene 
therapy. 
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APPENDIX 
 
Establishment of a suitable tetR antibody for ChIP and Co-IP 
 
First, for the functional and biochemical characterization of the artificial centromere 
that is established after initial targeting of CENP-A to the plasmids, it is important to 
show, that the targeting of sctetR:CENP-A itself is functional. An antibody is 
essential to precipitate the sctetR:CENP-A protein and to analyze the co-precipitating 
DNA fragments in a ChIP experiment. The commercial tetR antibodies, which were 
tested for ChIP in our laboratory before this work, are not of sufficient quality for the 
planned experiments. Therefore, I decided to establish new monoclonal tetR 
antibodies in close collaboration with the Monoclonal Antibody Core Facility of the 
Helmholtz Centre Munich.  
Different tetR peptides, tetR1, tetR2 and tetR, were used for the immunization of rats 
and mice. After fusion splenic B-cells of the immunized animals with a 
myeloblastoma cell line, primary supernatants containing immune globulins were 
collected to test the generation of specific antibodies. The core facility already 
determined the immune globulin class and the subtype of candidate antibodies. 
In the further experiments the specificity and the suitability of these antibody 
supernatants to work in ChIP were described.  
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tetR antibody related methods 
tetR antibody validation 
New monoclonal α-tetR antibodies were established in collaboration with the 
Monoclonal Antibody Core Facility of the Helmholtz Centre Munich. I received the 
primary antibody supernatants and determined their specificity in recognizing tetR 
fusion proteins by Western Blot (chapter 3.2.5). Positive clones were then also 
analyzed in their immune precipitation capacity by performing an immune 
precipitation according to the ChIP protocol (chapter 3.2.7) and visualizing 
precipitated tetR proteins by Western Blot. Cells producing primary antibodies with 
high immune precipitation capacity were then used for generation of stable 
hybridoma cells by the core facility. Supernatants of these stable clones were then 
tested again according to their subtype and specificity. In addition immune 
precipitation and ChIP efficiency was determined again.  
 
Covalent coupling of antibodies to protein G sepharose beads 
For co-immune precipitation experiments the tetR antibody was covalently coupled 
to sepharose beads to enhance IP efficiency. Since the tetR antibody used for co-
immune precipitation was the 31B3 mouse-IgG2b α-tetR1, protein G coated 
sepharose beads were utilized.  
In order to couple antibodies to protein G beads, 500 µl beads were washed first 3x 
with 10 ml PBS. For washing beads, these were resuspended in the respective buffer 
and centrifuged at 1000 g for 5 min at 4 °C. After washing, beads were resuspended 
in 10 ml hybridoma supernatant of 31B3 α-tetR antibody and incubated for 1 h at 
room temperature on the roller. Beads were washed 2x in 5 ml Sodium-borate buffer. 
Coupling of antibody to beads was performed by adding 20 mM DMP containing 
Sodium-borate buffer and incubation for 30 min at room temperature on the roller. 
Beads were washed once with 5 ml Ethanolamine buffer and afterwards incubated 
for 2 h in Ethanolamine buffer at room temperature. After washing beads again 2x 
with 5 ml PBS, beads were resuspended in 500 µl PBS+0.02 % Sodium azide and 
stored at 4 ° until use. 
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Screening of primary antibody supernatants 
 
The primary supernatants, which I obtained from the antibody core facility, were 
first tested according to their specificity to recognize a sctetR fusion protein. 
Therefore cell lysates of cells expressing a sctetR:HMGA1a fusion protein were 
analyzed by Western Blot. In general the primary antibodies originating from mouse 
cells were more sensitive in detecting the specific sctetR:HMGA1a signal and had 
lower background signals than those obtained from rats (data not shown). For that 
reason I concentrated on mouse antibodies for further validation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix Figure 1: Western Blot of sctetR:HMGA1a+ cell lysate with different 
tetR antibodies 
The predicted molecular weight of sctetR:HMGA1a is 65 kDa. In a Western Blot the α-
HMGA1 antibody shows a signal between 55 and 70 kDa. All primary antibody 
supernatants depicted here show a specific signal for sctetR:HMGA1a. The difference 
between the tested antibody supernatants is in the background signals appearing at 
higher molecular weights. Blue lines 6, 7, 19, 20 and 22 display no additional unwanted 
signal, these are very specific antibodies. Green lines 9, 10 and 21 also show specific 
recognition, but also weak background. Black lines either have to high background 
recognition or an immune globulin subtype, not optimal for protein A or G purification 
in ChIP and IP. (n=1) 
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In Appendix Figure 1 a Western Blot of different primary mouse antibody 
supernatants is shown. All mouse antibodies recognized the sctetR:HMGA1a fusion 
protein with a molecular weight of 65 kDa. For the generation of these antibodies 
two different peptides, tetR1 and tetR2, were initially used for immunization. The 
lanes in this blot were arranged according to the original peptide and the immune 
globulin subclass of the resulting antibodies. For immune precipitation experiments 
IgG2 subclass antibodies are the most promising, because they show a high affinity 
to protein G that was used for precipitation of the antibody-target protein complex. 
Therefore stable hybridoma cells of antibodies from lanes 6 (26G3),7 (30B11), 20 
(25G7) and 22 (31B3) (Appendix Figure 1; blue marked lanes) were established by the 
antibody core facility. The tetR1 IgG1 antibody (31A7) (Appendix Figure 1; lane 19) 
was also used for generation of stable hybridoma cells because of its high specificity. 
The antibodies marked in green (Appendix Figure 1; lanes 9 (26H4), 10 (28B10) and 
21 (27B6)) were kept as backup antibodies for the case that no stable cells could be 
generated out of the other clones. 
 
Immune precipitation with primary antibody supernatants 
 
For the further validation of the tetR antibodies immune precipitations of cell extract 
generated of cells and cross-linked for 5 min with 1 % formaldehyde were 
performed. The immune precipitates of different primary antibodies was determined 
by Western Blot of the sctetR:HMGA1a fusion protein by comparing the unbound 
and eluted fraction. 
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This Western Blot analysis (Appendix Figure 2) reveals that the different antibodies 
show huge differences in their IP efficiency of their target protein. The tetR1, M-IgG1 
antibody 31A7 did not precipitate at all. The efficiency of 25G7 (tetR1, M-IgG2b) was 
also low compared to the three other antibodies 31B3, 26G3 and 27B6. The strong 
second band appearing for the antibodies 26G3 and 27B6 (Appendix Figure 2; *) 
might be the sctetR degradation product of sctetR:HMGA1a, since sctetR without 
HMGA1a fusion has a molecular weight of 55 kDa. 
According to the specificity shown in Appendix Figure 1 and the IP efficiency 
depicted in Appendix Figure 2 the generation of stable hybridoma cells was 
continued for the clones 31B3 and 26G3 in the antibody core facility.  
 
 
 
Appendix Figure 2: Immune precipitation with different primary antibody 
supernatants 
An immune precipitation (IP) with different primary mouse (M-IgG) tetR antibody 
supernatants was performed according to the ChIP protocol (cross-linked and 
sonicated). 31B3 and 26G3 give a high IP efficiency (low unbound, strong elution), 
31A7 does not work in IP and 25G7 only shows a weaker elution than 31B3, 26G3 and 
27B6. 27B6 is also suitable for IP, but in this IP a high degradation of sctetR:HMGA1a 
was observed. (n=1) 
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ChIP with primary vs. stable generated antibody supernatant 
 
The next step of the tetR antibody validation was to compare the original primary 
antibody supernatant with the supernatant obtained from stable hybridoma clones of 
the antibodies 31B3 and 26G3 in their IP (Appendix Figure 3) and ChIP efficiency. 
 
 
 
 
 
 
 
 
The highest IP efficiency, according to the Western Blot signal, was obtained by the 
26G3 antibody supernatant of hybridoma cells. But also the 31B3 antibody shows an 
efficient and specific binding to the sctetR target proteins. The signals obtained from 
the primary supernatants in this experiment were slightly lower (Appendix Figure 
3).  
The same samples used for the Western Blot, were also analyzed by qPCR to 
determine the ChIP capacity for these two antibodies. 
As qPCR readout of the tetR ChIP different regions on the plasmid were chosen. The 
primer pairs covered the region in close proximity of the tetO repeats (tetO), the DS 
primer is next to DS element and the reference primer pair is several kilobases away 
from DS and tetO (Figure 20 A).  
Appendix Figure 3: Immune precipitation with 31B3 and 26G3 primary 
and stable supernatant  
An IP with the primary and stable (supernatant obtained from hybridoma cell 
clones) tetR antibody supernatants was performed according to the ChIP 
protocol. IP efficiencies are depicted by Western Blot with the rat α-tetR 
antibody 12A7. The highest IP efficiency is observed with the stable 26G3 
antibody. (n=1)  
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Since the readout of the ChIP of the samples was not clear (data not shown) and the 
tetR antibodies need to detect slight differences in binding capacity of the tetR 
proteins to tetO sites, a second analysis was performed. 
HEK293EBNA1+ cells transfected with 0.5 µg or 1 µg the tetO-DS reporter plasmids, 
expressing either sctetR:HMGA1a or sctetR:CENP-A, were incubated with 2 µg/ml 
doxycycline for 24 h. Doxycycline inhibits the binding of sctetR to the tetO sites on 
the reporter plasmids. After ChIP with the tetR antibody it is expected that a 
difference in binding of tetR to tetO is detectable, at least for the sctetR:HMGA1a 
targeting (Pich et al., 2008). 
 
 
 
 
 
 
 
 
 
 
By comparing the sensitivities of the 26G3 and 31B3 antibodies it is striking that only 
the 31B3 antibody detects a difference in binding of sctetR:HMGA1a to tetO (0.5 µg 
and 1 µg plasmid transfected) and with both representations of the qPCR readout 
(relative enrichment and % input) (Appendix Figure 4; black stars). The 26G3 only 
depicts 50 % reduced binding in the relative enrichment representation when 0.5 µg 
plasmid was transfected (Appendix Figure 4; black arrow).  
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Appendix Figure 4: ChIP  with and without doxycycline 
Both graphs represent the same ChIP experiment. The relative enrichment against a mouse 
IgG control IP is shown on the left and the % input values are depicted on the right. Both 
representations demonstrate that 31B3 is more sensitive to doxycycline treatment (black stars). 
The qPCR product is amplified by the tetO primer pair next to tetO sites. (n=1) 
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In conclusion, the 31B3 α-tetR antibody is more sensitive in detecting the targeting 
differences upon doxycycline treatment and shows high specificity in tetR protein 
recognition. Consequently, this antibody was used for further experiments. 
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Targeting independent plasmid maintenance after 4 days 
 
HEK293EBNA1+ cells were transfected with the different reporter plasmids (oriP, 
sctetR:HMGA1a tetO-DS and pCONCENP-A) and incubated for four days. After this 
incubation time (= establishment phase) cells were FACS sorted according to gfp 
expression and performed as already described in 4.6.2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
Appendix Figure 5: Targeting independent plasmid maintenance 4 
days after establishment 
A) Timeline of experimental setup. 4 days after transfection cells are sorted 
according to gfp expression and then splitted into condition with and 
without doxycycline. Plasmid maintenance was analyzed by FACS count 
every 4 to 6 days.  
B) Plasmid maintenance after 4 days establishment time. (n=3) 
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